TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-70171	Glycolysis	1.21492121358342e-10	-22.8311717000378	32	15	0.0237341772151899	632	10285	5230,2597,7167,226,2821,3098,5210,3099,230,5315,5223,5214,2026,5209,2023	PGK1,GAPDH,TPI1,ALDOA,GPI,HK1,PFKFB4,HK2,ALDOC,PKM,PGAM1,PFKP,ENO2,PFKFB3,ENO1
R-HSA-71387	Metabolism of carbohydrates	1.34638655662126e-09	-20.4258414577859	296	47	0.0743670886075949	632	10285	4126,144195,2632,3339,5236,3036,5223,3074,6120,5230,2997,2720,5634,9818,22856,3099,55706,8480,56548,6482,6382,6484,226,5507,5836,230,9469,2023,5214,9060,2026,6513,9951,8702,55276,10402,2821,79369,5315,5210,5209,2597,3098,7167,6515,10855,90161	MANBA,SLC2A14,GBE1,HSPG2,PGM1,HAS1,PGAM1,HEXB,RPE,PGK1,GYS1,GLB1,PRPS2,NUP58,CHSY1,HK2,NDC1,RAE1,CHST7,ST3GAL1,SDC1,ST3GAL4,ALDOA,PPP1R3C,PYGL,ALDOC,CHST3,ENO1,PFKP,PAPSS2,ENO2,SLC2A1,HS3ST4,B4GALT4,PGM2,ST3GAL6,GPI,B3GNT4,PKM,PFKFB4,PFKFB3,GAPDH,HK1,TPI1,SLC2A3,HPSE,HS6ST2
R-HSA-70326	Glucose metabolism	1.08183403040414e-08	-18.3420229667872	81	21	0.0332278481012658	632	10285	2997,3098,226,7167,2821,5507,5836,2597,55276,5230,2023,2632,5209,5214,5236,2026,5223,5315,230,3099,5210	GYS1,HK1,ALDOA,TPI1,GPI,PPP1R3C,PYGL,GAPDH,PGM2,PGK1,ENO1,GBE1,PFKFB3,PFKP,PGM1,ENO2,PGAM1,PKM,ALDOC,HK2,PFKFB4
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	6.49813021258436e-07	-14.2465811750411	48	14	0.0221518987341772	632	10285	8841,5187,8553,10135,6256,10891,8864,1628,25819,6095,1408,79365,4783,9572	HDAC3,PER1,BHLHE40,NAMPT,RXRA,PPARGC1A,PER2,DBP,NOCT,RORA,CRY2,BHLHE41,NFIL3,NR1D1
R-HSA-400253	Circadian Clock	9.33573358315264e-07	-13.8842462928902	71	17	0.0268987341772152	632	10285	9572,4783,1408,79365,6095,25819,6720,10891,1386,8864,1628,6256,5187,8841,10135,8553,5500	NR1D1,NFIL3,CRY2,BHLHE41,RORA,NOCT,SREBF1,PPARGC1A,ATF2,PER2,DBP,RXRA,PER1,HDAC3,NAMPT,BHLHE40,PPP1CB
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	2.03025996110206e-05	-10.8047616204593	27	9	0.0142405063291139	632	10285	9372,56937,5500,4092,4088,7514,23645,9110,23327	ZFYVE9,PMEPA1,PPP1CB,SMAD7,SMAD3,XPO1,PPP1R15A,MTMR4,NEDD4L
R-HSA-70263	Gluconeogenesis	9.207065212718e-05	-9.29295431773989	32	9	0.0142405063291139	632	10285	2023,7167,2821,226,5223,2026,230,2597,5230	ENO1,TPI1,GPI,ALDOA,PGAM1,ENO2,ALDOC,GAPDH,PGK1
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.000154129063397726	-8.77772023252738	34	9	0.0142405063291139	632	10285	56937,9372,5500,4092,4088,7514,23327,9110,23645	PMEPA1,ZFYVE9,PPP1CB,SMAD7,SMAD3,XPO1,NEDD4L,MTMR4,PPP1R15A
R-HSA-3214842	HDMs demethylate histones	0.00107801866374537	-6.83263049333781	52	10	0.0158227848101266	632	10285	23135,84678,10765,8242,23081,5927,23210,55818,80853,23030	KDM6B,KDM2B,KDM5B,KDM5C,KDM4C,KDM5A,JMJD6,KDM3A,KDM7A,KDM4B
R-HSA-1630316	Glycosaminoglycan metabolism	0.00147734015477967	-6.51751200081092	124	17	0.0268987341772152	632	10285	22856,9469,56548,3339,3074,3036,6482,9060,6382,9951,8702,10402,6484,10855,2720,90161,79369	CHSY1,CHST3,CHST7,HSPG2,HEXB,HAS1,ST3GAL1,PAPSS2,SDC1,HS3ST4,B4GALT4,ST3GAL6,ST3GAL4,HPSE,GLB1,HS6ST2,B3GNT4
R-HSA-3322077	Glycogen synthesis	0.00154408048828066	-6.47332669902281	15	5	0.00791139240506329	632	10285	5507,55276,5236,2997,2632	PPP1R3C,PGM2,PGM1,GYS1,GBE1
R-HSA-422475	Axon guidance	0.00187682429650727	-6.27817413443953	549	51	0.0806962025316456	632	10285	6478,2043,2046,1942,8911,817,4478,5909,10125,7525,153090,5526,3560,8828,6330,1742,2042,27289,5365,5621,7414,90249,1299,5924,8829,3690,2549,3815,7422,88,8650,1949,3716,2261,1847,25791,2675,8913,23129,5604,28964,9252,8986,5598,1852,6456,5923,284217,6386,5335,55816	SIAH2,EPHA4,EPHA8,EFNA1,CACNA1I,CAMK2D,MSN,RAP1GAP,RASGRP1,YES1,DAB2IP,PPP2R5B,IL2RB,NRP2,SCN4B,DLG4,EPHA3,RND1,PLXNB3,PRNP,VCL,UNC5A,COL9A3,RASGRF2,NRP1,ITGB3,GAB1,KIT,VEGFA,ACTN2,NUMB,EFNB3,JAK1,FGFR3,DUSP5,NGEF,GFRA2,CACNA1G,PLXND1,MAP2K1,GIT1,RPS6KA5,RPS6KA4,MAPK7,DUSP9,SH3GL2,RASGRF1,LAMA1,SDCBP,PLCG1,DOK5
R-HSA-446353	Cell-extracellular matrix interactions	0.00213352217292432	-6.14998106264388	16	5	0.00791139240506329	632	10285	10979,87,2316,5829,2318	FERMT2,ACTN1,FLNA,PXN,FLNC
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.00242002904897806	-6.02397573517565	77	12	0.0189873417721519	632	10285	4088,23645,3726,9372,4092,57530,23327,9110,7514,56937,5500,50848	SMAD3,PPP1R15A,JUNB,ZFYVE9,SMAD7,CGN,NEDD4L,MTMR4,XPO1,PMEPA1,PPP1CB,F11R
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.00265228528631805	-5.93233363841778	88	13	0.0205696202531646	632	10285	51129,6720,168544,8841,9967,1051,10891,5970,6256,23389,9282,4023,23097	ANGPTL4,SREBF1,ZNF467,HDAC3,THRAP3,CEBPB,PPARGC1A,RELA,RXRA,MED13L,MED14,LPL,CDK19
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.00335923336771571	-5.6960424954108	33	7	0.0110759493670886	632	10285	8702,10402,79369,2720,3074,6482,6484	B4GALT4,ST3GAL6,B3GNT4,GLB1,HEXB,ST3GAL1,ST3GAL4
R-HSA-3928663	EPHA-mediated growth cone collapse	0.00401049294655182	-5.51884111590418	34	7	0.0110759493670886	632	10285	2042,2043,2046,7525,1942,25791,7422	EPHA3,EPHA4,EPHA8,YES1,EFNA1,NGEF,VEGFA
R-HSA-5362517	Signaling by Retinoic Acid	0.00415357391481478	-5.48378613105325	43	8	0.0126582278481013	632	10285	56603,5915,6256,5163,1382,9249,5165,5914	CYP26B1,RARB,RXRA,PDK1,CRABP2,DHRS3,PDK3,RARA
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.00487132593267114	-5.32438911350959	19	5	0.00791139240506329	632	10285	5924,88,1742,817,5923	RASGRF2,ACTN2,DLG4,CAMK2D,RASGRF1
R-HSA-1368082	RORA activates gene expression	0.00618744380723321	-5.08523323278785	28	6	0.00949367088607595	632	10285	6256,6720,9572,6095,10891,8841	RXRA,SREBF1,NR1D1,RORA,PPARGC1A,HDAC3
R-HSA-70153	Glucose transport	0.00635768818028739	-5.05809046137545	46	8	0.0126582278481013	632	10285	3098,6515,3099,55706,8480,144195,6513,9818	HK1,SLC2A3,HK2,NDC1,RAE1,SLC2A14,SLC2A1,NUP58
R-HSA-3247509	Chromatin modifying enzymes	0.00701718708809058	-4.95939284094819	279	28	0.0443037974683544	632	10285	5970,55818,117143,55257,51147,54014,1386,8242,23210,4791,55689,23186,8819,10765,84678,79960,23135,8841,8341,80853,23030,3015,51317,64754,26009,5927,23081,8330	RELA,KDM3A,TADA1,MRGBP,ING4,BRWD1,ATF2,KDM5C,JMJD6,NFKB2,YEATS2,RCOR1,SAP30,KDM5B,KDM2B,JADE1,KDM6B,HDAC3,H2BC15,KDM7A,KDM4B,H2AZ1,PHF21A,SMYD3,ZZZ3,KDM5A,KDM4C,H2AC15
R-HSA-4839726	Chromatin organization	0.00701718708809058	-4.95939284094819	279	28	0.0443037974683544	632	10285	10765,84678,23186,8819,8841,23135,8341,79960,3015,80853,23030,51317,64754,26009,5927,8330,23081,55257,55818,117143,5970,54014,1386,51147,8242,23210,55689,4791	KDM5B,KDM2B,RCOR1,SAP30,HDAC3,KDM6B,H2BC15,JADE1,H2AZ1,KDM7A,KDM4B,PHF21A,SMYD3,ZZZ3,KDM5A,H2AC15,KDM4C,MRGBP,KDM3A,TADA1,RELA,BRWD1,ATF2,ING4,KDM5C,JMJD6,YEATS2,NFKB2
R-HSA-373760	L1CAM interactions	0.0087041063782368	-4.7439603671789	101	13	0.0205696202531646	632	10285	4478,8986,9252,8829,5604,3690,1742,8828,6330,6386,284217,6456,8650	MSN,RPS6KA4,RPS6KA5,NRP1,MAP2K1,ITGB3,DLG4,NRP2,SCN4B,SDCBP,LAMA1,SH3GL2,NUMB
R-HSA-1989781	PPARA activates gene expression	0.00890270216027479	-4.72140043481128	124	15	0.0237341772151899	632	10285	9572,6095,51129,2274,6720,7004,405,10891,23389,6256,19,23097,9282,8841,9967	NR1D1,RORA,ANGPTL4,FHL2,SREBF1,TEAD4,ARNT,PPARGC1A,MED13L,RXRA,ABCA1,CDK19,MED14,HDAC3,THRAP3
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.0108490203937408	-4.52368048936289	3	2	0.00316455696202532	632	10285	8841,9572	HDAC3,NR1D1
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.0108490203937408	-4.52368048936289	3	2	0.00316455696202532	632	10285	890,8900	CCNA2,CCNA1
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.0109994117734141	-4.50991348275778	127	15	0.0237341772151899	632	10285	405,10891,23389,6256,23097,19,9282,8841,9967,9572,6095,51129,2274,6720,7004	ARNT,PPARGC1A,MED13L,RXRA,CDK19,ABCA1,MED14,HDAC3,THRAP3,NR1D1,RORA,ANGPTL4,FHL2,SREBF1,TEAD4
R-HSA-1430728	Metabolism	0.0114637367443986	-4.46856655239765	2158	156	0.246835443037975	632	10285	9572,9818,22856,3099,9871,123099,56548,5165,56261,253430,8877,6382,80347,51004,10891,3615,1159,226,6484,5507,5836,144195,1040,1615,4504,29923,5236,79153,5223,3036,4023,4036,5335,84706,6120,2997,8841,5634,10226,6472,5315,25902,114,1491,5660,7368,23097,2729,23259,9110,5471,2170,5125,3098,5500,230,59338,84725,10449,9469,2023,2026,84803,10797,6513,9951,8702,9967,2821,8904,79369,26227,8480,55706,134429,6122,6482,79001,6256,9663,5333,6520,771,79668,4126,2628,10606,3790,56267,5163,7436,5565,56603,84879,125061,166929,2632,2058,6616,2274,3074,3339,55190,201164,19,6392,25816,9282,5230,405,1371,9123,2720,51141,114757,145482,3162,5210,83401,5209,64210,128,6319,6095,51129,2597,5286,645,23389,51171,55191,59339,56898,7167,10855,6515,3708,90161,3638,7004,6720,9060,5214,205,153642,3706,10402,55276,51205,4501,10295,219970,3155,10135,1633,5331	NR1D1,NUP58,CHSY1,HK2,SEC24D,DEGS2,CHST7,PDK3,GPCPD1,IPMK,SPHK1,SDC1,COASY,COQ6,PPARGC1A,IMPDH2,CKMT1B,ALDOA,ST3GAL4,PPP1R3C,PYGL,SLC2A14,CDS1,DARS1,MT3,HILPDA,PGM1,GDPD3,PGAM1,HAS1,LPL,LRP2,PLCG1,GPT2,RPE,GYS1,HDAC3,PRPS2,PLIN3,SHMT2,PKM,MTHFD1L,ADCY8,CTH,PSAP,UGT8,CDK19,GCLC,DDHD2,MTMR4,PPAT,FABP3,PCSK5,HK1,PPP1CB,ALDOC,PLEKHA1,PLEKHA8,ACAA2,CHST3,ENO1,ENO2,GPAT3,MTHFD2,SLC2A1,HS3ST4,B4GALT4,THRAP3,GPI,CPNE1,B3GNT4,PHGDH,RAE1,NDC1,STARD4,RPL3,ST3GAL1,VKORC1,RXRA,LPIN2,PLCD1,SLC3A2,CA12,PARP8,MANBA,GATM,PAICS,KCNS3,KYAT3,PDK1,VLDLR,PRKAB2,CYP26B1,MFSD2A,AFMID,SGMS2,GBE1,EPRS1,SNAP25,FHL2,HEXB,HSPG2,NUDT11,PLD6,ABCA1,SDHD,TNFAIP8,MED14,PGK1,ARNT,CPOX,SLC16A3,GLB1,INSIG2,CYGB,PTGR2,HMOX1,PFKFB4,ELOVL3,PFKFB3,MMS19,ADH5,SCD,RORA,ANGPTL4,GAPDH,PIK3C2A,BLVRB,MED13L,HSD17B14,NADSYN1,PLEKHA2,BDH2,TPI1,HPSE,SLC2A3,ITPR1,HS6ST2,INSIG1,TEAD4,SREBF1,PAPSS2,PFKP,AK4,ARSK,ITPKA,ST3GAL6,PGM2,ACP6,MT1X,BCKDK,GLYATL2,HMGCL,NAMPT,DCK,PLCB3
R-HSA-112409	RAF-independent MAPK1/3 activation	0.0115017893405661	-4.46525266088472	23	5	0.00791139240506329	632	10285	3716,1852,5604,1847,3572	JAK1,DUSP9,MAP2K1,DUSP5,IL6ST
R-HSA-383280	Nuclear Receptor transcription pathway	0.0118607802973461	-4.43451809522045	51	8	0.0126582278481013	632	10285	5914,6095,9572,9975,3164,6256,2063,5915	RARA,RORA,NR1D1,NR1D2,NR4A1,RXRA,NR2F6,RARB
R-HSA-201451	Signaling by BMP	0.013811361325522	-4.28226374107362	24	5	0.00791139240506329	632	10285	9241,4093,4092,11167,91851	NOG,SMAD9,SMAD7,FSTL1,CHRDL1
R-HSA-392517	Rap1 signalling	0.0142001818832868	-4.25450050577478	16	4	0.00632911392405063	632	10285	10125,5909,6494,23108	RASGRP1,RAP1GAP,SIPA1,RAP1GAP2
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	0.0142001818832868	-4.25450050577478	16	4	0.00632911392405063	632	10285	3815,7039,7422,29028	KIT,TGFA,VEGFA,ATAD2
R-HSA-1266738	Developmental Biology	0.0156510039946934	-4.15722021103814	1075	83	0.131329113924051	632	10285	8829,5924,3690,2549,3815,1495,5600,64344,7422,88,8650,1949,1829,3716,1051,10891,1847,25791,2261,6256,5970,2675,8913,23129,5604,28964,9252,8986,91653,5598,1852,8341,8841,6456,5923,284217,130399,6386,5335,55816,4023,9282,6478,51129,2043,3725,2046,1942,8911,91,817,4478,5437,5909,10125,7525,153090,5526,3560,8828,23389,6330,23097,1742,9935,2042,27289,6720,5365,5621,3516,27086,5915,4088,168544,7414,90249,2309,5914,9967,9063,3015,1299	NRP1,RASGRF2,ITGB3,GAB1,KIT,CTNNA1,MAPK11,HIF3A,VEGFA,ACTN2,NUMB,EFNB3,DSG2,JAK1,CEBPB,PPARGC1A,DUSP5,NGEF,FGFR3,RXRA,RELA,GFRA2,CACNA1G,PLXND1,MAP2K1,GIT1,RPS6KA5,RPS6KA4,BOC,MAPK7,DUSP9,H2BC15,HDAC3,SH3GL2,RASGRF1,LAMA1,ACVR1C,SDCBP,PLCG1,DOK5,LPL,MED14,SIAH2,ANGPTL4,EPHA4,JUN,EPHA8,EFNA1,CACNA1I,ACVR1B,CAMK2D,MSN,POLR2H,RAP1GAP,RASGRP1,YES1,DAB2IP,PPP2R5B,IL2RB,NRP2,MED13L,SCN4B,CDK19,DLG4,MAFB,EPHA3,RND1,SREBF1,PLXNB3,PRNP,RBPJ,FOXP1,RARB,SMAD3,ZNF467,VCL,UNC5A,FOXO3,RARA,THRAP3,PIAS2,H2AZ1,COL9A3
R-HSA-1500931	Cell-Cell communication	0.0163417405554702	-4.11403267408064	133	15	0.0237341772151899	632	10285	84063,10979,50848,1004,87,283,55243,2316,5829,1001,88,1495,5600,2318,57453	KIRREL2,FERMT2,F11R,CDH6,ACTN1,ANG,KIRREL1,FLNA,PXN,CDH3,ACTN2,CTNNA1,MAPK11,FLNC,DSCAML1
R-HSA-189200	Hexose transport	0.0165070548715975	-4.10396742148113	54	8	0.0126582278481013	632	10285	6513,9818,3099,8480,55706,144195,3098,6515	SLC2A1,NUP58,HK2,RAE1,NDC1,SLC2A14,HK1,SLC2A3
R-HSA-2262752	Cellular responses to stress	0.0187588584868663	-3.97608918550345	451	39	0.0617088607594937	632	10285	5600,8480,55706,2878,9818,64344,817,64121,7422,3725,58528,1051,23043,8900,3005,5970,79065,3397,30001,5598,5565,890,9529,84938,56270,54583,8994,23710,405,9531,3015,3310,8341,1031,23135,84733,3006,23523,1032	MAPK11,RAE1,NDC1,GPX3,NUP58,HIF3A,CAMK2D,RRAGC,VEGFA,JUN,RRAGD,CEBPB,TNIK,CCNA1,H1-0,RELA,ATG9A,ID1,ERO1A,MAPK7,PRKAB2,CCNA2,BAG5,ATG4C,WDR45B,EGLN1,LIMD1,GABARAPL1,ARNT,BAG3,H2AZ1,HSPA6,H2BC15,CDKN2C,KDM6B,CBX2,H1-2,CABIN1,CDKN2D
R-HSA-379716	Cytosolic tRNA aminoacylation	0.0193219657904163	-3.94651270638749	26	5	0.00791139240506329	632	10285	1615,16,6897,2617,2058	DARS1,AARS1,TARS1,GARS1,EPRS1
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.0200168866428299	-3.91117902953452	10	3	0.00474683544303797	632	10285	1386,3725,5600	ATF2,JUN,MAPK11
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.0200168866428299	-3.91117902953452	10	3	0.00474683544303797	632	10285	5565,5600,10891	PRKAB2,MAPK11,PPARGC1A
R-HSA-110056	MAPK3 (ERK1) activation	0.0200168866428299	-3.91117902953452	10	3	0.00474683544303797	632	10285	3572,5604,3716	IL6ST,MAP2K1,JAK1
R-HSA-8849474	PTK6 Activates STAT3	0.02081645769218	-3.87201136993545	4	2	0.00316455696202532	632	10285	55620,9021	STAP2,SOCS3
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.02081645769218	-3.87201136993545	4	2	0.00316455696202532	632	10285	8828,8829	NRP2,NRP1
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.0224045845120608	-3.79848967534531	253	24	0.0379746835443038	632	10285	6319,51129,6095,9572,10226,83401,56898,23097,6256,23389,10891,9663,10449,7004,6720,2274,84803,5565,9967,8841,3155,9282,19,405	SCD,ANGPTL4,RORA,NR1D1,PLIN3,ELOVL3,BDH2,CDK19,RXRA,MED13L,PPARGC1A,LPIN2,ACAA2,TEAD4,SREBF1,FHL2,GPAT3,PRKAB2,THRAP3,HDAC3,HMGCL,MED14,ABCA1,ARNT
R-HSA-438064	Post NMDA receptor activation events	0.0239423618589274	-3.73210592628641	37	6	0.00949367088607595	632	10285	5924,5923,114,817,1742,88	RASGRF2,RASGRF1,ADCY8,CAMK2D,DLG4,ACTN2
R-HSA-437239	Recycling pathway of L1	0.0261060695374998	-3.6455874423594	28	5	0.00791139240506329	632	10285	6456,8986,9252,8650,4478	SH3GL2,RPS6KA4,RPS6KA5,NUMB,MSN
R-HSA-2022854	Keratan sulfate biosynthesis	0.0261060695374998	-3.6455874423594	28	5	0.00791139240506329	632	10285	6484,10402,6482,8702,79369	ST3GAL4,ST3GAL6,ST3GAL1,B4GALT4,B3GNT4
R-HSA-1059683	Interleukin-6 signaling	0.0262889993125821	-3.63860470438881	11	3	0.00474683544303797	632	10285	3716,3572,9021	JAK1,IL6ST,SOCS3
R-HSA-194138	Signaling by VEGF	0.0267140298366024	-3.62256638953774	338	30	0.0474683544303797	632	10285	7414,1852,5604,5829,10787,5335,10810,5923,88,7422,817,1495,5600,3815,253260,3690,8829,5924,1742,8877,2675,8828,2261,1847,3560,3716,5526,153090,3708,10125	VCL,DUSP9,MAP2K1,PXN,NCKAP1,PLCG1,WASF3,RASGRF1,ACTN2,VEGFA,CAMK2D,CTNNA1,MAPK11,KIT,RICTOR,ITGB3,NRP1,RASGRF2,DLG4,SPHK1,GFRA2,NRP2,FGFR3,DUSP5,IL2RB,JAK1,PPP2R5B,DAB2IP,ITPR1,RASGRP1
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.0300021154453557	-3.50648738496085	29	5	0.00791139240506329	632	10285	5923,817,1742,88,5924	RASGRF1,CAMK2D,DLG4,ACTN2,RASGRF2
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.0325871875298312	-3.42383608841962	84	10	0.0158227848101266	632	10285	1386,5600,5598,4791,9252,3656,5970,5604,3725,1326	ATF2,MAPK11,MAPK7,NFKB2,RPS6KA5,IRAK2,RELA,MAP2K1,JUN,MAP3K8
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.0325871875298312	-3.42383608841962	84	10	0.0158227848101266	632	10285	1326,3725,5604,9252,4791,5598,5600,1386,5970,3656	MAP3K8,JUN,MAP2K1,RPS6KA5,NFKB2,MAPK7,MAPK11,ATF2,RELA,IRAK2
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.0325871875298312	-3.42383608841962	84	10	0.0158227848101266	632	10285	1326,5604,3725,4791,9252,1386,5598,5600,3656,5970	MAP3K8,MAP2K1,JUN,NFKB2,RPS6KA5,ATF2,MAPK7,MAPK11,IRAK2,RELA
R-HSA-68911	G2 Phase	0.0332919934522818	-3.40243834777373	5	2	0.00316455696202532	632	10285	890,8900	CCNA2,CCNA1
R-HSA-70370	Galactose catabolism	0.0332919934522818	-3.40243834777373	5	2	0.00316455696202532	632	10285	55276,5236	PGM2,PGM1
R-HSA-210990	PECAM1 interactions	0.0334855882616024	-3.39664013386037	12	3	0.00474683544303797	632	10285	3690,7525,5335	ITGB3,YES1,PLCG1
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.0334855882616024	-3.39664013386037	12	3	0.00474683544303797	632	10285	7422,64344,405	VEGFA,HIF3A,ARNT
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.0334855882616024	-3.39664013386037	12	3	0.00474683544303797	632	10285	3615,5471,10606	IMPDH2,PPAT,PAICS
R-HSA-2028269	Signaling by Hippo	0.0366405021729251	-3.3066010336772	21	4	0.00632911392405063	632	10285	1856,60485,9414,26524	DVL2,SAV1,TJP2,LATS2
R-HSA-1181150	Signaling by NODAL	0.0366405021729251	-3.3066010336772	21	4	0.00632911392405063	632	10285	2309,130399,91,4088	FOXO3,ACVR1C,ACVR1B,SMAD3
R-HSA-2024096	HS-GAG degradation	0.0366405021729251	-3.3066010336772	21	4	0.00632911392405063	632	10285	6382,10855,3339,2720	SDC1,HPSE,HSPG2,GLB1
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.037710928384322	-3.27780534896633	41	6	0.00949367088607595	632	10285	114,5924,5923,817,88,1742	ADCY8,RASGRF2,RASGRF1,CAMK2D,ACTN2,DLG4
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.038841801172321	-3.24825826247564	31	5	0.00791139240506329	632	10285	9252,5600,5598,3725,1386	RPS6KA5,MAPK11,MAPK7,JUN,ATF2
R-HSA-6785807	Interleukin-4 and 13 signaling	0.039515545604894	-3.23106112488176	111	12	0.0189873417721519	632	10285	2309,7076,9021,6095,6624,7422,7431,3383,3726,5292,3716,3162	FOXO3,TIMP1,SOCS3,RORA,FSCN1,VEGFA,VIM,ICAM1,JUNB,PIM1,JAK1,HMOX1
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.0400618313233649	-3.21733123527699	99	11	0.0174050632911392	632	10285	3656,5970,1386,5598,5600,4791,9252,7187,5604,3725,1326	IRAK2,RELA,ATF2,MAPK7,MAPK11,NFKB2,RPS6KA5,TRAF3,MAP2K1,JUN,MAP3K8
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.0400618313233649	-3.21733123527699	99	11	0.0174050632911392	632	10285	1386,5970,7187,9252,4791,5600,5598,3656,1326,3725,5604	ATF2,RELA,TRAF3,RPS6KA5,NFKB2,MAPK11,MAPK7,IRAK2,MAP3K8,JUN,MAP2K1
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.0400618313233649	-3.21733123527699	99	11	0.0174050632911392	632	10285	4791,9252,5600,5598,3656,1326,5604,3725,1386,5970,7187	NFKB2,RPS6KA5,MAPK11,MAPK7,IRAK2,MAP3K8,MAP2K1,JUN,ATF2,RELA,TRAF3
R-HSA-450294	MAP kinase activation in TLR cascade	0.0412869186919952	-3.18720956788005	64	8	0.0126582278481013	632	10285	3656,1386,5598,5600,9252,5604,3725,1326	IRAK2,ATF2,MAPK7,MAPK11,RPS6KA5,MAP2K1,JUN,MAP3K8
R-HSA-1502540	Signaling by Activin	0.0415927317038552	-3.17982984563733	13	3	0.00474683544303797	632	10285	4088,91,130399	SMAD3,ACVR1B,ACVR1C
R-HSA-140342	Apoptosis induced DNA fragmentation	0.0415927317038552	-3.17982984563733	13	3	0.00474683544303797	632	10285	3006,3005,3148	H1-2,H1-0,HMGB2
R-HSA-71240	Tryptophan catabolism	0.0415927317038552	-3.17982984563733	13	3	0.00474683544303797	632	10285	6520,56267,125061	SLC3A2,KYAT3,AFMID
R-HSA-211227	Activation of DNA fragmentation factor	0.0415927317038552	-3.17982984563733	13	3	0.00474683544303797	632	10285	3005,3148,3006	H1-0,HMGB2,H1-2
R-HSA-373753	Nephrin interactions	0.0426784527643776	-3.15406110521185	22	4	0.00632911392405063	632	10285	55243,87,84063,88	KIRREL1,ACTN1,KIRREL2,ACTN2
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.0426784527643776	-3.15406110521185	22	4	0.00632911392405063	632	10285	8900,7514,890,4331	CCNA1,XPO1,CCNA2,MNAT1
R-HSA-446728	Cell junction organization	0.0429242538005764	-3.14831825614524	88	10	0.0158227848101266	632	10285	283,2318,1495,50848,10979,1004,2316,5829,1001,87	ANG,FLNC,CTNNA1,F11R,FERMT2,CDH6,FLNA,PXN,CDH3,ACTN1
R-HSA-1592230	Mitochondrial biogenesis	0.0460649025108716	-3.07770395276188	54	7	0.0110759493670886	632	10285	9572,6256,5565,5600,1386,10891,8841	NR1D1,RXRA,PRKAB2,MAPK11,ATF2,PPARGC1A,HDAC3
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.0479307240068853	-3.03799856041904	6	2	0.00316455696202532	632	10285	1855,1856	DVL1,DVL2
R-HSA-189483	Heme degradation	0.0479307240068853	-3.03799856041904	6	2	0.00316455696202532	632	10285	3162,645	HMOX1,BLVRB
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.0479307240068853	-3.03799856041904	6	2	0.00316455696202532	632	10285	4088,9372	SMAD3,ZFYVE9
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.0505872038318677	-2.98405662336872	14	3	0.00474683544303797	632	10285	144195,6513,6515	SLC2A14,SLC2A1,SLC2A3
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.0505872038318677	-2.98405662336872	14	3	0.00474683544303797	632	10285	5163,6256,5165	PDK1,RXRA,PDK3
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.0511370072733741	-2.97324683110183	330	28	0.0443037974683544	632	10285	5604,10787,5829,7414,1852,10810,5923,5335,253260,5924,3690,88,7422,817,3815,1495,5600,153090,3708,10125,8877,1742,2675,1847,2261,3716,5526,3560	MAP2K1,NCKAP1,PXN,VCL,DUSP9,WASF3,RASGRF1,PLCG1,RICTOR,RASGRF2,ITGB3,ACTN2,VEGFA,CAMK2D,KIT,CTNNA1,MAPK11,DAB2IP,ITPR1,RASGRP1,SPHK1,DLG4,GFRA2,DUSP5,FGFR3,JAK1,PPP2R5B,IL2RB
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.0520054969080306	-2.95640585621778	91	10	0.0158227848101266	632	10285	5604,3725,1326,1386,5600,5598,4791,9252,3656,5970	MAP2K1,JUN,MAP3K8,ATF2,MAPK11,MAPK7,NFKB2,RPS6KA5,IRAK2,RELA
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.0524221023007341	-2.94842697695527	387	32	0.0506329113924051	632	10285	5335,6456,2309,23239,5923,9252,1852,5598,7414,5604,3716,5526,3560,2261,1847,3164,2675,1742,10125,3708,153090,114,2549,3815,5600,1399,817,88,6016,5924,3690,253260	PLCG1,SH3GL2,FOXO3,PHLPP1,RASGRF1,RPS6KA5,DUSP9,MAPK7,VCL,MAP2K1,JAK1,PPP2R5B,IL2RB,FGFR3,DUSP5,NR4A1,GFRA2,DLG4,RASGRP1,ITPR1,DAB2IP,ADCY8,GAB1,KIT,MAPK11,CRKL,CAMK2D,ACTN2,RIT1,RASGRF2,ITGB3,RICTOR
R-HSA-194840	Rho GTPase cycle	0.0536714718565924	-2.92487366897356	142	14	0.0221518987341772	632	10285	9743,55288,58504,85360,5924,23526,23433,9411,54509,64411,25791,94134,395,9754	ARHGAP32,RHOT1,ARHGAP22,SYDE1,RASGRF2,ARHGAP45,RHOQ,ARHGAP29,RHOF,ARAP3,NGEF,ARHGAP12,ARHGAP6,STARD8
R-HSA-216083	Integrin cell surface interactions	0.055852056526908	-2.88504893181884	68	8	0.0126582278481013	632	10285	50848,7087,3383,1299,3679,3339,3690,58494	F11R,ICAM5,ICAM1,COL9A3,ITGA7,HSPG2,ITGB3,JAM2
R-HSA-2559583	Cellular Senescence	0.0568217442395826	-2.86783620539293	196	18	0.0284810126582278	632	10285	23523,3397,1032,1031,23135,84733,8341,3006,3015,8900,5970,3005,23043,1051,3725,5598,5600,890	CABIN1,ID1,CDKN2D,CDKN2C,KDM6B,CBX2,H2BC15,H1-2,H2AZ1,CCNA1,RELA,H1-0,TNIK,CEBPB,JUN,MAPK7,MAPK11,CCNA2
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.0587204188454924	-2.83496776177399	93	10	0.0158227848101266	632	10285	5970,3656,9252,4791,5598,5600,1386,1326,3725,5604	RELA,IRAK2,RPS6KA5,NFKB2,MAPK7,MAPK11,ATF2,MAP3K8,JUN,MAP2K1
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.0587204188454924	-2.83496776177399	93	10	0.0158227848101266	632	10285	5600,5598,1386,9252,4791,5970,3656,3725,5604,1326	MAPK11,MAPK7,ATF2,RPS6KA5,NFKB2,RELA,IRAK2,JUN,MAP2K1,MAP3K8
R-HSA-6804757	Regulation of TP53 Degradation	0.0608359555650846	-2.79957429037723	35	5	0.00791139240506329	632	10285	890,11200,900,8900,253260	CCNA2,CHEK2,CCNG1,CCNA1,RICTOR
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.0614487117155767	-2.78955240794858	1	1	0.00158227848101266	632	10285	4248	MGAT3
R-HSA-2033515	t(4;14) translocations of FGFR3	0.0614487117155767	-2.78955240794858	1	1	0.00158227848101266	632	10285	2261	FGFR3
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.0642215902180668	-2.74541582858955	70	8	0.0126582278481013	632	10285	871,64175,5033,8974,5351,5352,9509,1299	SERPINH1,P3H1,P4HA1,P4HA2,PLOD1,PLOD2,ADAMTS2,COL9A3
R-HSA-448706	Interleukin-1 processing	0.0644205511681921	-2.74232257926048	7	2	0.00316455696202532	632	10285	4791,5970	NFKB2,RELA
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	0.0644205511681921	-2.74232257926048	7	2	0.00316455696202532	632	10285	9372,4088	ZFYVE9,SMAD3
R-HSA-5603029	IkBA variant leads to EDA-ID	0.0644205511681921	-2.74232257926048	7	2	0.00316455696202532	632	10285	4791,5970	NFKB2,RELA
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.0644205511681921	-2.74232257926048	7	2	0.00316455696202532	632	10285	51008,54890	ASCC1,ALKBH5
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.0644205511681921	-2.74232257926048	7	2	0.00316455696202532	632	10285	4088,9372	SMAD3,ZFYVE9
R-HSA-447038	NrCAM interactions	0.0644205511681921	-2.74232257926048	7	2	0.00316455696202532	632	10285	8828,1742	NRP2,DLG4
R-HSA-1474244	Extracellular matrix organization	0.0654261147562558	-2.72683379202166	296	25	0.0395569620253165	632	10285	2202,8974,871,5352,6382,2199,5351,3679,3690,7076,30008,50848,284217,87,9510,9509,1299,7087,3339,64175,5033,58494,4015,3383,831	EFEMP1,P4HA2,SERPINH1,PLOD2,SDC1,FBLN2,PLOD1,ITGA7,ITGB3,TIMP1,EFEMP2,F11R,LAMA1,ACTN1,ADAMTS1,ADAMTS2,COL9A3,ICAM5,HSPG2,P3H1,P4HA1,JAM2,LOX,ICAM1,CAST
R-HSA-2682334	EPH-Ephrin signaling	0.0659772871309506	-2.71844473056307	95	10	0.0158227848101266	632	10285	25791,28964,6386,7422,2042,2043,2046,7525,1942,1949	NGEF,GIT1,SDCBP,VEGFA,EPHA3,EPHA4,EPHA8,YES1,EFNA1,EFNB3
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.0659772871309506	-2.71844473056307	95	10	0.0158227848101266	632	10285	5970,3656,9252,4791,5598,5600,1386,1326,3725,5604	RELA,IRAK2,RPS6KA5,NFKB2,MAPK7,MAPK11,ATF2,MAP3K8,JUN,MAP2K1
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.0659772871309506	-2.71844473056307	95	10	0.0158227848101266	632	10285	3725,5604,1326,5598,5600,1386,9252,4791,5970,3656	JUN,MAP2K1,MAP3K8,MAPK7,MAPK11,ATF2,RPS6KA5,NFKB2,RELA,IRAK2
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.0659772871309506	-2.71844473056307	95	10	0.0158227848101266	632	10285	5604,3725,1326,1386,5598,5600,4791,9252,3656,5970	MAP2K1,JUN,MAP3K8,ATF2,MAPK7,MAPK11,NFKB2,RPS6KA5,IRAK2,RELA
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.0659772871309506	-2.71844473056307	95	10	0.0158227848101266	632	10285	4791,9252,1386,5600,5598,3656,5970,1326,5604,3725	NFKB2,RPS6KA5,ATF2,MAPK11,MAPK7,IRAK2,RELA,MAP3K8,MAP2K1,JUN
R-HSA-1483249	Inositol phosphate metabolism	0.0663511796757339	-2.71279373877292	47	6	0.00949367088607595	632	10285	5333,5335,253430,3706,5331,55190	PLCD1,PLCG1,IPMK,ITPKA,PLCB3,NUDT11
R-HSA-6806003	Regulation of TP53 Expression and Degradation	0.0672416185397283	-2.69946289964683	36	5	0.00791139240506329	632	10285	253260,8900,900,890,11200	RICTOR,CCNA1,CCNG1,CCNA2,CHEK2
R-HSA-8853659	RET signaling	0.0695006876395702	-2.6664186323658	270	23	0.0363924050632911	632	10285	5335,55816,5923,7414,5598,1852,5604,2675,1742,3560,3716,5526,2261,1847,153090,5909,10125,817,88,2549,3815,3690,5924	PLCG1,DOK5,RASGRF1,VCL,MAPK7,DUSP9,MAP2K1,GFRA2,DLG4,IL2RB,JAK1,PPP2R5B,FGFR3,DUSP5,DAB2IP,RAP1GAP,RASGRP1,CAMK2D,ACTN2,GAB1,KIT,ITGB3,RASGRF2
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.071108420243919	-2.64354952100049	16	3	0.00474683544303797	632	10285	3006,3005,23523	H1-2,H1-0,CABIN1
R-HSA-1433559	Regulation of KIT signaling	0.071108420243919	-2.64354952100049	16	3	0.00474683544303797	632	10285	3815,10603,7525	KIT,SH2B2,YES1
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.0720415667191682	-2.63051201100459	26	4	0.00632911392405063	632	10285	6484,8702,4248,4122	ST3GAL4,B4GALT4,MGAT3,MAN2A2
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.0720883194415362	-2.62986325278721	48	6	0.00949367088607595	632	10285	2043,2042,1949,1942,2046,7525	EPHA4,EPHA3,EFNB3,EFNA1,EPHA8,YES1
R-HSA-6794362	Protein-protein interactions at synapses	0.0733304291491586	-2.61277962459356	72	8	0.0126582278481013	632	10285	9456,22871,57497,5792,2037,8825,1742,143425	HOMER1,NLGN1,LRFN2,PTPRF,EPB41L2,LIN7A,DLG4,SYT9
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.0737843920872827	-2.60660805907494	97	10	0.0158227848101266	632	10285	3656,5970,1386,5598,5600,4791,9252,5604,3725,1326	IRAK2,RELA,ATF2,MAPK7,MAPK11,NFKB2,RPS6KA5,MAP2K1,JUN,MAP3K8
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.0739578542178059	-2.60425988562333	258	22	0.0348101265822785	632	10285	153090,10125,3708,2675,8877,1742,3716,5526,3560,2261,1847,5924,3690,7422,817,88,3815,5923,5335,5604,7414,1852	DAB2IP,RASGRP1,ITPR1,GFRA2,SPHK1,DLG4,JAK1,PPP2R5B,IL2RB,FGFR3,DUSP5,RASGRF2,ITGB3,VEGFA,CAMK2D,ACTN2,KIT,RASGRF1,PLCG1,MAP2K1,VCL,DUSP9
R-HSA-419037	NCAM1 interactions	0.0740071273945489	-2.60359387427352	37	5	0.00791139240506329	632	10285	8913,1299,8911,5621,2675	CACNA1G,COL9A3,CACNA1I,PRNP,GFRA2
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	0.0740071273945489	-2.60359387427352	37	5	0.00791139240506329	632	10285	7058,9509,54437,80070,9510	THBS2,ADAMTS2,SEMA5B,ADAMTS20,ADAMTS1
R-HSA-6783589	Interleukin-6 family signaling	0.080648939698002	-2.5176496214533	27	4	0.00632911392405063	632	10285	9021,3572,3977,3716	SOCS3,IL6ST,LIFR,JAK1
R-HSA-5632681	Ligand-receptor interactions	0.0824794628698511	-2.49520595154184	8	2	0.00316455696202532	632	10285	6469,91653	SHH,BOC
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.0824794628698511	-2.49520595154184	8	2	0.00316455696202532	632	10285	4088,9372	SMAD3,ZFYVE9
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.0824794628698511	-2.49520595154184	8	2	0.00316455696202532	632	10285	4791,5970	NFKB2,RELA
R-HSA-77111	Synthesis of Ketone Bodies	0.0824794628698511	-2.49520595154184	8	2	0.00316455696202532	632	10285	56898,3155	BDH2,HMGCL
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.0824794628698511	-2.49520595154184	8	2	0.00316455696202532	632	10285	7514,8125	XPO1,ANP32A
R-HSA-73942	DNA Damage Reversal	0.0824794628698511	-2.49520595154184	8	2	0.00316455696202532	632	10285	51008,54890	ASCC1,ALKBH5
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.0824794628698511	-2.49520595154184	8	2	0.00316455696202532	632	10285	9372,4088	ZFYVE9,SMAD3
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.0824794628698511	-2.49520595154184	8	2	0.00316455696202532	632	10285	5829,87	PXN,ACTN1
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.0824794628698511	-2.49520595154184	8	2	0.00316455696202532	632	10285	6675,9945	UAP1,GFPT2
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.0824794628698511	-2.49520595154184	8	2	0.00316455696202532	632	10285	6515,6513	SLC2A3,SLC2A1
R-HSA-189445	Metabolism of porphyrins	0.0825560939186065	-2.49427729040052	17	3	0.00474683544303797	632	10285	645,1371,3162	BLVRB,CPOX,HMOX1
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.0825560939186065	-2.49427729040052	17	3	0.00474683544303797	632	10285	88,1742,817	ACTN2,DLG4,CAMK2D
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.0825560939186065	-2.49427729040052	17	3	0.00474683544303797	632	10285	5236,5836,55276	PGM1,PYGL,PGM2
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.0825560939186065	-2.49427729040052	17	3	0.00474683544303797	632	10285	817,88,1742	CAMK2D,ACTN2,DLG4
R-HSA-375165	NCAM signaling for neurite out-growth	0.0838637258992893	-2.47856210823259	276	23	0.0363924050632911	632	10285	8911,3690,5924,88,817,3815,153090,10125,1742,2675,1847,2261,3560,3716,5526,5621,5604,8913,7414,1852,9252,5923,1299	CACNA1I,ITGB3,RASGRF2,ACTN2,CAMK2D,KIT,DAB2IP,RASGRP1,DLG4,GFRA2,DUSP5,FGFR3,IL2RB,JAK1,PPP2R5B,PRNP,MAP2K1,CACNA1G,VCL,DUSP9,RPS6KA5,RASGRF1,COL9A3
R-HSA-187687	Signalling to ERKs	0.0866532237568672	-2.44584105916328	263	22	0.0348101265822785	632	10285	1742,2675,1847,2261,3716,5526,3560,153090,10125,88,1399,817,3815,5600,5924,3690,6016,5335,5923,7414,1852,5604	DLG4,GFRA2,DUSP5,FGFR3,JAK1,PPP2R5B,IL2RB,DAB2IP,RASGRP1,ACTN2,CRKL,CAMK2D,KIT,MAPK11,RASGRF2,ITGB3,RIT1,PLCG1,RASGRF1,VCL,DUSP9,MAP2K1
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.0886008591732333	-2.4236137242033	39	5	0.00791139240506329	632	10285	80070,9510,54437,7058,9509	ADAMTS20,ADAMTS1,SEMA5B,THBS2,ADAMTS2
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.0897394180591675	-2.41084516319828	28	4	0.00632911392405063	632	10285	5333,5335,3706,5331	PLCD1,PLCG1,ITPKA,PLCB3
R-HSA-70268	Pyruvate metabolism	0.0897394180591675	-2.41084516319828	28	4	0.00632911392405063	632	10285	6256,9123,5163,5165	RXRA,SLC16A3,PDK1,PDK3
R-HSA-177929	Signaling by EGFR	0.0899148465700434	-2.40889220575532	364	29	0.0458860759493671	632	10285	10252,1852,7414,5829,5604,5335,6456,23239,5923,2309,114,2549,3815,817,88,3690,5924,253260,3560,3716,5526,1847,2261,2675,3164,1742,10125,3708,153090	SPRY1,DUSP9,VCL,PXN,MAP2K1,PLCG1,SH3GL2,PHLPP1,RASGRF1,FOXO3,ADCY8,GAB1,KIT,CAMK2D,ACTN2,ITGB3,RASGRF2,RICTOR,IL2RB,JAK1,PPP2R5B,DUSP5,FGFR3,GFRA2,NR4A1,DLG4,RASGRP1,ITPR1,DAB2IP
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.0904355166152933	-2.40311820582975	63	7	0.0110759493670886	632	10285	6482,2720,4351,6484,10402,6675,9945	ST3GAL1,GLB1,MPI,ST3GAL4,ST3GAL6,UAP1,GFPT2
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.0909449766374413	-2.39750060767704	51	6	0.00949367088607595	632	10285	3339,3074,9469,56548,22856,6382	HSPG2,HEXB,CHST3,CHST7,CHSY1,SDC1
R-HSA-196757	Metabolism of folate and pterines	0.094735357335623	-2.35666798695556	18	3	0.00474683544303797	632	10285	25902,10797,6472	MTHFD1L,MTHFD2,SHMT2
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.094735357335623	-2.35666798695556	18	3	0.00474683544303797	632	10285	6484,4853,10402	ST3GAL4,NOTCH2,ST3GAL6
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.094735357335623	-2.35666798695556	18	3	0.00474683544303797	632	10285	11340,7538,54464	EXOSC8,ZFP36,XRN1
R-HSA-166054	Activated TLR4 signalling	0.0953006261568536	-2.35071889796735	115	11	0.0174050632911392	632	10285	3725,5604,1326,5598,5600,9252,4791,3656,7187,1386,5970	JUN,MAP2K1,MAP3K8,MAPK7,MAPK11,RPS6KA5,NFKB2,IRAK2,TRAF3,ATF2,RELA
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	0.096417578178412	-2.33906674773961	40	5	0.00791139240506329	632	10285	3815,7039,10765,7422,29028	KIT,TGFA,KDM5B,VEGFA,ATAD2
R-HSA-556833	Metabolism of lipids and lipoproteins	0.0987788195277642	-2.31487207445975	813	59	0.0933544303797468	632	10285	6095,51129,7368,5660,6319,145482,10226,83401,5500,56898,59339,51171,9110,23389,5286,23259,23097,5125,2170,6720,10449,7004,84803,84725,3638,59338,8904,9967,3155,153642,51205,56261,123099,9871,9572,134429,6256,51004,8877,9663,10891,29923,166929,201164,79153,3074,2274,7436,5565,84879,1040,51141,2720,8841,25816,9282,19,4023,405	RORA,ANGPTL4,UGT8,PSAP,SCD,PTGR2,PLIN3,ELOVL3,PPP1CB,BDH2,PLEKHA2,HSD17B14,MTMR4,MED13L,PIK3C2A,DDHD2,CDK19,PCSK5,FABP3,SREBF1,ACAA2,TEAD4,GPAT3,PLEKHA8,INSIG1,PLEKHA1,CPNE1,THRAP3,HMGCL,ARSK,ACP6,GPCPD1,DEGS2,SEC24D,NR1D1,STARD4,RXRA,COQ6,SPHK1,LPIN2,PPARGC1A,HILPDA,SGMS2,PLD6,GDPD3,HEXB,FHL2,VLDLR,PRKAB2,MFSD2A,CDS1,INSIG2,GLB1,HDAC3,TNFAIP8,MED14,ABCA1,LPL,ARNT
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.0992973864774662	-2.30963602773894	29	4	0.00632911392405063	632	10285	6256,860,204851,7004	RXRA,RUNX2,HIPK1,TEAD4
R-HSA-74182	Ketone body metabolism	0.101853023382049	-2.28422445209552	9	2	0.00316455696202532	632	10285	3155,56898	HMGCL,BDH2
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.101853023382049	-2.28422445209552	9	2	0.00316455696202532	632	10285	27113,90427	BBC3,BMF
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	0.101853023382049	-2.28422445209552	9	2	0.00316455696202532	632	10285	55276,6120	PGM2,RPE
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.101853023382049	-2.28422445209552	9	2	0.00316455696202532	632	10285	2309,3164	FOXO3,NR4A1
R-HSA-112411	MAPK1 (ERK2) activation	0.101853023382049	-2.28422445209552	9	2	0.00316455696202532	632	10285	3716,3572	JAK1,IL6ST
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.101853023382049	-2.28422445209552	9	2	0.00316455696202532	632	10285	4088,9372	SMAD3,ZFYVE9
R-HSA-75153	Apoptotic execution  phase	0.104860571396352	-2.25512370271707	53	6	0.00949367088607595	632	10285	9414,3005,7431,3148,3006,1829	TJP2,H1-0,VIM,HMGB2,H1-2,DSG2
R-HSA-2428928	IRS-related events triggered by IGF1R	0.105007833362154	-2.25372032815823	298	24	0.0379746835443038	632	10285	58528,5924,3690,64121,817,88,2549,3815,153090,10125,2675,1975,1742,3716,5526,3560,1847,2261,5604,7414,1852,5565,5923,8471	RRAGD,RASGRF2,ITGB3,RRAGC,CAMK2D,ACTN2,GAB1,KIT,DAB2IP,RASGRP1,GFRA2,EIF4B,DLG4,JAK1,PPP2R5B,IL2RB,DUSP5,FGFR3,MAP2K1,VCL,DUSP9,PRKAB2,RASGRF1,IRS4
R-HSA-2428924	IGF1R signaling cascade	0.105007833362154	-2.25372032815823	298	24	0.0379746835443038	632	10285	3815,2549,88,817,64121,5924,3690,58528,1847,2261,5526,3716,3560,1975,1742,2675,10125,153090,1852,5565,7414,5604,8471,5923	KIT,GAB1,ACTN2,CAMK2D,RRAGC,RASGRF2,ITGB3,RRAGD,DUSP5,FGFR3,PPP2R5B,JAK1,IL2RB,EIF4B,DLG4,GFRA2,RASGRP1,DAB2IP,DUSP9,PRKAB2,VCL,MAP2K1,IRS4,RASGRF1
R-HSA-3928664	Ephrin signaling	0.107597606130276	-2.22935687936183	19	3	0.00474683544303797	632	10285	1949,6386,28964	EFNB3,SDCBP,GIT1
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.107909728950967	-2.22646024441609	299	24	0.0379746835443038	632	10285	5923,8471,5604,1852,5565,7414,10125,153090,3560,3716,5526,2261,1847,2675,1742,1975,58528,3690,5924,2549,3815,817,64121,88	RASGRF1,IRS4,MAP2K1,DUSP9,PRKAB2,VCL,RASGRP1,DAB2IP,IL2RB,JAK1,PPP2R5B,FGFR3,DUSP5,GFRA2,DLG4,EIF4B,RRAGD,ITGB3,RASGRF2,GAB1,KIT,CAMK2D,RRAGC,ACTN2
R-HSA-114608	Platelet degranulation	0.111779104642574	-2.19123063516932	132	12	0.0189873417721519	632	10285	88,7277,7422,7414,3690,2316,5660,226,7076,308,374354,87	ACTN2,TUBA4A,VEGFA,VCL,ITGB3,FLNA,PSAP,ALDOA,TIMP1,ANXA5,NHLRC2,ACTN1
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.112210030004322	-2.18738289591103	54	6	0.00949367088607595	632	10285	9951,6382,3339,90161,2720,10855	HS3ST4,SDC1,HSPG2,HS6ST2,GLB1,HPSE
R-HSA-1566948	Elastic fibre formation	0.113053449681714	-2.17989456606902	42	5	0.00791139240506329	632	10285	3690,4015,2199,2202,30008	ITGB3,LOX,FBLN2,EFEMP1,EFEMP2
R-HSA-166520	Signalling by NGF	0.11535419060383	-2.15974796555691	477	36	0.0569620253164557	632	10285	5335,6456,8841,2309,23239,5923,1852,5598,9252,7414,5604,2261,1847,25791,3716,5526,5125,3560,1742,3164,5970,2675,3708,10125,153090,3815,5600,2549,114,88,1399,817,5924,3690,6016,253260	PLCG1,SH3GL2,HDAC3,FOXO3,PHLPP1,RASGRF1,DUSP9,MAPK7,RPS6KA5,VCL,MAP2K1,FGFR3,DUSP5,NGEF,JAK1,PPP2R5B,PCSK5,IL2RB,DLG4,NR4A1,RELA,GFRA2,ITPR1,RASGRP1,DAB2IP,KIT,MAPK11,GAB1,ADCY8,ACTN2,CRKL,CAMK2D,RASGRF2,ITGB3,RIT1,RICTOR
R-HSA-1632852	Macroautophagy	0.115870936413759	-2.15527832441646	67	7	0.0110759493670886	632	10285	79065,56270,58528,64121,5565,23710,84938	ATG9A,WDR45B,RRAGD,RRAGC,PRKAB2,GABARAPL1,ATG4C
R-HSA-1474290	Collagen formation	0.116962147154926	-2.14590492512142	93	9	0.0142405063291139	632	10285	5033,4015,64175,871,8974,5351,1299,9509,5352	P4HA1,LOX,P3H1,SERPINH1,P4HA2,PLOD1,COL9A3,ADAMTS2,PLOD2
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.119127087270542	-2.12756439547782	2	1	0.00158227848101266	632	10285	2997	GYS1
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.119127087270542	-2.12756439547782	2	1	0.00158227848101266	632	10285	2997	GYS1
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.119127087270542	-2.12756439547782	2	1	0.00158227848101266	632	10285	51305	KCNK9
R-HSA-198765	Signalling to ERK5	0.119127087270542	-2.12756439547782	2	1	0.00158227848101266	632	10285	5598	MAPK7
R-HSA-1614603	Cysteine formation from homocysteine	0.119127087270542	-2.12756439547782	2	1	0.00158227848101266	632	10285	1491	CTH
R-HSA-1483152	Hydrolysis of LPE	0.119127087270542	-2.12756439547782	2	1	0.00158227848101266	632	10285	56261	GPCPD1
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.119744462978875	-2.12239528193236	31	4	0.00632911392405063	632	10285	8480,55706,9818,7514	RAE1,NDC1,NUP58,XPO1
R-HSA-8875878	MET promotes cell motility	0.119744462978875	-2.12239528193236	31	4	0.00632911392405063	632	10285	64759,2549,284217,1399	TNS3,GAB1,LAMA1,CRKL
R-HSA-73772	RNA Polymerase I Promoter Escape	0.119744462978875	-2.12239528193236	31	4	0.00632911392405063	632	10285	79101,51082,5437,4331	TAF1D,POLR1D,POLR2H,MNAT1
R-HSA-418990	Adherens junctions interactions	0.119744462978875	-2.12239528193236	31	4	0.00632911392405063	632	10285	1001,1004,1495,283	CDH3,CDH6,CTNNA1,ANG
R-HSA-2129379	Molecules associated with elastic fibres	0.119744462978875	-2.12239528193236	31	4	0.00632911392405063	632	10285	2202,30008,3690,2199	EFEMP1,EFEMP2,ITGB3,FBLN2
R-HSA-2022928	HS-GAG biosynthesis	0.119744462978875	-2.12239528193236	31	4	0.00632911392405063	632	10285	9951,90161,3339,6382	HS3ST4,HS6ST2,HSPG2,SDC1
R-HSA-352230	Amino acid transport across the plasma membrane	0.119744462978875	-2.12239528193236	31	4	0.00632911392405063	632	10285	6520,6533,6519,10991	SLC3A2,SLC6A6,SLC3A1,SLC38A3
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.119813858501343	-2.12181591967953	55	6	0.00949367088607595	632	10285	6319,51141,3638,9871,6720,6256	SCD,INSIG2,INSIG1,SEC24D,SREBF1,RXRA
R-HSA-186797	Signaling by PDGF	0.120754351814552	-2.11399694722681	376	29	0.0458860759493671	632	10285	5604,7414,1852,2309,5923,23239,5335,1299,253260,7058,5924,3690,1399,817,88,2549,114,3815,153090,10125,3708,3164,2675,1742,3716,5526,3560,1847,2261	MAP2K1,VCL,DUSP9,FOXO3,RASGRF1,PHLPP1,PLCG1,COL9A3,RICTOR,THBS2,RASGRF2,ITGB3,CRKL,CAMK2D,ACTN2,GAB1,ADCY8,KIT,DAB2IP,RASGRP1,ITPR1,NR4A1,GFRA2,DLG4,JAK1,PPP2R5B,IL2RB,DUSP5,FGFR3
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	0.121092273514305	-2.11120243298287	20	3	0.00474683544303797	632	10285	3716,3572,3977	JAK1,IL6ST,LIFR
R-HSA-3000170	Syndecan interactions	0.121092273514305	-2.11120243298287	20	3	0.00474683544303797	632	10285	3690,87,6382	ITGB3,ACTN1,SDC1
R-HSA-419812	Calcitonin-like ligand receptors	0.122312057568769	-2.10117965105246	10	2	0.00316455696202532	632	10285	133,797	ADM,CALCB
R-HSA-201688	WNT mediated activation of DVL	0.122312057568769	-2.10117965105246	10	2	0.00316455696202532	632	10285	1856,1855	DVL2,DVL1
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	0.122312057568769	-2.10117965105246	10	2	0.00316455696202532	632	10285	2549,2261	GAB1,FGFR3
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.122312057568769	-2.10117965105246	10	2	0.00316455696202532	632	10285	5507,2997	PPP1R3C,GYS1
R-HSA-3229121	Glycogen storage diseases	0.122312057568769	-2.10117965105246	10	2	0.00316455696202532	632	10285	2997,5507	GYS1,PPP1R3C
R-HSA-8875656	MET receptor recycling	0.122312057568769	-2.10117965105246	10	2	0.00316455696202532	632	10285	2549,1399	GAB1,CRKL
R-HSA-5663084	Diseases of carbohydrate metabolism	0.122312057568769	-2.10117965105246	10	2	0.00316455696202532	632	10285	5507,2997	PPP1R3C,GYS1
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.122312057568769	-2.10117965105246	10	2	0.00316455696202532	632	10285	5286,9110	PIK3C2A,MTMR4
R-HSA-449147	Signaling by Interleukins	0.12364117089608	-2.0903716915586	525	39	0.0617088607594937	632	10285	9021,5924,3690,6095,3572,88,7431,1399,817,7422,3815,3162,4791,7525,153090,132014,10125,3977,1742,5970,2675,2261,1847,54014,5526,3716,5292,3560,5604,6624,1326,3726,3656,3383,7414,1852,2309,7076,5923	SOCS3,RASGRF2,ITGB3,RORA,IL6ST,ACTN2,VIM,CRKL,CAMK2D,VEGFA,KIT,HMOX1,NFKB2,YES1,DAB2IP,IL17RE,RASGRP1,LIFR,DLG4,RELA,GFRA2,FGFR3,DUSP5,BRWD1,PPP2R5B,JAK1,PIM1,IL2RB,MAP2K1,FSCN1,MAP3K8,JUNB,IRAK2,ICAM1,VCL,DUSP9,FOXO3,TIMP1,RASGRF1
R-HSA-5683057	MAPK family signaling cascades	0.124661055823348	-2.08215677801314	290	23	0.0363924050632911	632	10285	3716,5526,3560,1847,2261,2675,7514,1742,10125,2309,5923,153090,3815,1852,817,7414,3572,88,5924,5604,3725,3690,989	JAK1,PPP2R5B,IL2RB,DUSP5,FGFR3,GFRA2,XPO1,DLG4,RASGRP1,FOXO3,RASGRF1,DAB2IP,KIT,DUSP9,CAMK2D,VCL,IL6ST,ACTN2,RASGRF2,MAP2K1,JUN,ITGB3,SEPTIN7
R-HSA-977443	GABA receptor activation	0.127666242249234	-2.05833590289366	56	6	0.00949367088607595	632	10285	114,2555,2773,3762,2561,3761	ADCY8,GABRA2,GNAI3,KCNJ5,GABRB2,KCNJ4
R-HSA-73863	RNA Polymerase I Transcription Termination	0.130594152610291	-2.03566083641712	32	4	0.00632911392405063	632	10285	79101,4331,5437,51082	TAF1D,MNAT1,POLR2H,POLR1D
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.130594152610291	-2.03566083641712	32	4	0.00632911392405063	632	10285	8480,55706,7514,9818	RAE1,NDC1,XPO1,NUP58
R-HSA-445144	Signal transduction by L1	0.135167568740897	-2.00124002032497	21	3	0.00474683544303797	632	10285	5604,8829,3690	MAP2K1,NRP1,ITGB3
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.135167568740897	-2.00124002032497	21	3	0.00474683544303797	632	10285	22856,56548,9469	CHSY1,CHST7,CHST3
R-HSA-8849932	SALM protein interactions at the synapses	0.135167568740897	-2.00124002032497	21	3	0.00474683544303797	632	10285	57497,1742,5792	LRFN2,DLG4,PTPRF
R-HSA-1433557	Signaling by SCF-KIT	0.135582664886887	-1.99817375171528	337	26	0.0411392405063291	632	10285	5924,3690,253260,2549,3815,817,88,10125,7525,153090,3716,5526,3560,2261,1847,3164,2675,1742,10076,5604,1852,7414,2309,23239,5923,10603	RASGRF2,ITGB3,RICTOR,GAB1,KIT,CAMK2D,ACTN2,RASGRP1,YES1,DAB2IP,JAK1,PPP2R5B,IL2RB,FGFR3,DUSP5,NR4A1,GFRA2,DLG4,PTPRU,MAP2K1,DUSP9,VCL,FOXO3,PHLPP1,RASGRF1,SH2B2
R-HSA-170968	Frs2-mediated activation	0.136075788549652	-1.99454327971521	250	20	0.0316455696202532	632	10285	5923,153090,10125,1742,2675,5335,1847,2261,3560,3716,5526,3690,5604,5924,88,817,7414,1399,1852,3815	RASGRF1,DAB2IP,RASGRP1,DLG4,GFRA2,PLCG1,DUSP5,FGFR3,IL2RB,JAK1,PPP2R5B,ITGB3,MAP2K1,RASGRF2,ACTN2,CAMK2D,VCL,CRKL,DUSP9,KIT
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.136115506936018	-1.99425143800457	137	12	0.0189873417721519	632	10285	2316,5660,3690,7422,7414,88,7277,87,308,374354,7076,226	FLNA,PSAP,ITGB3,VEGFA,VCL,ACTN2,TUBA4A,ACTN1,ANXA5,NHLRC2,TIMP1,ALDOA
R-HSA-186763	Downstream signal transduction	0.13665735714388	-1.99027852873148	352	27	0.0427215189873418	632	10285	2675,3164,1742,3560,5526,3716,2261,1847,153090,10125,3708,817,1399,88,2549,114,3815,253260,3690,5924,5335,5923,23239,2309,7414,1852,5604	GFRA2,NR4A1,DLG4,IL2RB,PPP2R5B,JAK1,FGFR3,DUSP5,DAB2IP,RASGRP1,ITPR1,CAMK2D,CRKL,ACTN2,GAB1,ADCY8,KIT,RICTOR,ITGB3,RASGRF2,PLCG1,RASGRF1,PHLPP1,FOXO3,VCL,DUSP9,MAP2K1
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.138032325216761	-1.98026738055383	110	10	0.0158227848101266	632	10285	1032,8341,3725,1031,3015,8900,5970,5598,890,1051	CDKN2D,H2BC15,JUN,CDKN2C,H2AZ1,CCNA1,RELA,MAPK7,CCNA2,CEBPB
R-HSA-112399	IRS-mediated signalling	0.138212920342591	-1.97895988184057	294	23	0.0363924050632911	632	10285	7414,5565,1852,5604,5923,88,817,64121,3815,2549,5924,3690,58528,1975,1742,2675,2261,1847,3716,5526,3560,153090,10125	VCL,PRKAB2,DUSP9,MAP2K1,RASGRF1,ACTN2,CAMK2D,RRAGC,KIT,GAB1,RASGRF2,ITGB3,RRAGD,EIF4B,DLG4,GFRA2,FGFR3,DUSP5,JAK1,PPP2R5B,IL2RB,DAB2IP,RASGRP1
R-HSA-212436	Generic Transcription Pathway	0.13910951608704	-1.97249377055203	865	61	0.0965189873417722	632	10285	2063,9282,7039,10765,890,147837,84874,5565,4331,7571,5876,4853,158399,84449,1386,54989,23327,860,6256,7832,8793,3815,5600,7767,388566,64121,7422,9572,58528,204851,253260,7700,90338,27244,79744,7762,5914,2821,3516,5915,4088,84626,3726,9975,7559,11200,7004,3622,3164,900,8900,29028,5437,665,54541,27113,85456,10397,6095,3725,4092	NR2F6,MED14,TGFA,KDM5B,CCNA2,ZNF563,ZNF514,PRKAB2,MNAT1,ZNF23,RABGGTB,NOTCH2,ZNF483,ZNF333,ATF2,ZNF770,NEDD4L,RUNX2,RXRA,BTG2,TNFRSF10D,KIT,MAPK11,ZNF224,ZNF470,RRAGC,VEGFA,NR1D1,RRAGD,HIPK1,RICTOR,ZNF141,ZNF160,SESN1,ZNF419,ZNF215,RARA,GPI,RBPJ,RARB,SMAD3,KRBA1,JUNB,NR1D2,ZNF12,CHEK2,TEAD4,ING2,NR4A1,CCNG1,CCNA1,ATAD2,POLR2H,BNIP3L,DDIT4,BBC3,TNKS1BP1,NDRG1,RORA,JUN,SMAD7
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	0.140371651103997	-1.96346172299174	45	5	0.00791139240506329	632	10285	665,5876,10397,8793,27113	BNIP3L,RABGGTB,NDRG1,TNFRSF10D,BBC3
R-HSA-379724	tRNA Aminoacylation	0.140371651103997	-1.96346172299174	45	5	0.00791139240506329	632	10285	16,1615,2058,6897,2617	AARS1,DARS1,EPRS1,TARS1,GARS1
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.140371651103997	-1.96346172299174	45	5	0.00791139240506329	632	10285	9572,6256,1386,10891,8841	NR1D1,RXRA,ATF2,PPARGC1A,HDAC3
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.140371651103997	-1.96346172299174	45	5	0.00791139240506329	632	10285	3339,87,3690,6382,284217	HSPG2,ACTN1,ITGB3,SDC1,LAMA1
R-HSA-4085001	Sialic acid metabolism	0.141832930186653	-1.95310546203813	33	4	0.00632911392405063	632	10285	6484,2720,6482,10402	ST3GAL4,GLB1,ST3GAL1,ST3GAL6
R-HSA-418889	Ligand-independent caspase activation via DCC	0.143650514955929	-1.94037190876738	11	2	0.00316455696202532	632	10285	26060,90249	APPL1,UNC5A
R-HSA-5655291	Signaling by FGFR4 in disease	0.143650514955929	-1.94037190876738	11	2	0.00316455696202532	632	10285	2549,5335	GAB1,PLCG1
R-HSA-5660526	Response to metal ions	0.143650514955929	-1.94037190876738	11	2	0.00316455696202532	632	10285	4504,4501	MT3,MT1X
R-HSA-5661231	Metallothioneins bind metals	0.143650514955929	-1.94037190876738	11	2	0.00316455696202532	632	10285	4501,4504	MT1X,MT3
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	0.143650514955929	-1.94037190876738	11	2	0.00316455696202532	632	10285	7494,1649	XBP1,DDIT3
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.143650514955929	-1.94037190876738	11	2	0.00316455696202532	632	10285	6256,5565	RXRA,PRKAB2
R-HSA-71288	Creatine metabolism	0.143650514955929	-1.94037190876738	11	2	0.00316455696202532	632	10285	1159,2628	CKMT1B,GATM
R-HSA-376172	DSCAM interactions	0.143650514955929	-1.94037190876738	11	2	0.00316455696202532	632	10285	57453,5600	DSCAML1,MAPK11
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.143650514955929	-1.94037190876738	11	2	0.00316455696202532	632	10285	1829,9414	DSG2,TJP2
R-HSA-8875555	MET activates RAP1 and RAC1	0.143650514955929	-1.94037190876738	11	2	0.00316455696202532	632	10285	2549,1399	GAB1,CRKL
R-HSA-169893	Prolonged ERK activation events	0.143707510041885	-1.93997522531506	252	20	0.0316455696202532	632	10285	10125,153090,5923,1847,2261,3560,5526,3716,1742,5335,2675,3690,5604,5924,1852,3815,88,817,7414,1399	RASGRP1,DAB2IP,RASGRF1,DUSP5,FGFR3,IL2RB,PPP2R5B,JAK1,DLG4,PLCG1,GFRA2,ITGB3,MAP2K1,RASGRF2,DUSP9,KIT,ACTN2,CAMK2D,VCL,CRKL
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	0.144090619720033	-1.93731287372328	58	6	0.00949367088607595	632	10285	9456,22871,2037,8825,143425,1742	HOMER1,NLGN1,EPB41L2,LIN7A,SYT9,DLG4
R-HSA-2586552	Signaling by Leptin	0.147613374559258	-1.91315875737582	253	20	0.0316455696202532	632	10285	3690,5604,5924,9021,1852,3815,88,817,7414,10125,153090,5923,2261,1847,3560,3716,5526,1742,3953,2675	ITGB3,MAP2K1,RASGRF2,SOCS3,DUSP9,KIT,ACTN2,CAMK2D,VCL,RASGRP1,DAB2IP,RASGRF1,FGFR3,DUSP5,IL2RB,JAK1,PPP2R5B,DLG4,LEPR,GFRA2
R-HSA-74751	Insulin receptor signalling cascade	0.148923144979067	-1.90432491161972	297	23	0.0363924050632911	632	10285	5604,1852,5565,7414,5923,58528,5924,3690,2549,3815,64121,817,88,10125,153090,3716,5526,3560,1847,2261,2675,1975,1742	MAP2K1,DUSP9,PRKAB2,VCL,RASGRF1,RRAGD,RASGRF2,ITGB3,GAB1,KIT,RRAGC,CAMK2D,ACTN2,RASGRP1,DAB2IP,JAK1,PPP2R5B,IL2RB,DUSP5,FGFR3,GFRA2,EIF4B,DLG4
R-HSA-198753	ERK/MAPK targets	0.149771113367436	-1.89864706115733	22	3	0.00474683544303797	632	10285	9252,5600,5598	RPS6KA5,MAPK11,MAPK7
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	0.149771113367436	-1.89864706115733	22	3	0.00474683544303797	632	10285	2549,2261,5335	GAB1,FGFR3,PLCG1
R-HSA-166208	mTORC1-mediated signalling	0.149771113367436	-1.89864706115733	22	3	0.00474683544303797	632	10285	1975,64121,58528	EIF4B,RRAGC,RRAGD
R-HSA-5655332	Signaling by FGFR3 in disease	0.149771113367436	-1.89864706115733	22	3	0.00474683544303797	632	10285	5335,2549,2261	PLCG1,GAB1,FGFR3
R-HSA-1660662	Glycosphingolipid metabolism	0.150064476748403	-1.89669023225342	46	5	0.00791139240506329	632	10285	3074,5660,2720,7368,153642	HEXB,PSAP,GLB1,UGT8,ARSK
R-HSA-3781865	Diseases of glycosylation	0.150333757388907	-1.89489740738277	85	8	0.0126582278481013	632	10285	7058,4853,3339,80070,9510,54437,9509,6382	THBS2,NOTCH2,HSPG2,ADAMTS20,ADAMTS1,SEMA5B,ADAMTS2,SDC1
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.151367658426379	-1.88804357753271	126	11	0.0174050632911392	632	10285	7187,5604,3725,1326,1386,5600,5598,4791,9252,3656,5970	TRAF3,MAP2K1,JUN,MAP3K8,ATF2,MAPK11,MAPK7,NFKB2,RPS6KA5,IRAK2,RELA
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	0.152648297868942	-1.8796187104108	59	6	0.00949367088607595	632	10285	9509,9510,54437,80070,4853,7058	ADAMTS2,ADAMTS1,SEMA5B,ADAMTS20,NOTCH2,THBS2
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.15343829449585	-1.87445678302967	34	4	0.00632911392405063	632	10285	7514,9818,55706,8480	XPO1,NUP58,NDC1,RAE1
R-HSA-73847	Purine metabolism	0.15343829449585	-1.87445678302967	34	4	0.00632911392405063	632	10285	1633,3615,5471,10606	DCK,IMPDH2,PPAT,PAICS
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.153675293971143	-1.87291338325032	372	28	0.0443037974683544	632	10285	5335,5923,23239,2309,7414,1852,5604,5970,2675,3164,1742,3560,3716,5526,1847,2261,153090,10125,3708,817,88,2549,3815,8915,253260,3725,3690,5924	PLCG1,RASGRF1,PHLPP1,FOXO3,VCL,DUSP9,MAP2K1,RELA,GFRA2,NR4A1,DLG4,IL2RB,JAK1,PPP2R5B,DUSP5,FGFR3,DAB2IP,RASGRP1,ITPR1,CAMK2D,ACTN2,GAB1,KIT,BCL10,RICTOR,JUN,ITGB3,RASGRF2
R-HSA-112043	PLC beta mediated events	0.160030345451049	-1.83239182266226	47	5	0.00791139240506329	632	10285	3708,2781,2773,114,5331	ITPR1,GNAZ,GNAI3,ADCY8,PLCB3
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.160030345451049	-1.83239182266226	47	5	0.00791139240506329	632	10285	6484,4853,3516,10402,3725	ST3GAL4,NOTCH2,RBPJ,ST3GAL6,JUN
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	0.160172218521717	-1.83150567685386	73	7	0.0110759493670886	632	10285	6619,5437,84524,64859,22936,2961,55726	SNAPC3,POLR2H,ZC3H8,NABP1,ELL2,GTF2E2,INTS13
R-HSA-6802952	Signaling by BRAF and RAF fusions	0.161425975871199	-1.82370859513432	60	6	0.00949367088607595	632	10285	8087,11044,3690,5604,7414,80853	FXR1,TENT4A,ITGB3,MAP2K1,VCL,KDM7A
R-HSA-5173105	O-linked glycosylation	0.162336514237877	-1.81808384986512	114	10	0.0158227848101266	632	10285	79695,9509,6482,79369,80070,54437,9510,374378,7058,6484	GALNT12,ADAMTS2,ST3GAL1,B3GNT4,ADAMTS20,SEMA5B,ADAMTS1,GALNT18,THBS2,ST3GAL4
R-HSA-8863678	Neurodegenerative Diseases	0.164850486244219	-1.80271635985261	23	3	0.00474683544303797	632	10285	3725,2309,831	JUN,FOXO3,CAST
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	0.164850486244219	-1.80271635985261	23	3	0.00474683544303797	632	10285	831,2309,3725	CAST,FOXO3,JUN
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.164850486244219	-1.80271635985261	23	3	0.00474683544303797	632	10285	8497,6616,8825	PPFIA4,SNAP25,LIN7A
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.165683500297633	-1.79767593526119	12	2	0.00316455696202532	632	10285	6382,3339	SDC1,HSPG2
R-HSA-2022857	Keratan sulfate degradation	0.165683500297633	-1.79767593526119	12	2	0.00316455696202532	632	10285	2720,3074	GLB1,HEXB
R-HSA-5578768	Physiological factors	0.165683500297633	-1.79767593526119	12	2	0.00316455696202532	632	10285	4880,204851	NPPC,HIPK1
R-HSA-1433617	Regulation of signaling by NODAL	0.165683500297633	-1.79767593526119	12	2	0.00316455696202532	632	10285	130399,91	ACVR1C,ACVR1B
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.165683500297633	-1.79767593526119	12	2	0.00316455696202532	632	10285	6382,3339	SDC1,HSPG2
R-HSA-6802957	Oncogenic MAPK signaling	0.168215895682072	-1.78250703125892	74	7	0.0110759493670886	632	10285	7414,80853,153090,8087,5604,3690,11044	VCL,KDM7A,DAB2IP,FXR1,MAP2K1,ITGB3,TENT4A
R-HSA-4570464	SUMOylation of RNA binding proteins	0.170256162422736	-1.77045113829196	48	5	0.00791139240506329	632	10285	9818,3183,84733,8480,55706	NUP58,HNRNPC,CBX2,RAE1,NDC1
R-HSA-112040	G-protein mediated events	0.170256162422736	-1.77045113829196	48	5	0.00791139240506329	632	10285	5331,114,2773,3708,2781	PLCB3,ADCY8,GNAI3,ITPR1,GNAZ
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.173266120712335	-1.75292659639626	3	1	0.00158227848101266	632	10285	6616	SNAP25
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.173266120712335	-1.75292659639626	3	1	0.00158227848101266	632	10285	23433	RHOQ
R-HSA-5653890	Lactose synthesis	0.173266120712335	-1.75292659639626	3	1	0.00158227848101266	632	10285	6513	SLC2A1
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.173266120712335	-1.75292659639626	3	1	0.00158227848101266	632	10285	5634	PRPS2
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.173266120712335	-1.75292659639626	3	1	0.00158227848101266	632	10285	6616	SNAP25
R-HSA-5658034	HHAT G278V abrogates palmitoylation of Hh-Np	0.173266120712335	-1.75292659639626	3	1	0.00158227848101266	632	10285	6469	SHH
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.173266120712335	-1.75292659639626	3	1	0.00158227848101266	632	10285	4088	SMAD3
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.173266120712335	-1.75292659639626	3	1	0.00158227848101266	632	10285	4088	SMAD3
R-HSA-5602571	TRAF3 deficiency - HSE	0.173266120712335	-1.75292659639626	3	1	0.00158227848101266	632	10285	7187	TRAF3
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.173266120712335	-1.75292659639626	3	1	0.00158227848101266	632	10285	90427	BMF
R-HSA-6806664	Metabolism of vitamin K	0.173266120712335	-1.75292659639626	3	1	0.00158227848101266	632	10285	79001	VKORC1
R-HSA-112316	Neuronal System	0.177434905744921	-1.72915146552553	349	26	0.0411392405063291	632	10285	170850,5923,5331,51305,2037,2561,3752,6616,9456,143425,8497,3790,3762,5792,57497,3761,1742,8825,2555,2773,5924,57030,22871,88,817,114	KCNG3,RASGRF1,PLCB3,KCNK9,EPB41L2,GABRB2,KCND3,SNAP25,HOMER1,SYT9,PPFIA4,KCNS3,KCNJ5,PTPRF,LRFN2,KCNJ4,DLG4,LIN7A,GABRA2,GNAI3,RASGRF2,SLC17A7,NLGN1,ACTN2,CAMK2D,ADCY8
R-HSA-177243	Interactions of Rev with host cellular proteins	0.17765515399744	-1.72791094484791	36	4	0.00632911392405063	632	10285	55706,8480,7514,9818	NDC1,RAE1,XPO1,NUP58
R-HSA-8852135	Protein ubiquitination	0.179607857395267	-1.71697937465416	62	6	0.00949367088607595	632	10285	55236,8341,51255,92912,220441,8915	UBA6,H2BC15,RNF181,UBE2Q2,RNF152,BCL10
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.18035368702529	-1.71283542811941	24	3	0.00474683544303797	632	10285	4791,7187,5970	NFKB2,TRAF3,RELA
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.18035368702529	-1.71283542811941	24	3	0.00474683544303797	632	10285	8497,6616,57030	PPFIA4,SNAP25,SLC17A7
R-HSA-5260271	Diseases of Immune System	0.18035368702529	-1.71283542811941	24	3	0.00474683544303797	632	10285	7187,4791,5970	TRAF3,NFKB2,RELA
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.180728346336378	-1.7107602240886	49	5	0.00791139240506329	632	10285	5165,6392,9123,5163,6256	PDK3,SDHD,SLC16A3,PDK1,RXRA
R-HSA-196854	Metabolism of vitamins and cofactors	0.18277939003308	-1.69947537230811	174	14	0.0221518987341772	632	10285	55191,80347,79001,6513,4023,10797,6382,4036,79668,10135,6515,25902,6472,3339	NADSYN1,COASY,VKORC1,SLC2A1,LPL,MTHFD2,SDC1,LRP2,PARP8,NAMPT,SLC2A3,MTHFD1L,SHMT2,HSPG2
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.184818951825242	-1.68837857186587	76	7	0.0110759493670886	632	10285	3841,55706,8480,3716,9818,5335,2317	KPNA5,NDC1,RAE1,JAK1,NUP58,PLCG1,FLNB
R-HSA-1169408	ISG15 antiviral mechanism	0.184818951825242	-1.68837857186587	76	7	0.0110759493670886	632	10285	9818,5335,2317,8480,55706,3716,3841	NUP58,PLCG1,FLNB,RAE1,NDC1,JAK1,KPNA5
R-HSA-194315	Signaling by Rho GTPases	0.184823970509715	-1.68835141763583	426	31	0.0490506329113924	632	10285	5924,1730,58504,85360,1495,9743,5585,1856,51517,5500,9411,54509,25791,64411,94134,5526,1742,23433,2316,1855,10787,23526,85415,23081,55288,9754,8341,10810,395,7514,3015	RASGRF2,DIAPH2,ARHGAP22,SYDE1,CTNNA1,ARHGAP32,PKN1,DVL2,NCKIPSD,PPP1CB,ARHGAP29,RHOF,NGEF,ARAP3,ARHGAP12,PPP2R5B,DLG4,RHOQ,FLNA,DVL1,NCKAP1,ARHGAP45,RHPN2,KDM4C,RHOT1,STARD8,H2BC15,WASF3,ARHGAP6,XPO1,H2AZ1
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.186478148581578	-1.67944121254514	146	12	0.0189873417721519	632	10285	2561,5924,817,88,114,5923,3762,5331,3761,1742,2773,2555	GABRB2,RASGRF2,CAMK2D,ACTN2,ADCY8,RASGRF1,KCNJ5,PLCB3,KCNJ4,DLG4,GNAI3,GABRA2
R-HSA-428157	Sphingolipid metabolism	0.18751644933397	-1.67388870763853	90	8	0.0126582278481013	632	10285	153642,8877,3074,7368,2720,5660,123099,166929	ARSK,SPHK1,HEXB,UGT8,GLB1,PSAP,DEGS2,SGMS2
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.188245458223134	-1.67000853889791	13	2	0.00316455696202532	632	10285	7128,8717	TNFAIP3,TRADD
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	0.188245458223134	-1.67000853889791	13	2	0.00316455696202532	632	10285	1649,7494	DDIT3,XBP1
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	0.188245458223134	-1.67000853889791	13	2	0.00316455696202532	632	10285	890,8900	CCNA2,CCNA1
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.188245458223134	-1.67000853889791	13	2	0.00316455696202532	632	10285	4791,5970	NFKB2,RELA
R-HSA-977441	GABA A receptor activation	0.188245458223134	-1.67000853889791	13	2	0.00316455696202532	632	10285	2555,2561	GABRA2,GABRB2
R-HSA-350054	Notch-HLH transcription pathway	0.188245458223134	-1.67000853889791	13	2	0.00316455696202532	632	10285	4853,3516	NOTCH2,RBPJ
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.188245458223134	-1.67000853889791	13	2	0.00316455696202532	632	10285	5335,2261	PLCG1,FGFR3
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.188245458223134	-1.67000853889791	13	2	0.00316455696202532	632	10285	4853,3516	NOTCH2,RBPJ
R-HSA-75205	Dissolution of Fibrin Clot	0.188245458223134	-1.67000853889791	13	2	0.00316455696202532	632	10285	302,5329	ANXA2,PLAUR
R-HSA-2408517	SeMet incorporation into proteins	0.188245458223134	-1.67000853889791	13	2	0.00316455696202532	632	10285	1615,2058	DARS1,EPRS1
R-HSA-5689896	Ovarian tumor domain proteases	0.19021855115784	-1.65958159862266	37	4	0.00632911392405063	632	10285	10318,7128,79589,7187	TNIP1,TNFAIP3,RNF128,TRAF3
R-HSA-187706	Signalling to p38 via RIT and RIN	0.193339632446649	-1.64330688301995	249	19	0.0300632911392405	632	10285	1847,2261,5526,3716,3560,1742,2675,10125,5923,153090,3815,1852,88,7414,817,5604,5924,3690,6016	DUSP5,FGFR3,PPP2R5B,JAK1,IL2RB,DLG4,GFRA2,RASGRP1,RASGRF1,DAB2IP,KIT,DUSP9,ACTN2,VCL,CAMK2D,MAP2K1,RASGRF2,ITGB3,RIT1
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.19622952723138	-1.62847024760142	25	3	0.00474683544303797	632	10285	253260,3164,2309	RICTOR,NR4A1,FOXO3
R-HSA-5654708	Downstream signaling of activated FGFR3	0.19622952723138	-1.62847024760142	25	3	0.00474683544303797	632	10285	5335,2549,2261	PLCG1,GAB1,FGFR3
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.19622952723138	-1.62847024760142	25	3	0.00474683544303797	632	10285	9252,5600,5598	RPS6KA5,MAPK11,MAPK7
R-HSA-3000157	Laminin interactions	0.19622952723138	-1.62847024760142	25	3	0.00474683544303797	632	10285	284217,3339,3679	LAMA1,HSPG2,ITGA7
R-HSA-2871796	FCERI mediated MAPK activation	0.19898615018293	-1.61452005375034	265	20	0.0316455696202532	632	10285	5526,3716,3560,1847,2261,2675,5335,1742,10125,153090,5923,3815,1852,7414,817,88,5924,5604,3725,3690	PPP2R5B,JAK1,IL2RB,DUSP5,FGFR3,GFRA2,PLCG1,DLG4,RASGRP1,DAB2IP,RASGRF1,KIT,DUSP9,VCL,CAMK2D,ACTN2,RASGRF2,MAP2K1,JUN,ITGB3
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.202067333983453	-1.59915430057347	78	7	0.0110759493670886	632	10285	9945,6675,10402,6484,4351,2720,6482	GFPT2,UAP1,ST3GAL6,ST3GAL4,MPI,GLB1,ST3GAL1
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.202067333983453	-1.59915430057347	78	7	0.0110759493670886	632	10285	9063,9818,5893,55706,8480,493861,84733	PIAS2,NUP58,RAD52,NDC1,RAE1,EID3,CBX2
R-HSA-5684996	MAPK1/MAPK3 signaling	0.20281505111778	-1.59546079346192	251	19	0.0300632911392405	632	10285	5924,5604,3690,7414,817,3572,88,3815,1852,153090,5923,10125,2675,1742,5526,3716,3560,1847,2261	RASGRF2,MAP2K1,ITGB3,VCL,CAMK2D,IL6ST,ACTN2,KIT,DUSP9,DAB2IP,RASGRF1,RASGRP1,GFRA2,DLG4,PPP2R5B,JAK1,IL2RB,DUSP5,FGFR3
R-HSA-381119	Unfolded Protein Response (UPR)	0.203394389428317	-1.5926083796797	92	8	0.0126582278481013	632	10285	5526,11340,55033,23480,1649,7494,467,9695	PPP2R5B,EXOSC8,FKBP14,SEC61G,DDIT3,XBP1,ATF3,EDEM1
R-HSA-1483257	Phospholipid metabolism	0.203918772591143	-1.59003353800289	207	16	0.0253164556962025	632	10285	56261,79153,201164,84803,59338,84725,1040,84879,59339,8904,23259,25816,5286,9110,9663,51205	GPCPD1,GDPD3,PLD6,GPAT3,PLEKHA1,PLEKHA8,CDS1,MFSD2A,PLEKHA2,CPNE1,DDHD2,TNFAIP8,PIK3C2A,MTMR4,LPIN2,ACP6
R-HSA-2424491	DAP12 signaling	0.204721816520392	-1.5861032139754	356	26	0.0411392405063291	632	10285	153090,10125,3708,2675,3164,1742,3560,5526,3716,1847,2261,253260,3690,5924,817,88,114,2549,3815,5923,23239,2309,5335,5604,7414,1852	DAB2IP,RASGRP1,ITPR1,GFRA2,NR4A1,DLG4,IL2RB,PPP2R5B,JAK1,DUSP5,FGFR3,RICTOR,ITGB3,RASGRF2,CAMK2D,ACTN2,ADCY8,GAB1,KIT,RASGRF1,PHLPP1,FOXO3,PLCG1,MAP2K1,VCL,DUSP9
R-HSA-1483255	PI Metabolism	0.210916811891618	-1.5562914796834	79	7	0.0110759493670886	632	10285	9110,84725,5286,25816,59338,79153,59339	MTMR4,PLEKHA8,PIK3C2A,TNFAIP8,PLEKHA1,GDPD3,PLEKHA2
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.210916811891618	-1.5562914796834	79	7	0.0110759493670886	632	10285	3015,3005,8900,890,23523,8341,3006	H2AZ1,H1-0,CCNA1,CCNA2,CABIN1,H2BC15,H1-2
R-HSA-877312	Regulation of IFNG signaling	0.211188500617901	-1.55500417646428	14	2	0.00316455696202532	632	10285	3716,9021	JAK1,SOCS3
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.211188500617901	-1.55500417646428	14	2	0.00316455696202532	632	10285	9110,5286	MTMR4,PIK3C2A
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	0.211188500617901	-1.55500417646428	14	2	0.00316455696202532	632	10285	5876,10397	RABGGTB,NDRG1
R-HSA-2980766	Nuclear Envelope Breakdown	0.213481548919793	-1.54420487196939	52	5	0.00791139240506329	632	10285	9818,255919,9663,55706,8480	NUP58,CNEP1R1,LPIN2,NDC1,RAE1
R-HSA-165159	mTOR signalling	0.216132870202369	-1.53186192059314	39	4	0.00632911392405063	632	10285	64121,1975,58528,5565	RRAGC,EIF4B,RRAGD,PRKAB2
R-HSA-69236	G1 Phase	0.216132870202369	-1.53186192059314	39	4	0.00632911392405063	632	10285	4331,894,1031,1032	MNAT1,CCND2,CDKN2C,CDKN2D
R-HSA-69231	Cyclin D associated events in G1	0.216132870202369	-1.53186192059314	39	4	0.00632911392405063	632	10285	1032,1031,894,4331	CDKN2D,CDKN2C,CCND2,MNAT1
R-HSA-1296053	Classical Kir channels	0.224082675048938	-1.49574021018232	4	1	0.00158227848101266	632	10285	3761	KCNJ4
R-HSA-2408550	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	0.224082675048938	-1.49574021018232	4	1	0.00158227848101266	632	10285	9060	PAPSS2
R-HSA-390650	Histamine receptors	0.224082675048938	-1.49574021018232	4	1	0.00158227848101266	632	10285	3269	HRH1
R-HSA-1369007	Mitochondrial ABC transporters	0.224082675048938	-1.49574021018232	4	1	0.00158227848101266	632	10285	10058	ABCB6
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.224082675048938	-1.49574021018232	4	1	0.00158227848101266	632	10285	51008	ASCC1
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.224082675048938	-1.49574021018232	4	1	0.00158227848101266	632	10285	5829	PXN
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.224082675048938	-1.49574021018232	4	1	0.00158227848101266	632	10285	5335	PLCG1
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.224082675048938	-1.49574021018232	4	1	0.00158227848101266	632	10285	2997	GYS1
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.224082675048938	-1.49574021018232	4	1	0.00158227848101266	632	10285	6616	SNAP25
R-HSA-5083630	Defective LFNG causes SCDO3	0.224082675048938	-1.49574021018232	4	1	0.00158227848101266	632	10285	4853	NOTCH2
R-HSA-167060	NGF processing	0.224082675048938	-1.49574021018232	4	1	0.00158227848101266	632	10285	5125	PCSK5
R-HSA-417973	Adenosine P1 receptors	0.224082675048938	-1.49574021018232	4	1	0.00158227848101266	632	10285	136	ADORA2B
R-HSA-1855191	Synthesis of IPs in the nucleus	0.224082675048938	-1.49574021018232	4	1	0.00158227848101266	632	10285	253430	IPMK
R-HSA-6806667	Metabolism of fat-soluble vitamins	0.224796234079717	-1.49256091341735	53	5	0.00791139240506329	632	10285	3339,79001,6382,4036,4023	HSPG2,VKORC1,SDC1,LRP2,LPL
R-HSA-167044	Signalling to RAS	0.227441416379541	-1.48086258417223	256	19	0.0300632911392405	632	10285	3690,5604,5924,1852,5600,3815,817,7414,88,10125,153090,5923,3560,3716,5526,2261,1847,2675,1742	ITGB3,MAP2K1,RASGRF2,DUSP9,MAPK11,KIT,CAMK2D,VCL,ACTN2,RASGRP1,DAB2IP,RASGRF1,IL2RB,JAK1,PPP2R5B,FGFR3,DUSP5,GFRA2,DLG4
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.227574887115404	-1.4802759206234	271	20	0.0316455696202532	632	10285	1847,2261,5526,3716,3560,1742,2675,10125,7525,5923,153090,3815,1852,88,1399,817,7414,5924,5604,3690	DUSP5,FGFR3,PPP2R5B,JAK1,IL2RB,DLG4,GFRA2,RASGRP1,YES1,RASGRF1,DAB2IP,KIT,DUSP9,ACTN2,CRKL,CAMK2D,VCL,RASGRF2,MAP2K1,ITGB3
R-HSA-380994	ATF4 activates genes	0.228900334004301	-1.47446859285342	27	3	0.00474683544303797	632	10285	467,11340,1649	ATF3,EXOSC8,DDIT3
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	0.228900334004301	-1.47446859285342	27	3	0.00474683544303797	632	10285	8731,5437,4331	RNMT,POLR2H,MNAT1
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.228900334004301	-1.47446859285342	27	3	0.00474683544303797	632	10285	8731,4331,5437	RNMT,MNAT1,POLR2H
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.229434569318289	-1.47213739114019	40	4	0.00632911392405063	632	10285	8480,55706,9818,3841	RAE1,NDC1,NUP58,KPNA5
R-HSA-991365	Activation of GABAB receptors	0.229434569318289	-1.47213739114019	40	4	0.00632911392405063	632	10285	114,3761,2773,3762	ADCY8,KCNJ4,GNAI3,KCNJ5
R-HSA-109703	PKB-mediated events	0.229434569318289	-1.47213739114019	40	4	0.00632911392405063	632	10285	1975,64121,5565,58528	EIF4B,RRAGC,PRKAB2,RRAGD
R-HSA-977444	GABA B receptor activation	0.229434569318289	-1.47213739114019	40	4	0.00632911392405063	632	10285	3762,3761,114,2773	KCNJ5,KCNJ4,ADCY8,GNAI3
R-HSA-5675221	Negative regulation of MAPK pathway	0.229434569318289	-1.47213739114019	40	4	0.00632911392405063	632	10285	1852,5604,1847,5526	DUSP9,MAP2K1,DUSP5,PPP2R5B
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.234380866018864	-1.45080785422351	15	2	0.00316455696202532	632	10285	255919,9663	CNEP1R1,LPIN2
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.234380866018864	-1.45080785422351	15	2	0.00316455696202532	632	10285	2773,114	GNAI3,ADCY8
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.234380866018864	-1.45080785422351	15	2	0.00316455696202532	632	10285	2773,114	GNAI3,ADCY8
R-HSA-975577	N-Glycan antennae elongation	0.234380866018864	-1.45080785422351	15	2	0.00316455696202532	632	10285	6484,8702	ST3GAL4,B4GALT4
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.234380866018864	-1.45080785422351	15	2	0.00316455696202532	632	10285	27289,8829	RND1,NRP1
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.234380866018864	-1.45080785422351	15	2	0.00316455696202532	632	10285	6422,79412	SFRP1,KREMEN2
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.24559964391673	-1.40405253256065	28	3	0.00474683544303797	632	10285	26060,8717,90249	APPL1,TRADD,UNC5A
R-HSA-6803529	FGFR2 alternative splicing	0.24559964391673	-1.40405253256065	28	3	0.00474683544303797	632	10285	5437,5725,3185	POLR2H,PTBP1,HNRNPF
R-HSA-174800	Chylomicron-mediated lipid transport	0.24559964391673	-1.40405253256065	28	3	0.00474683544303797	632	10285	4023,5125,51129	LPL,PCSK5,ANGPTL4
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.24559964391673	-1.40405253256065	28	3	0.00474683544303797	632	10285	58528,5565,64121	RRAGD,PRKAB2,RRAGC
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.24559964391673	-1.40405253256065	28	3	0.00474683544303797	632	10285	6619,51082,5437	SNAPC3,POLR1D,POLR2H
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	0.246114063530501	-1.40196017762461	126	10	0.0158227848101266	632	10285	9063,6256,3015,9935,5915,5914,5437,8341,3725,8841	PIAS2,RXRA,H2AZ1,MAFB,RARB,RARA,POLR2H,H2BC15,JUN,HDAC3
R-HSA-5619507	Activation of HOX genes during differentiation	0.246114063530501	-1.40196017762461	126	10	0.0158227848101266	632	10285	8341,8841,3725,5437,5914,5915,3015,9935,9063,6256	H2BC15,HDAC3,JUN,POLR2H,RARA,RARB,H2AZ1,MAFB,PIAS2,RXRA
R-HSA-112412	SOS-mediated signalling	0.248332527386513	-1.39298659469939	245	18	0.0284810126582278	632	10285	3815,1852,88,817,7414,5604,5924,3690,1847,2261,3716,5526,3560,1742,2675,10125,5923,153090	KIT,DUSP9,ACTN2,CAMK2D,VCL,MAP2K1,RASGRF2,ITGB3,DUSP5,FGFR3,JAK1,PPP2R5B,IL2RB,DLG4,GFRA2,RASGRP1,RASGRF1,DAB2IP
R-HSA-180336	SHC1 events in EGFR signaling	0.248332527386513	-1.39298659469939	245	18	0.0284810126582278	632	10285	3560,3716,5526,1847,2261,2675,1742,10125,5923,153090,1852,3815,7414,817,88,3690,5604,5924	IL2RB,JAK1,PPP2R5B,DUSP5,FGFR3,GFRA2,DLG4,RASGRP1,RASGRF1,DAB2IP,DUSP9,KIT,VCL,CAMK2D,ACTN2,ITGB3,MAP2K1,RASGRF2
R-HSA-5673001	RAF/MAP kinase cascade	0.248332527386513	-1.39298659469939	245	18	0.0284810126582278	632	10285	1847,2261,3716,5526,3560,1742,2675,10125,5923,153090,3815,1852,88,7414,817,5604,5924,3690	DUSP5,FGFR3,JAK1,PPP2R5B,IL2RB,DLG4,GFRA2,RASGRP1,RASGRF1,DAB2IP,KIT,DUSP9,ACTN2,VCL,CAMK2D,MAP2K1,RASGRF2,ITGB3
R-HSA-179812	GRB2 events in EGFR signaling	0.248332527386513	-1.39298659469939	245	18	0.0284810126582278	632	10285	5923,153090,10125,1742,2675,1847,2261,3560,5526,3716,3690,5924,5604,88,7414,817,1852,3815	RASGRF1,DAB2IP,RASGRP1,DLG4,GFRA2,DUSP5,FGFR3,IL2RB,PPP2R5B,JAK1,ITGB3,RASGRF2,MAP2K1,ACTN2,VCL,CAMK2D,DUSP9,KIT
R-HSA-6806834	Signaling by MET	0.248852994276278	-1.39089294129556	69	6	0.00949367088607595	632	10285	10653,1399,2549,284217,64759,6456	SPINT2,CRKL,GAB1,LAMA1,TNS3,SH3GL2
R-HSA-74752	Signaling by Insulin receptor	0.254977239062805	-1.36658099638473	322	23	0.0363924050632911	632	10285	1975,1742,2675,1847,2261,3716,5526,3560,153090,10125,88,817,64121,3815,2549,5924,3690,58528,5923,7414,1852,5565,5604	EIF4B,DLG4,GFRA2,DUSP5,FGFR3,JAK1,PPP2R5B,IL2RB,DAB2IP,RASGRP1,ACTN2,CAMK2D,RRAGC,KIT,GAB1,RASGRF2,ITGB3,RRAGD,RASGRF1,VCL,DUSP9,PRKAB2,MAP2K1
R-HSA-168253	Host Interactions with Influenza Factors	0.256604866888011	-1.36021786015268	42	4	0.00632911392405063	632	10285	55706,8480,9818,3841	NDC1,RAE1,NUP58,KPNA5
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	0.256604866888011	-1.36021786015268	42	4	0.00632911392405063	632	10285	8915,8341,220441,51255	BCL10,H2BC15,RNF152,RNF181
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.25770550112624	-1.35593781453482	16	2	0.00316455696202532	632	10285	2549,5335	GAB1,PLCG1
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.25770550112624	-1.35593781453482	16	2	0.00316455696202532	632	10285	5604,1326	MAP2K1,MAP3K8
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.25770550112624	-1.35593781453482	16	2	0.00316455696202532	632	10285	5335,2549	PLCG1,GAB1
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.259325875772495	-1.34966980054667	70	6	0.00949367088607595	632	10285	9529,9531,55706,8480,9818,3310	BAG5,BAG3,NDC1,RAE1,NUP58,HSPA6
R-HSA-381038	XBP1(S) activates chaperone genes	0.259722429638537	-1.34814179654756	56	5	0.00791139240506329	632	10285	7494,5526,23480,55033,9695	XBP1,PPP2R5B,SEC61G,FKBP14,EDEM1
R-HSA-112315	Transmission across Chemical Synapses	0.259951572721838	-1.34725992407709	217	16	0.0253164556962025	632	10285	8497,88,817,114,2561,6616,5924,57030,1742,2773,2555,8825,3762,5923,3761,5331	PPFIA4,ACTN2,CAMK2D,ADCY8,GABRB2,SNAP25,RASGRF2,SLC17A7,DLG4,GNAI3,GABRA2,LIN7A,KCNJ5,RASGRF1,KCNJ4,PLCB3
R-HSA-72086	mRNA Capping	0.262480673621958	-1.33757782395816	29	3	0.00474683544303797	632	10285	5437,4331,8731	POLR2H,MNAT1,RNMT
R-HSA-196807	Nicotinate metabolism	0.262480673621958	-1.33757782395816	29	3	0.00474683544303797	632	10285	79668,10135,55191	PARP8,NAMPT,NADSYN1
R-HSA-375170	CDO in myogenesis	0.262480673621958	-1.33757782395816	29	3	0.00474683544303797	632	10285	91653,5600,1495	BOC,MAPK11,CTNNA1
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.262480673621958	-1.33757782395816	29	3	0.00474683544303797	632	10285	5970,3656,4791	RELA,IRAK2,NFKB2
R-HSA-525793	Myogenesis	0.262480673621958	-1.33757782395816	29	3	0.00474683544303797	632	10285	91653,1495,5600	BOC,CTNNA1,MAPK11
R-HSA-2172127	DAP12 interactions	0.269497741131496	-1.31119527036952	371	26	0.0411392405063291	632	10285	3690,5924,253260,3815,2549,114,88,817,3708,10125,153090,1847,2261,3560,5526,3716,1742,2675,3164,5604,1852,7414,23239,5923,2309,5335	ITGB3,RASGRF2,RICTOR,KIT,GAB1,ADCY8,ACTN2,CAMK2D,ITPR1,RASGRP1,DAB2IP,DUSP5,FGFR3,IL2RB,PPP2R5B,JAK1,DLG4,GFRA2,NR4A1,MAP2K1,DUSP9,VCL,PHLPP1,RASGRF1,FOXO3,PLCG1
R-HSA-170984	ARMS-mediated activation	0.270326101205365	-1.30812626652389	249	18	0.0284810126582278	632	10285	1852,3815,88,817,7414,3690,5924,5604,1847,2261,3560,5526,3716,1742,2675,10125,5923,153090	DUSP9,KIT,ACTN2,CAMK2D,VCL,ITGB3,RASGRF2,MAP2K1,DUSP5,FGFR3,IL2RB,PPP2R5B,JAK1,DLG4,GFRA2,RASGRP1,RASGRF1,DAB2IP
R-HSA-168325	Viral Messenger RNA Synthesis	0.270425406012267	-1.30775898208107	43	4	0.00632911392405063	632	10285	9818,5437,8480,55706	NUP58,POLR2H,RAE1,NDC1
R-HSA-429914	Deadenylation-dependent mRNA decay	0.271641817118872	-1.30327092932117	57	5	0.00791139240506329	632	10285	1975,85456,11340,10767,54464	EIF4B,TNKS1BP1,EXOSC8,HBS1L,XRN1
R-HSA-8865999	MET activates PTPN11	0.271780345448712	-1.3027610924305	5	1	0.00158227848101266	632	10285	2549	GAB1
R-HSA-2142850	Hyaluronan biosynthesis and export	0.271780345448712	-1.3027610924305	5	1	0.00158227848101266	632	10285	3036	HAS1
R-HSA-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors	0.271780345448712	-1.3027610924305	5	1	0.00158227848101266	632	10285	10765	KDM5B
R-HSA-8849468	PTK6 Regulates Proteins Involved in RNA Processing	0.271780345448712	-1.3027610924305	5	1	0.00158227848101266	632	10285	10656	KHDRBS3
R-HSA-446205	Synthesis of GDP-mannose	0.271780345448712	-1.3027610924305	5	1	0.00158227848101266	632	10285	4351	MPI
R-HSA-1169092	Activation of RAS in B cells	0.271780345448712	-1.3027610924305	5	1	0.00158227848101266	632	10285	10125	RASGRP1
R-HSA-8852405	Signaling by MST1	0.271780345448712	-1.3027610924305	5	1	0.00158227848101266	632	10285	10653	SPINT2
R-HSA-8866376	Reelin signalling pathway	0.271780345448712	-1.3027610924305	5	1	0.00158227848101266	632	10285	7436	VLDLR
R-HSA-1483226	Synthesis of PI	0.271780345448712	-1.3027610924305	5	1	0.00158227848101266	632	10285	1040	CDS1
R-HSA-8853383	Lysosomal oligosaccharide catabolism	0.271780345448712	-1.3027610924305	5	1	0.00158227848101266	632	10285	4126	MANBA
R-HSA-8875513	MET interacts with TNS proteins	0.271780345448712	-1.3027610924305	5	1	0.00158227848101266	632	10285	64759	TNS3
R-HSA-397014	Muscle contraction	0.272262677793933	-1.30098795151705	204	15	0.0237341772151899	632	10285	4880,88,817,7414,7431,302,3752,786,204851,5829,51305,6330,444,3708,3761	NPPC,ACTN2,CAMK2D,VCL,VIM,ANXA2,KCND3,CACNG1,HIPK1,PXN,KCNK9,SCN4B,ASPH,ITPR1,KCNJ4
R-HSA-381042	PERK regulates gene expression	0.279500147380393	-1.27475245908697	30	3	0.00474683544303797	632	10285	1649,467,11340	DDIT3,ATF3,EXOSC8
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.279500147380393	-1.27475245908697	30	3	0.00474683544303797	632	10285	4853,3516,3725	NOTCH2,RBPJ,JUN
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	0.281058755424192	-1.26919153746923	17	2	0.00316455696202532	632	10285	11340,10767	EXOSC8,HBS1L
R-HSA-2142845	Hyaluronan metabolism	0.281058755424192	-1.26919153746923	17	2	0.00316455696202532	632	10285	3074,3036	HEXB,HAS1
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.281058755424192	-1.26919153746923	17	2	0.00316455696202532	632	10285	6616,8497	SNAP25,PPFIA4
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.281058755424192	-1.26919153746923	17	2	0.00316455696202532	632	10285	50848,57530	F11R,CGN
R-HSA-381070	IRE1alpha activates chaperones	0.28367494894932	-1.25992624226696	58	5	0.00791139240506329	632	10285	9695,7494,5526,55033,23480	EDEM1,XBP1,PPP2R5B,FKBP14,SEC61G
R-HSA-975634	Retinoid metabolism and transport	0.284371506657266	-1.25747377363452	44	4	0.00632911392405063	632	10285	3339,4023,6382,4036	HSPG2,LPL,SDC1,LRP2
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.296616827852428	-1.21531411504002	31	3	0.00474683544303797	632	10285	8480,55706,9818	RAE1,NDC1,NUP58
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.296616827852428	-1.21531411504002	31	3	0.00474683544303797	632	10285	8480,55706,9818	RAE1,NDC1,NUP58
R-HSA-5654687	Downstream signaling of activated FGFR1	0.296616827852428	-1.21531411504002	31	3	0.00474683544303797	632	10285	2549,23769,5335	GAB1,FLRT1,PLCG1
R-HSA-6798695	Neutrophil degranulation	0.302636076181135	-1.19522426404298	487	33	0.0522151898734177	632	10285	5660,302,5315,158747,5836,6515,10855,226,54509,3615,2040,1265,5329,23526,5223,3074,5236,6616,51646,7414,10549,230,4126,2720,11322,8836,8904,2821,8987,6386,25801,55276,3310	PSAP,ANXA2,PKM,MOSPD2,PYGL,SLC2A3,HPSE,ALDOA,RHOF,IMPDH2,STOM,CNN2,PLAUR,ARHGAP45,PGAM1,HEXB,PGM1,SNAP25,YPEL5,VCL,PRDX4,ALDOC,MANBA,GLB1,TMC6,GGH,CPNE1,GPI,STBD1,SDCBP,GCA,PGM2,HSPA6
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.304349180190126	-1.18957961768761	18	2	0.00316455696202532	632	10285	7187,51330	TRAF3,TNFRSF12A
R-HSA-197264	Nicotinamide salvaging	0.304349180190126	-1.18957961768761	18	2	0.00316455696202532	632	10285	79668,10135	PARP8,NAMPT
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.304349180190126	-1.18957961768761	18	2	0.00316455696202532	632	10285	8497,6616	PPFIA4,SNAP25
R-HSA-73780	RNA Polymerase III Chain Elongation	0.304349180190126	-1.18957961768761	18	2	0.00316455696202532	632	10285	51082,5437	POLR1D,POLR2H
R-HSA-912631	Regulation of signaling by CBL	0.304349180190126	-1.18957961768761	18	2	0.00316455696202532	632	10285	7525,1399	YES1,CRKL
R-HSA-5654710	PI-3K cascade:FGFR3	0.304349180190126	-1.18957961768761	18	2	0.00316455696202532	632	10285	2549,2261	GAB1,FGFR3
R-HSA-5635838	Activation of SMO	0.304349180190126	-1.18957961768761	18	2	0.00316455696202532	632	10285	91653,6469	BOC,SHH
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.304349180190126	-1.18957961768761	18	2	0.00316455696202532	632	10285	6616,8497	SNAP25,PPFIA4
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.304349180190126	-1.18957961768761	18	2	0.00316455696202532	632	10285	11340,54464	EXOSC8,XRN1
R-HSA-912526	Interleukin receptor SHC signaling	0.304558926435475	-1.188890691883	255	18	0.0284810126582278	632	10285	10125,5923,153090,3716,5526,3560,1847,2261,2675,1742,5604,5924,3690,3815,1852,817,7414,88	RASGRP1,RASGRF1,DAB2IP,JAK1,PPP2R5B,IL2RB,DUSP5,FGFR3,GFRA2,DLG4,MAP2K1,RASGRF2,ITGB3,KIT,DUSP9,CAMK2D,VCL,ACTN2
R-HSA-190236	Signaling by FGFR	0.305936921960808	-1.18437633566197	89	7	0.0110759493670886	632	10285	2261,2549,5437,5725,5335,3185,23769	FGFR3,GAB1,POLR2H,PTBP1,PLCG1,HNRNPF,FLRT1
R-HSA-3371556	Cellular response to heat stress	0.305936921960808	-1.18437633566197	89	7	0.0110759493670886	632	10285	817,9818,3310,9529,9531,55706,8480	CAMK2D,NUP58,HSPA6,BAG5,BAG3,NDC1,RAE1
R-HSA-2672351	Stimuli-sensing channels	0.307920751850837	-1.17791282830127	104	8	0.0126582278481013	632	10285	65267,50636,23327,94015,6340,2040,54795,444	WNK3,ANO7,NEDD4L,TTYH2,SCNN1G,STOM,TRPM4,ASPH
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.307920751850837	-1.17791282830127	104	8	0.0126582278481013	632	10285	84733,493861,8480,55706,5893,9063,9818,3183	CBX2,EID3,RAE1,NDC1,RAD52,PIAS2,NUP58,HNRNPC
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.312549396511703	-1.16299275345979	46	4	0.00632911392405063	632	10285	4092,23327,3726,4088	SMAD7,NEDD4L,JUNB,SMAD3
R-HSA-2559585	Oncogene Induced Senescence	0.313791587356419	-1.15902624797686	32	3	0.00474683544303797	632	10285	1031,3397,1032	CDKN2C,ID1,CDKN2D
R-HSA-168638	NOD1/2 Signaling Pathway	0.313791587356419	-1.15902624797686	32	3	0.00474683544303797	632	10285	5600,3656,7128	MAPK11,IRAK2,TNFAIP3
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.313791587356419	-1.15902624797686	32	3	0.00474683544303797	632	10285	1856,5526,1855	DVL2,PPP2R5B,DVL1
R-HSA-162582	Signal Transduction	0.315590223804311	-1.15331066702914	2547	162	0.256329113924051	632	10285	51517,7525,5500,5143,84634,5526,5125,9411,3164,9110,1975,5660,6016,9021,4092,85360,339745,114,797,80346,3269,817,2831,5914,2309,395,6469,10810,6422,9580,7128,1299,5829,8717,4093,989,91851,3516,5915,10252,7414,3726,8650,388531,4986,79809,6484,1395,2773,3716,2261,64411,1847,54509,2675,5970,3953,8877,6382,58528,5924,3690,79412,8313,253260,10014,5165,7058,5732,10653,5585,3572,7481,8841,9754,10603,57530,1382,5335,4023,4036,7514,10787,23526,1855,10076,27152,5598,8490,60485,5437,10125,3708,8887,136,153090,94134,55620,3560,8828,23433,11167,1742,1730,9372,3725,23769,91,1399,9743,56937,5331,50848,23239,10402,3015,2316,3185,85415,4088,23645,25791,10656,6256,23327,2150,8829,5725,58504,2549,9414,3815,133,5600,1495,64121,1856,7422,88,8341,9249,2781,6456,5923,284217,130399,8471,64759,3339,5604,9241,162998,4853,26524,23081,9252,91653,5565,1852,56603,55288,5163	NCKIPSD,YES1,PPP1CB,PDE4C,KISS1R,PPP2R5B,PCSK5,ARHGAP29,NR4A1,MTMR4,EIF4B,PSAP,RIT1,SOCS3,SMAD7,SYDE1,SPOPL,ADCY8,CALCB,REEP4,HRH1,CAMK2D,NPBWR1,RARA,FOXO3,ARHGAP6,SHH,WASF3,SFRP1,SOX13,TNFAIP3,COL9A3,PXN,TRADD,SMAD9,SEPTIN7,CHRDL1,RBPJ,RARB,SPRY1,VCL,JUNB,NUMB,RGS9BP,OPRK1,TTC21B,ST3GAL4,CRHR2,GNAI3,JAK1,FGFR3,ARAP3,DUSP5,RHOF,GFRA2,RELA,LEPR,SPHK1,SDC1,RRAGD,RASGRF2,ITGB3,KREMEN2,AXIN2,RICTOR,HDAC5,PDK3,THBS2,PTGER2,SPINT2,PKN1,IL6ST,WNT11,HDAC3,STARD8,SH2B2,CGN,CRABP2,PLCG1,LPL,LRP2,XPO1,NCKAP1,ARHGAP45,DVL1,PTPRU,INTU,MAPK7,RGS5,SAV1,POLR2H,RASGRP1,ITPR1,TAX1BP1,ADORA2B,DAB2IP,ARHGAP12,STAP2,IL2RB,NRP2,RHOQ,FSTL1,DLG4,DIAPH2,ZFYVE9,JUN,FLRT1,ACVR1B,CRKL,ARHGAP32,PMEPA1,PLCB3,F11R,PHLPP1,ST3GAL6,H2AZ1,FLNA,HNRNPF,RHPN2,SMAD3,PPP1R15A,NGEF,KHDRBS3,RXRA,NEDD4L,F2RL1,NRP1,PTBP1,ARHGAP22,GAB1,TJP2,KIT,ADM,MAPK11,CTNNA1,RRAGC,DVL2,VEGFA,ACTN2,H2BC15,DHRS3,GNAZ,SH3GL2,RASGRF1,LAMA1,ACVR1C,IRS4,TNS3,HSPG2,MAP2K1,NOG,OR7D2,NOTCH2,LATS2,KDM4C,RPS6KA5,BOC,PRKAB2,DUSP9,CYP26B1,RHOT1,PDK1
R-HSA-5660668	CLEC7A/inflammasome pathway	0.316550269733849	-1.15027321988733	6	1	0.00158227848101266	632	10285	5970	RELA
R-HSA-6806942	MET Receptor Activation	0.316550269733849	-1.15027321988733	6	1	0.00158227848101266	632	10285	10653	SPINT2
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.316550269733849	-1.15027321988733	6	1	0.00158227848101266	632	10285	9249	DHRS3
R-HSA-8851907	MET activates PI3K/AKT signaling	0.316550269733849	-1.15027321988733	6	1	0.00158227848101266	632	10285	2549	GAB1
R-HSA-193144	Estrogen biosynthesis	0.316550269733849	-1.15027321988733	6	1	0.00158227848101266	632	10285	51171	HSD17B14
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.316550269733849	-1.15027321988733	6	1	0.00158227848101266	632	10285	79412	KREMEN2
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.316550269733849	-1.15027321988733	6	1	0.00158227848101266	632	10285	27031	NPHP3
R-HSA-177135	Conjugation of benzoate with glycine	0.316550269733849	-1.15027321988733	6	1	0.00158227848101266	632	10285	219970	GLYATL2
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.316550269733849	-1.15027321988733	6	1	0.00158227848101266	632	10285	8841	HDAC3
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.316550269733849	-1.15027321988733	6	1	0.00158227848101266	632	10285	5604	MAP2K1
R-HSA-211916	Vitamins	0.316550269733849	-1.15027321988733	6	1	0.00158227848101266	632	10285	56603	CYP26B1
R-HSA-421270	Cell-cell junction organization	0.32030994719254	-1.13846616698743	61	5	0.00791139240506329	632	10285	50848,283,1004,1001,1495	F11R,ANG,CDH6,CDH3,CTNNA1
R-HSA-3700989	Transcriptional Regulation by TP53	0.324355425077591	-1.12591537346452	367	25	0.0395569620253165	632	10285	7832,8793,2821,54541,27113,665,5437,900,27244,8900,1386,3622,204851,253260,11200,3725,5876,58528,10397,85456,64121,5600,5565,4331,890	BTG2,TNFRSF10D,GPI,DDIT4,BBC3,BNIP3L,POLR2H,CCNG1,SESN1,CCNA1,ATF2,ING2,HIPK1,RICTOR,CHEK2,JUN,RABGGTB,RRAGD,NDRG1,TNKS1BP1,RRAGC,MAPK11,PRKAB2,MNAT1,CCNA2
R-HSA-416700	Other semaphorin interactions	0.327496424186855	-1.11627814247986	19	2	0.00316455696202532	632	10285	5365,23129	PLXNB3,PLXND1
R-HSA-5576886	Phase 4 - resting membrane potential	0.327496424186855	-1.11627814247986	19	2	0.00316455696202532	632	10285	3761,51305	KCNJ4,KCNK9
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.327496424186855	-1.11627814247986	19	2	0.00316455696202532	632	10285	6382,3339	SDC1,HSPG2
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.327496424186855	-1.11627814247986	19	2	0.00316455696202532	632	10285	11340,5600	EXOSC8,MAPK11
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.327496424186855	-1.11627814247986	19	2	0.00316455696202532	632	10285	3339,6382	HSPG2,SDC1
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.327496424186855	-1.11627814247986	19	2	0.00316455696202532	632	10285	6382,3339	SDC1,HSPG2
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.330987453078562	-1.10567481043059	33	3	0.00474683544303797	632	10285	9818,8480,55706	NUP58,RAE1,NDC1
R-HSA-180746	Nuclear import of Rev protein	0.330987453078562	-1.10567481043059	33	3	0.00474683544303797	632	10285	55706,8480,9818	NDC1,RAE1,NUP58
R-HSA-5357905	Regulation of TNFR1 signaling	0.330987453078562	-1.10567481043059	33	3	0.00474683544303797	632	10285	8717,8887,7128	TRADD,TAX1BP1,TNFAIP3
R-HSA-389356	CD28 co-stimulation	0.330987453078562	-1.10567481043059	33	3	0.00474683544303797	632	10285	1326,253260,7525	MAP3K8,RICTOR,YES1
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.33483193851902	-1.09412654910124	122	9	0.0142405063291139	632	10285	6513,80347,10797,6472,25902,55191,6515,10135,79668	SLC2A1,COASY,MTHFD2,SHMT2,MTHFD1L,NADSYN1,SLC2A3,NAMPT,PARP8
R-HSA-427413	NoRC negatively regulates rRNA expression	0.335789290070149	-1.09127142862293	107	8	0.0126582278481013	632	10285	8819,5437,1789,8341,3015,79101,51082,4331	SAP30,POLR2H,DNMT3B,H2BC15,H2AZ1,TAF1D,POLR1D,MNAT1
R-HSA-597592	Post-translational protein modification	0.338086666438638	-1.08445300678467	1034	67	0.106012658227848	632	10285	9804,9510,4248,79369,79091,7187,7128,9509,9063,9945,153642,8702,10402,51014,51299,5329,10282,54732,8330,4088,26286,7416,8900,4092,493861,6478,4351,116372,51255,3183,5277,349667,6675,5893,9695,80070,2720,79589,84733,7039,8341,57646,5876,374378,55236,55288,79695,10318,890,6484,55647,220441,8313,3998,7058,9871,7417,54437,6482,9818,25837,9363,4122,92912,55706,8480,8915	TOMM20,ADAMTS1,MGAT3,B3GNT4,METTL22,TRAF3,TNFAIP3,ADAMTS2,PIAS2,GFPT2,ARSK,B4GALT4,ST3GAL6,TMED7,NRN1,PLAUR,BET1,TMED9,H2AC15,SMAD3,ARFGAP3,VDAC1,CCNA1,SMAD7,EID3,SIAH2,MPI,LYPD1,RNF181,HNRNPC,PIGA,RTN4RL2,UAP1,RAD52,EDEM1,ADAMTS20,GLB1,RNF128,CBX2,TGFA,H2BC15,USP28,RABGGTB,GALNT18,UBA6,RHOT1,GALNT12,TNIP1,CCNA2,ST3GAL4,RAB20,RNF152,AXIN2,LMAN1,THBS2,SEC24D,VDAC2,SEMA5B,ST3GAL1,NUP58,RAB26,RAB33A,MAN2A2,UBE2Q2,NDC1,RAE1,BCL10
R-HSA-168898	Toll-Like Receptors Cascades	0.339519568739648	-1.08022369376336	153	11	0.0174050632911392	632	10285	5604,3725,1326,3656,5600,5598,4791,9252,7187,5970,1386	MAP2K1,JUN,MAP3K8,IRAK2,MAPK11,MAPK7,NFKB2,RPS6KA5,TRAF3,RELA,ATF2
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.340962765467397	-1.07598199983824	48	4	0.00632911392405063	632	10285	4331,5437,51082,79101	MNAT1,POLR2H,POLR1D,TAF1D
R-HSA-451927	Interleukin-2 signaling	0.346013357723518	-1.06127789853228	262	18	0.0284810126582278	632	10285	3560,5526,3716,1847,2261,2675,1742,10125,153090,5923,1852,3815,7414,817,88,3690,5604,5924	IL2RB,PPP2R5B,JAK1,DUSP5,FGFR3,GFRA2,DLG4,RASGRP1,DAB2IP,RASGRF1,DUSP9,KIT,VCL,CAMK2D,ACTN2,ITGB3,MAP2K1,RASGRF2
R-HSA-1483166	Synthesis of PA	0.34816962972076	-1.05506547624247	34	3	0.00474683544303797	632	10285	23259,84803,51205	DDHD2,GPAT3,ACP6
R-HSA-1489509	DAG and IP3 signaling	0.34816962972076	-1.05506547624247	34	3	0.00474683544303797	632	10285	114,3708,5335	ADCY8,ITPR1,PLCG1
R-HSA-5694530	Cargo concentration in the ER	0.34816962972076	-1.05506547624247	34	3	0.00474683544303797	632	10285	3998,9871,7039	LMAN1,SEC24D,TGFA
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.34816962972076	-1.05506547624247	34	3	0.00474683544303797	632	10285	4092,3726,4088	SMAD7,JUNB,SMAD3
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.34816962972076	-1.05506547624247	34	3	0.00474683544303797	632	10285	9818,55706,8480	NUP58,NDC1,RAE1
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.350430218707148	-1.04859368303582	20	2	0.00316455696202532	632	10285	3656,5600	IRAK2,MAPK11
R-HSA-1643713	Signaling by EGFR in Cancer	0.350430218707148	-1.04859368303582	20	2	0.00316455696202532	632	10285	5335,2549	PLCG1,GAB1
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.350430218707148	-1.04859368303582	20	2	0.00316455696202532	632	10285	5335,2549	PLCG1,GAB1
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.350430218707148	-1.04859368303582	20	2	0.00316455696202532	632	10285	5335,2549	PLCG1,GAB1
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.350430218707148	-1.04859368303582	20	2	0.00316455696202532	632	10285	2170,5500	FABP3,PPP1CB
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	0.355205824948373	-1.03505786893222	49	4	0.00632911392405063	632	10285	85456,8900,7832,890	TNKS1BP1,CCNA1,BTG2,CCNA2
R-HSA-109704	PI3K Cascade	0.357491300478636	-1.02864425146965	79	6	0.00949367088607595	632	10285	1975,64121,2261,5565,58528,2549	EIF4B,RRAGC,FGFR3,PRKAB2,RRAGD,GAB1
R-HSA-447043	Neurofascin interactions	0.358571889503363	-1.0256261104449	7	1	0.00158227848101266	632	10285	6386	SDCBP
R-HSA-162791	Attachment of GPI anchor to uPAR	0.358571889503363	-1.0256261104449	7	1	0.00158227848101266	632	10285	5329	PLAUR
R-HSA-174362	Transport and synthesis of PAPS	0.358571889503363	-1.0256261104449	7	1	0.00158227848101266	632	10285	9060	PAPSS2
R-HSA-6814848	Glycerophospholipid catabolism	0.358571889503363	-1.0256261104449	7	1	0.00158227848101266	632	10285	79153	GDPD3
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	0.358571889503363	-1.0256261104449	7	1	0.00158227848101266	632	10285	3752	KCND3
R-HSA-190371	FGFR3b ligand binding and activation	0.358571889503363	-1.0256261104449	7	1	0.00158227848101266	632	10285	2261	FGFR3
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.358571889503363	-1.0256261104449	7	1	0.00158227848101266	632	10285	4853	NOTCH2
R-HSA-199920	CREB phosphorylation	0.358571889503363	-1.0256261104449	7	1	0.00158227848101266	632	10285	9252	RPS6KA5
R-HSA-433692	Proton-coupled monocarboxylate transport	0.358571889503363	-1.0256261104449	7	1	0.00158227848101266	632	10285	9123	SLC16A3
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	0.358571889503363	-1.0256261104449	7	1	0.00158227848101266	632	10285	3516	RBPJ
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.358571889503363	-1.0256261104449	7	1	0.00158227848101266	632	10285	8313	AXIN2
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.358571889503363	-1.0256261104449	7	1	0.00158227848101266	632	10285	114	ADCY8
R-HSA-196791	Vitamin D (calciferol) metabolism	0.358571889503363	-1.0256261104449	7	1	0.00158227848101266	632	10285	4036	LRP2
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.364027837912849	-1.01052493648712	110	8	0.0126582278481013	632	10285	8819,5437,8341,1789,3015,79101,51082,4331	SAP30,POLR2H,H2BC15,DNMT3B,H2AZ1,TAF1D,POLR1D,MNAT1
R-HSA-2990846	SUMOylation	0.364027837912849	-1.01052493648712	110	8	0.0126582278481013	632	10285	8480,55706,5893,3183,9818,9063,84733,493861	RAE1,NDC1,RAD52,HNRNPC,NUP58,PIAS2,CBX2,EID3
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	0.365305502808288	-1.00702128148848	35	3	0.00474683544303797	632	10285	7414,5604,3690	VCL,MAP2K1,ITGB3
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.365305502808288	-1.00702128148848	35	3	0.00474683544303797	632	10285	55706,8480,9818	NDC1,RAE1,NUP58
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.365305502808288	-1.00702128148848	35	3	0.00474683544303797	632	10285	8480,55706,9818	RAE1,NDC1,NUP58
R-HSA-1280215	Cytokine Signaling in Immune system	0.367224749545417	-1.00178122178431	756	49	0.0775316455696203	632	10285	10125,132014,153090,7525,5292,3560,5526,1742,1154,6095,9021,4791,3162,817,1399,7431,7187,7076,2309,1326,6624,7414,3726,3841,3716,54014,1847,2261,5970,2675,3977,3690,5924,55706,8480,3815,7422,51330,9818,88,3572,5923,3394,2317,5335,5604,1852,3656,3383	RASGRP1,IL17RE,DAB2IP,YES1,PIM1,IL2RB,PPP2R5B,DLG4,CISH,RORA,SOCS3,NFKB2,HMOX1,CAMK2D,CRKL,VIM,TRAF3,TIMP1,FOXO3,MAP3K8,FSCN1,VCL,JUNB,KPNA5,JAK1,BRWD1,DUSP5,FGFR3,RELA,GFRA2,LIFR,ITGB3,RASGRF2,NDC1,RAE1,KIT,VEGFA,TNFRSF12A,NUP58,ACTN2,IL6ST,RASGRF1,IRF8,FLNB,PLCG1,MAP2K1,DUSP9,IRAK2,ICAM1
R-HSA-422356	Regulation of insulin secretion	0.368646770236079	-0.997916355642557	80	6	0.00949367088607595	632	10285	3790,6616,6513,3708,5331,114	KCNS3,SNAP25,SLC2A1,ITPR1,PLCB3,ADCY8
R-HSA-6802949	Signaling by RAS mutants	0.369446948473828	-0.995748125427477	50	4	0.00632911392405063	632	10285	7414,153090,5604,3690	VCL,DAB2IP,MAP2K1,ITGB3
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.369446948473828	-0.995748125427477	50	4	0.00632911392405063	632	10285	84725,5286,59339,59338	PLEKHA8,PIK3C2A,PLEKHA2,PLEKHA1
R-HSA-913709	O-linked glycosylation of mucins	0.369877383795424	-0.994583723414877	65	5	0.00791139240506329	632	10285	374378,79369,6482,6484,79695	GALNT18,B3GNT4,ST3GAL1,ST3GAL4,GALNT12
R-HSA-2559580	Oxidative Stress Induced Senescence	0.370079500343561	-0.994037430630808	126	9	0.0142405063291139	632	10285	3015,5600,23043,1032,84733,3725,1031,23135,8341	H2AZ1,MAPK11,TNIK,CDKN2D,CBX2,JUN,CDKN2C,KDM6B,H2BC15
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.373089445025248	-0.985937089090201	21	2	0.00316455696202532	632	10285	5970,4791	RELA,NFKB2
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.373089445025248	-0.985937089090201	21	2	0.00316455696202532	632	10285	3487,3485	IGFBP4,IGFBP2
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	0.373089445025248	-0.985937089090201	21	2	0.00316455696202532	632	10285	7832,85456	BTG2,TNKS1BP1
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	0.373089445025248	-0.985937089090201	21	2	0.00316455696202532	632	10285	665,27113	BNIP3L,BBC3
R-HSA-5576891	Cardiac conduction	0.374981081490204	-0.980879703643794	142	10	0.0158227848101266	632	10285	51305,4880,6330,817,444,786,204851,3752,3708,3761	KCNK9,NPPC,SCN4B,CAMK2D,ASPH,CACNG1,HIPK1,KCND3,ITPR1,KCNJ4
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.382364625429527	-0.961380608805851	36	3	0.00474683544303797	632	10285	6619,51082,5437	SNAPC3,POLR1D,POLR2H
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.382364625429527	-0.961380608805851	36	3	0.00474683544303797	632	10285	7128,8887,7187	TNFAIP3,TAX1BP1,TRAF3
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.382364625429527	-0.961380608805851	36	3	0.00474683544303797	632	10285	64344,27086,5437	HIF3A,FOXP1,POLR2H
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.382364625429527	-0.961380608805851	36	3	0.00474683544303797	632	10285	10810,51517,10787	WASF3,NCKIPSD,NCKAP1
R-HSA-167021	PLC-gamma1 signalling	0.382364625429527	-0.961380608805851	36	3	0.00474683544303797	632	10285	5335,114,3708	PLCG1,ADCY8,ITPR1
R-HSA-445355	Smooth Muscle Contraction	0.382364625429527	-0.961380608805851	36	3	0.00474683544303797	632	10285	7414,302,5829	VCL,ANXA2,PXN
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.382364625429527	-0.961380608805851	36	3	0.00474683544303797	632	10285	9818,8480,55706	NUP58,RAE1,NDC1
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.382364625429527	-0.961380608805851	36	3	0.00474683544303797	632	10285	114,3708,5335	ADCY8,ITPR1,PLCG1
R-HSA-157118	Signaling by NOTCH	0.382979906010948	-0.959772755901185	112	8	0.0126582278481013	632	10285	10402,3516,4853,10014,6484,8841,3725,8650	ST3GAL6,RBPJ,NOTCH2,HDAC5,ST3GAL4,HDAC3,JUN,NUMB
R-HSA-112310	Neurotransmitter Release Cycle	0.383667496832888	-0.957978995161232	51	4	0.00632911392405063	632	10285	8497,6616,57030,8825	PPFIA4,SNAP25,SLC17A7,LIN7A
R-HSA-180292	GAB1 signalosome	0.387845562994806	-0.947148052113772	128	9	0.0142405063291139	632	10285	3164,3815,2261,5526,2549,2309,23239,253260,5829	NR4A1,KIT,FGFR3,PPP2R5B,GAB1,FOXO3,PHLPP1,RICTOR,PXN
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.390989779232012	-0.93907385941001	82	6	0.00949367088607595	632	10285	58528,2821,54541,5565,64121,27244	RRAGD,GPI,DDIT4,PRKAB2,RRAGC,SESN1
R-HSA-8848021	Signaling by PTK6	0.394728595541055	-0.929556850138397	67	5	0.00791139240506329	632	10285	153090,9021,10656,5829,55620	DAB2IP,SOCS3,KHDRBS3,PXN,STAP2
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.395421278187748	-0.927803555359346	22	2	0.00316455696202532	632	10285	9252,5970	RPS6KA5,RELA
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.395421278187748	-0.927803555359346	22	2	0.00316455696202532	632	10285	253260,1326	RICTOR,MAP3K8
R-HSA-389513	CTLA4 inhibitory signaling	0.395421278187748	-0.927803555359346	22	2	0.00316455696202532	632	10285	7525,5526	YES1,PPP2R5B
R-HSA-1483206	Glycerophospholipid biosynthesis	0.396747490767789	-0.924455244062438	129	9	0.0142405063291139	632	10285	201164,84803,8904,56261,51205,9663,1040,84879,23259	PLD6,GPAT3,CPNE1,GPCPD1,ACP6,LPIN2,CDS1,MFSD2A,DDHD2
R-HSA-2142789	Ubiquinol biosynthesis	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	51004	COQ6
R-HSA-1483115	Hydrolysis of LPC	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	56261	GPCPD1
R-HSA-400451	Free fatty acids regulate insulin secretion	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	5331	PLCB3
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	6469	SHH
R-HSA-1483148	Synthesis of PG	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	201164	PLD6
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	27289	RND1
R-HSA-6787450	tRNA modification in the mitochondrion	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	54802	TRIT1
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	1491	CTH
R-HSA-448424	Interleukin-17 signaling	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	132014	IL17RE
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	5331	PLCB3
R-HSA-8937144	Aryl hydrocarbon receptor signalling	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	405	ARNT
R-HSA-196783	Coenzyme A biosynthesis	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	80347	COASY
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	5565	PRKAB2
R-HSA-177128	Conjugation of salicylate with glycine	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	219970	GLYATL2
R-HSA-977347	Serine biosynthesis	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	26227	PHGDH
R-HSA-194313	VEGF ligand-receptor interactions	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	7422	VEGFA
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.398013664731533	-0.921268940790767	8	1	0.00158227848101266	632	10285	7422	VEGFA
R-HSA-73923	Lipid digestion, mobilization, and transport	0.411482198191625	-0.88798952057448	115	8	0.0126582278481013	632	10285	5500,29923,51129,7436,19,4023,5125,2170	PPP1CB,HILPDA,ANGPTL4,VLDLR,ABCA1,LPL,PCSK5,FABP3
R-HSA-5205647	Mitophagy	0.417380401225171	-0.873757239861241	23	2	0.00316455696202532	632	10285	9804,7416	TOMM20,VDAC1
R-HSA-5365859	RA biosynthesis pathway	0.417380401225171	-0.873757239861241	23	2	0.00316455696202532	632	10285	9249,56603	DHRS3,CYP26B1
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.417380401225171	-0.873757239861241	23	2	0.00316455696202532	632	10285	7416,9804	VDAC1,TOMM20
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.417380401225171	-0.873757239861241	23	2	0.00316455696202532	632	10285	4088,23327	SMAD3,NEDD4L
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.417380401225171	-0.873757239861241	23	2	0.00316455696202532	632	10285	7277,84617	TUBA4A,TUBB6
R-HSA-73980	RNA Polymerase III Transcription Termination	0.417380401225171	-0.873757239861241	23	2	0.00316455696202532	632	10285	51082,5437	POLR1D,POLR2H
R-HSA-5627123	RHO GTPases activate PAKs	0.417380401225171	-0.873757239861241	23	2	0.00316455696202532	632	10285	2316,5500	FLNA,PPP1CB
R-HSA-111885	Opioid Signalling	0.424449079831975	-0.856963233707273	85	6	0.00949367088607595	632	10285	5143,3708,2781,5331,114,2773	PDE4C,ITPR1,GNAZ,PLCB3,ADCY8,GNAI3
R-HSA-948021	Transport to the Golgi and subsequent modification	0.426951841316568	-0.851084055916032	164	11	0.0174050632911392	632	10285	4248,26286,7039,51014,6484,9871,3998,8702,4122,54732,10282	MGAT3,ARFGAP3,TGFA,TMED7,ST3GAL4,SEC24D,LMAN1,B4GALT4,MAN2A2,TMED9,BET1
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.432808878343525	-0.83745903792754	39	3	0.00474683544303797	632	10285	3708,868,5335	ITPR1,CBLB,PLCG1
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	0.432808878343525	-0.83745903792754	39	3	0.00474683544303797	632	10285	3690,5604,7414	ITGB3,MAP2K1,VCL
R-HSA-5674135	MAP2K and MAPK activation	0.432808878343525	-0.83745903792754	39	3	0.00474683544303797	632	10285	7414,3690,5604	VCL,ITGB3,MAP2K1
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.432808878343525	-0.83745903792754	39	3	0.00474683544303797	632	10285	7431,1829,9414	VIM,DSG2,TJP2
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	0.432808878343525	-0.83745903792754	39	3	0.00474683544303797	632	10285	7414,5604,3690	VCL,MAP2K1,ITGB3
R-HSA-447041	CHL1 interactions	0.435033744909136	-0.832331676398439	9	1	0.00158227848101266	632	10285	8829	NRP1
R-HSA-1614558	Degradation of cysteine and homocysteine	0.435033744909136	-0.832331676398439	9	1	0.00158227848101266	632	10285	1491	CTH
R-HSA-2243919	Crosslinking of collagen fibrils	0.435033744909136	-0.832331676398439	9	1	0.00158227848101266	632	10285	4015	LOX
R-HSA-391908	Prostanoid ligand receptors	0.435033744909136	-0.832331676398439	9	1	0.00158227848101266	632	10285	5732	PTGER2
R-HSA-156587	Amino Acid conjugation	0.435033744909136	-0.832331676398439	9	1	0.00158227848101266	632	10285	219970	GLYATL2
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.435033744909136	-0.832331676398439	9	1	0.00158227848101266	632	10285	85415	RHPN2
R-HSA-159424	Conjugation of carboxylic acids	0.435033744909136	-0.832331676398439	9	1	0.00158227848101266	632	10285	219970	GLYATL2
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.435553017526024	-0.831138750659445	86	6	0.00949367088607595	632	10285	5335,7525,10810,10787,3708,51517	PLCG1,YES1,WASF3,NCKAP1,ITPR1,NCKIPSD
R-HSA-5654741	Signaling by FGFR3	0.449298687185643	-0.800067384820722	40	3	0.00474683544303797	632	10285	2549,2261,5335	GAB1,FGFR3,PLCG1
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	0.456277645266202	-0.7846537835568	72	5	0.00791139240506329	632	10285	9662,11190,55559,9702,7277	CEP135,CEP250,HAUS7,CEP57,TUBA4A
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.456277645266202	-0.7846537835568	72	5	0.00791139240506329	632	10285	7277,55559,9702,11190,9662	TUBA4A,HAUS7,CEP57,CEP250,CEP135
R-HSA-202733	Cell surface interactions at the vascular wall	0.458988041141013	-0.77873112342002	136	9	0.0142405063291139	632	10285	5335,6382,58494,3690,7525,50848,6520,9123,8793	PLCG1,SDC1,JAM2,ITGB3,YES1,F11R,SLC3A2,SLC16A3,TNFRSF10D
R-HSA-425410	Metal ion SLC transporters	0.460032524094263	-0.7764580874457	25	2	0.00316455696202532	632	10285	254428,27173	SLC41A1,SLC39A1
R-HSA-182971	EGFR downregulation	0.460032524094263	-0.7764580874457	25	2	0.00316455696202532	632	10285	10252,6456	SPRY1,SH3GL2
R-HSA-5673000	RAF activation	0.460032524094263	-0.7764580874457	25	2	0.00316455696202532	632	10285	5526,5604	PPP2R5B,MAP2K1
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.460032524094263	-0.7764580874457	25	2	0.00316455696202532	632	10285	5970,4791	RELA,NFKB2
R-HSA-982772	Growth hormone receptor signaling	0.460032524094263	-0.7764580874457	25	2	0.00316455696202532	632	10285	9021,1154	SOCS3,CISH
R-HSA-429947	Deadenylation of mRNA	0.460032524094263	-0.7764580874457	25	2	0.00316455696202532	632	10285	1975,85456	EIF4B,TNKS1BP1
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.460032524094263	-0.7764580874457	25	2	0.00316455696202532	632	10285	3762,3761	KCNJ5,KCNJ4
R-HSA-1296059	G protein gated Potassium channels	0.460032524094263	-0.7764580874457	25	2	0.00316455696202532	632	10285	3761,3762	KCNJ4,KCNJ5
R-HSA-1538133	G0 and Early G1	0.460032524094263	-0.7764580874457	25	2	0.00316455696202532	632	10285	890,8900	CCNA2,CCNA1
R-HSA-977068	Termination of O-glycan biosynthesis	0.460032524094263	-0.7764580874457	25	2	0.00316455696202532	632	10285	6482,6484	ST3GAL1,ST3GAL4
R-HSA-1614635	Sulfur amino acid metabolism	0.460032524094263	-0.7764580874457	25	2	0.00316455696202532	632	10285	2729,1491	GCLC,CTH
R-HSA-933542	TRAF6 mediated NF-kB activation	0.460032524094263	-0.7764580874457	25	2	0.00316455696202532	632	10285	5970,4791	RELA,NFKB2
R-HSA-1296041	Activation of G protein gated Potassium channels	0.460032524094263	-0.7764580874457	25	2	0.00316455696202532	632	10285	3762,3761	KCNJ5,KCNJ4
R-HSA-74158	RNA Polymerase III Transcription	0.465590691163757	-0.764448375969765	41	3	0.00474683544303797	632	10285	51082,5437,6619	POLR1D,POLR2H,SNAPC3
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.465590691163757	-0.764448375969765	41	3	0.00474683544303797	632	10285	5437,51082,6619	POLR2H,POLR1D,SNAPC3
R-HSA-3000178	ECM proteoglycans	0.467620913230415	-0.760097325768397	57	4	0.00632911392405063	632	10285	3690,3679,284217,1299	ITGB3,ITGA7,LAMA1,COL9A3
R-HSA-168799	Neurotoxicity of clostridium toxins	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	6616	SNAP25
R-HSA-399997	Acetylcholine regulates insulin secretion	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	5331	PLCB3
R-HSA-170660	Adenylate cyclase activating pathway	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	114	ADCY8
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	55190	NUDT11
R-HSA-196108	Pregnenolone biosynthesis	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	134429	STARD4
R-HSA-2046105	Linoleic acid (LA) metabolism	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	83401	ELOVL3
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	3656	IRAK2
R-HSA-6811555	PI5P Regulates TP53 Acetylation	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	3622	ING2
R-HSA-428643	Organic anion transporters	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	57030	SLC17A7
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	4122	MAN2A2
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	27173	SLC39A1
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	27113	BBC3
R-HSA-193692	Regulated proteolysis of p75NTR	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	5970	RELA
R-HSA-418886	Netrin mediated repulsion signals	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	90249	UNC5A
R-HSA-427601	Multifunctional anion exchangers	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	65010	SLC26A6
R-HSA-430116	GP1b-IX-V activation signalling	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	2316	FLNA
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.469780599057944	-0.755489503782993	10	1	0.00158227848101266	632	10285	5335	PLCG1
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.478543401900873	-0.737008368125434	106	7	0.0110759493670886	632	10285	9123,6515,6533,6513,27173,254428,144195	SLC16A3,SLC2A3,SLC6A6,SLC2A1,SLC39A1,SLC41A1,SLC2A14
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.4795107303083	-0.73498900678953	90	6	0.00949367088607595	632	10285	9662,11190,55559,9702,7277,5500	CEP135,CEP250,HAUS7,CEP57,TUBA4A,PPP1CB
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.4795107303083	-0.73498900678953	90	6	0.00949367088607595	632	10285	253260,2309,3164,2549,3815,2261	RICTOR,FOXO3,NR4A1,GAB1,KIT,FGFR3
R-HSA-174824	Lipoprotein metabolism	0.48044119167265	-0.733050447921249	74	5	0.00791139240506329	632	10285	51129,5125,7436,4023,19	ANGPTL4,PCSK5,VLDLR,LPL,ABCA1
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.480666238026041	-0.732582141568494	26	2	0.00316455696202532	632	10285	7277,84617	TUBA4A,TUBB6
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.480666238026041	-0.732582141568494	26	2	0.00316455696202532	632	10285	6382,3339	SDC1,HSPG2
R-HSA-2029485	Role of phospholipids in phagocytosis	0.480666238026041	-0.732582141568494	26	2	0.00316455696202532	632	10285	3708,5335	ITPR1,PLCG1
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.480666238026041	-0.732582141568494	26	2	0.00316455696202532	632	10285	8717,7128	TRADD,TNFAIP3
R-HSA-210991	Basigin interactions	0.480666238026041	-0.732582141568494	26	2	0.00316455696202532	632	10285	6520,9123	SLC3A2,SLC16A3
R-HSA-912694	Regulation of IFNA signaling	0.480666238026041	-0.732582141568494	26	2	0.00316455696202532	632	10285	9021,3716	SOCS3,JAK1
R-HSA-975298	Ligand-gated ion channel transport	0.480666238026041	-0.732582141568494	26	2	0.00316455696202532	632	10285	2561,2555	GABRB2,GABRA2
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.480666238026041	-0.732582141568494	26	2	0.00316455696202532	632	10285	6382,3339	SDC1,HSPG2
R-HSA-446203	Asparagine N-linked glycosylation	0.481256051206074	-0.731355819524495	284	18	0.0284810126582278	632	10285	10402,8702,9945,7039,26286,4248,2720,9695,6484,54732,6675,4122,10282,6482,4351,3998,9871,51014	ST3GAL6,B4GALT4,GFPT2,TGFA,ARFGAP3,MGAT3,GLB1,EDEM1,ST3GAL4,TMED9,UAP1,MAN2A2,BET1,ST3GAL1,MPI,LMAN1,SEC24D,TMED7
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.481666523806674	-0.730503263698899	42	3	0.00474683544303797	632	10285	6319,6720,6256	SCD,SREBF1,RXRA
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.481666523806674	-0.730503263698899	42	3	0.00474683544303797	632	10285	3708,114,3790	ITPR1,ADCY8,KCNS3
R-HSA-373752	Netrin-1 signaling	0.481666523806674	-0.730503263698899	42	3	0.00474683544303797	632	10285	5335,90249,6478	PLCG1,UNC5A,SIAH2
R-HSA-162599	Late Phase of HIV Life Cycle	0.485386252307733	-0.722810308489294	139	9	0.0142405063291139	632	10285	5437,4331,8480,55706,7514,9818,23327,2961,8731	POLR2H,MNAT1,RAE1,NDC1,XPO1,NUP58,NEDD4L,GTF2E2,RNMT
R-HSA-73777	RNA Polymerase I Chain Elongation	0.490348981565594	-0.712637934099989	91	6	0.00949367088607595	632	10285	8341,4331,5437,51082,3015,79101	H2BC15,MNAT1,POLR2H,POLR1D,H2AZ1,TAF1D
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.490348981565594	-0.712637934099989	91	6	0.00949367088607595	632	10285	54464,5600,8125,11340,7538,7514	XRN1,MAPK11,ANP32A,EXOSC8,ZFP36,XPO1
R-HSA-109581	Apoptosis	0.490560326083392	-0.712207018582275	172	11	0.0174050632911392	632	10285	27113,1829,8717,90249,3006,3005,7431,3148,90427,26060,9414	BBC3,DSG2,TRADD,UNC5A,H1-2,H1-0,VIM,HMGB2,BMF,APPL1,TJP2
R-HSA-8854518	AURKA Activation by TPX2	0.492387060970186	-0.708490162494381	75	5	0.00791139240506329	632	10285	55559,9702,7277,9662,11190	HAUS7,CEP57,TUBA4A,CEP135,CEP250
R-HSA-5654738	Signaling by FGFR2	0.492387060970186	-0.708490162494381	75	5	0.00791139240506329	632	10285	5437,2549,3185,5725,5335	POLR2H,GAB1,HNRNPF,PTBP1,PLCG1
R-HSA-75893	TNF signaling	0.497509607646772	-0.698140410717152	43	3	0.00474683544303797	632	10285	8717,8887,7128	TRADD,TAX1BP1,TNFAIP3
R-HSA-5655253	Signaling by FGFR2 in disease	0.497509607646772	-0.698140410717152	43	3	0.00474683544303797	632	10285	5437,2549,5335	POLR2H,GAB1,PLCG1
R-HSA-5654716	Downstream signaling of activated FGFR4	0.500807510336672	-0.69153346263004	27	2	0.00316455696202532	632	10285	5335,2549	PLCG1,GAB1
R-HSA-114508	Effects of PIP2 hydrolysis	0.500807510336672	-0.69153346263004	27	2	0.00316455696202532	632	10285	10125,3708	RASGRP1,ITPR1
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	0.500807510336672	-0.69153346263004	27	2	0.00316455696202532	632	10285	51082,5437	POLR1D,POLR2H
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	0.500807510336672	-0.69153346263004	27	2	0.00316455696202532	632	10285	5829,153090	PXN,DAB2IP
R-HSA-69416	Dimerization of procaspase-8	0.502393607456249	-0.688371387921343	11	1	0.00158227848101266	632	10285	8717	TRADD
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.502393607456249	-0.688371387921343	11	1	0.00158227848101266	632	10285	10592	SMC2
R-HSA-5218900	CASP8 activity is inhibited	0.502393607456249	-0.688371387921343	11	1	0.00158227848101266	632	10285	8717	TRADD
R-HSA-3371378	Regulation by c-FLIP	0.502393607456249	-0.688371387921343	11	1	0.00158227848101266	632	10285	8717	TRADD
R-HSA-189451	Heme biosynthesis	0.502393607456249	-0.688371387921343	11	1	0.00158227848101266	632	10285	1371	CPOX
R-HSA-73614	Pyrimidine salvage reactions	0.502393607456249	-0.688371387921343	11	1	0.00158227848101266	632	10285	1633	DCK
R-HSA-5663202	Diseases of signal transduction	0.503355495074227	-0.686458608861772	369	23	0.0363924050632911	632	10285	5335,80853,8841,2309,6469,3516,4088,7414,5604,8087,5526,2261,3164,5437,153090,2549,3815,9372,11044,3690,79412,253260,10014	PLCG1,KDM7A,HDAC3,FOXO3,SHH,RBPJ,SMAD3,VCL,MAP2K1,FXR1,PPP2R5B,FGFR3,NR4A1,POLR2H,DAB2IP,GAB1,KIT,ZFYVE9,TENT4A,ITGB3,KREMEN2,RICTOR,HDAC5
R-HSA-1257604	PIP3 activates AKT signaling	0.505397083376841	-0.682410854965074	125	8	0.0126582278481013	632	10285	2309,23239,253260,3164,3815,2261,5526,2549	FOXO3,PHLPP1,RICTOR,NR4A1,KIT,FGFR3,PPP2R5B,GAB1
R-HSA-5689880	Ub-specific processing proteases	0.506968467282831	-0.679306472033546	223	14	0.0221518987341772	632	10285	4088,8330,890,55288,6478,7417,4092,8313,57646,7416,8900,8341,79589,9804	SMAD3,H2AC15,CCNA2,RHOT1,SIAH2,VDAC2,SMAD7,AXIN2,USP28,VDAC1,CCNA1,H2BC15,RNF128,TOMM20
R-HSA-6784531	tRNA processing in the nucleus	0.508069444698707	-0.677137138583736	60	4	0.00632911392405063	632	10285	55706,8480,54913,9818	NDC1,RAE1,RPP25,NUP58
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	0.511796789198751	-0.66982762882292	93	6	0.00949367088607595	632	10285	8900,204851,5600,5565,11200,890	CCNA1,HIPK1,MAPK11,PRKAB2,CHEK2,CCNA2
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	0.511796789198751	-0.66982762882292	93	6	0.00949367088607595	632	10285	8341,5437,79101,23451,3015,51082	H2BC15,POLR2H,TAF1D,SF3B1,H2AZ1,POLR1D
R-HSA-1296072	Voltage gated Potassium channels	0.513105078448653	-0.667274623502507	44	3	0.00474683544303797	632	10285	3790,3752,170850	KCNS3,KCND3,KCNG3
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.513105078448653	-0.667274623502507	44	3	0.00474683544303797	632	10285	8877,166929,123099	SPHK1,SGMS2,DEGS2
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.513105078448653	-0.667274623502507	44	3	0.00474683544303797	632	10285	9818,55706,8480	NUP58,NDC1,RAE1
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.513105078448653	-0.667274623502507	44	3	0.00474683544303797	632	10285	6520,56267,125061	SLC3A2,KYAT3,AFMID
R-HSA-5357801	Programmed Cell Death	0.514042707131195	-0.665448929174692	175	11	0.0174050632911392	632	10285	9414,26060,90427,7431,3148,3005,90249,3006,8717,1829,27113	TJP2,APPL1,BMF,VIM,HMGB2,H1-0,UNC5A,H1-2,TRADD,DSG2,BBC3
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.515965125750342	-0.661716101539745	77	5	0.00791139240506329	632	10285	64344,7422,54583,405,8994	HIF3A,VEGFA,EGLN1,ARNT,LIMD1
R-HSA-2262749	Cellular response to hypoxia	0.515965125750342	-0.661716101539745	77	5	0.00791139240506329	632	10285	8994,405,64344,7422,54583	LIMD1,ARNT,HIF3A,VEGFA,EGLN1
R-HSA-168249	Innate Immune System	0.51742983395959	-0.658881349586817	1285	79	0.125	632	10285	1742,3164,2040,5526,3560,10855,6515,7525,153090,51517,8887,3708,5437,10125,158747,5315,817,4791,302,114,3725,5660,7128,55276,8987,10810,2821,8904,2309,23239,7187,8836,11322,230,4179,7414,51646,5329,1326,2675,5970,1847,2261,3615,1386,54509,3716,51082,226,5836,88,8915,3815,5600,2549,253260,5924,3690,3310,5335,25801,6386,5923,2720,4126,3656,10549,5598,1852,9252,6616,5236,5604,3074,5223,78989,23526,10787,1265	DLG4,NR4A1,STOM,PPP2R5B,IL2RB,HPSE,SLC2A3,YES1,DAB2IP,NCKIPSD,TAX1BP1,ITPR1,POLR2H,RASGRP1,MOSPD2,PKM,CAMK2D,NFKB2,ANXA2,ADCY8,JUN,PSAP,TNFAIP3,PGM2,STBD1,WASF3,GPI,CPNE1,FOXO3,PHLPP1,TRAF3,GGH,TMC6,ALDOC,CD46,VCL,YPEL5,PLAUR,MAP3K8,GFRA2,RELA,DUSP5,FGFR3,IMPDH2,ATF2,RHOF,JAK1,POLR1D,ALDOA,PYGL,ACTN2,BCL10,KIT,MAPK11,GAB1,RICTOR,RASGRF2,ITGB3,HSPA6,PLCG1,GCA,SDCBP,RASGRF1,GLB1,MANBA,IRAK2,PRDX4,MAPK7,DUSP9,RPS6KA5,SNAP25,PGM1,MAP2K1,HEXB,PGAM1,COLEC11,ARHGAP45,NCKAP1,CNN2
R-HSA-3214847	HATs acetylate histones	0.520066381800958	-0.65379881824463	143	9	0.0142405063291139	632	10285	79960,8341,51147,1386,8330,55689,26009,55257,117143	JADE1,H2BC15,ING4,ATF2,H2AC15,YEATS2,ZZZ3,MRGBP,TADA1
R-HSA-211976	Endogenous sterols	0.520438884674966	-0.65308281439165	28	2	0.00316455696202532	632	10285	405,6256	ARNT,RXRA
R-HSA-264876	Insulin processing	0.520438884674966	-0.65308281439165	28	2	0.00316455696202532	632	10285	56605,30001	ERO1B,ERO1A
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.520438884674966	-0.65308281439165	28	2	0.00316455696202532	632	10285	10125,3690	RASGRP1,ITGB3
R-HSA-1483191	Synthesis of PC	0.520438884674966	-0.65308281439165	28	2	0.00316455696202532	632	10285	9663,84879	LPIN2,MFSD2A
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.520438884674966	-0.65308281439165	28	2	0.00316455696202532	632	10285	5437,51082	POLR2H,POLR1D
R-HSA-1266695	Interleukin-7 signaling	0.520438884674966	-0.65308281439165	28	2	0.00316455696202532	632	10285	3716,54014	JAK1,BRWD1
R-HSA-72702	Ribosomal scanning and start codon recognition	0.521245549785771	-0.651534043486827	61	4	0.00632911392405063	632	10285	3646,7458,1975,8662	EIF3E,EIF4H,EIF4B,EIF3B
R-HSA-3214815	HDACs deacetylate histones	0.522394016639135	-0.649333154685939	94	6	0.00949367088607595	632	10285	23186,8819,8841,8341,8330,51317	RCOR1,SAP30,HDAC3,H2BC15,H2AC15,PHF21A
R-HSA-983712	Ion channel transport	0.523412804281748	-0.647384825521301	209	13	0.0205696202531646	632	10285	94015,817,50636,2561,65267,51076,54795,148229,6340,2040,23327,444,2555	TTYH2,CAMK2D,ANO7,GABRB2,WNK3,CUTC,TRPM4,ATP8B3,SCNN1G,STOM,NEDD4L,ASPH,GABRA2
R-HSA-163685	Integration of energy metabolism	0.527892103680873	-0.638863365247251	111	7	0.0110759493670886	632	10285	6513,3790,5565,114,6616,3708,5331	SLC2A1,KCNS3,PRKAB2,ADCY8,SNAP25,ITPR1,PLCB3
R-HSA-8854214	TBC/RABGAPs	0.528439707403481	-0.637826562670796	45	3	0.00474683544303797	632	10285	23062,9363,64786	GGA2,RAB33A,TBC1D15
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.528439707403481	-0.637826562670796	45	3	0.00474683544303797	632	10285	8480,55706,9818	RAE1,NDC1,NUP58
R-HSA-198203	PI3K/AKT activation	0.532744409836969	-0.629713501090901	128	8	0.0126582278481013	632	10285	5526,2549,3815,2261,3164,2309,253260,23239	PPP2R5B,GAB1,KIT,FGFR3,NR4A1,FOXO3,RICTOR,PHLPP1
R-HSA-203615	eNOS activation	0.533003617206876	-0.629227068334863	12	1	0.00158227848101266	632	10285	114757	CYGB
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.533003617206876	-0.629227068334863	12	1	0.00158227848101266	632	10285	1742	DLG4
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	0.533003617206876	-0.629227068334863	12	1	0.00158227848101266	632	10285	8793	TNFRSF10D
R-HSA-1296346	Tandem pore domain potassium channels	0.533003617206876	-0.629227068334863	12	1	0.00158227848101266	632	10285	51305	KCNK9
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.533003617206876	-0.629227068334863	12	1	0.00158227848101266	632	10285	1742	DLG4
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.533003617206876	-0.629227068334863	12	1	0.00158227848101266	632	10285	2261	FGFR3
R-HSA-176974	Unwinding of DNA	0.533003617206876	-0.629227068334863	12	1	0.00158227848101266	632	10285	4171	MCM2
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.533003617206876	-0.629227068334863	12	1	0.00158227848101266	632	10285	114799	ESCO1
R-HSA-1475029	Reversible hydration of carbon dioxide	0.533003617206876	-0.629227068334863	12	1	0.00158227848101266	632	10285	771	CA12
R-HSA-2033514	FGFR3 mutant receptor activation	0.533003617206876	-0.629227068334863	12	1	0.00158227848101266	632	10285	2261	FGFR3
R-HSA-8866427	VLDLR internalisation and degradation	0.533003617206876	-0.629227068334863	12	1	0.00158227848101266	632	10285	7436	VLDLR
R-HSA-71384	Ethanol oxidation	0.533003617206876	-0.629227068334863	12	1	0.00158227848101266	632	10285	128	ADH5
R-HSA-2160916	Hyaluronan uptake and degradation	0.533003617206876	-0.629227068334863	12	1	0.00158227848101266	632	10285	3074	HEXB
R-HSA-1268020	Mitochondrial protein import	0.534251985238194	-0.626887668854934	62	4	0.00632911392405063	632	10285	80273,7416,9804,134266	GRPEL1,VDAC1,TOMM20,GRPEL2
R-HSA-72649	Translation initiation complex formation	0.534251985238194	-0.626887668854934	62	4	0.00632911392405063	632	10285	8662,3646,7458,1975	EIF3B,EIF3E,EIF4H,EIF4B
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	0.539546900317283	-0.617025565129526	29	2	0.00316455696202532	632	10285	201164,5437	PLD6,POLR2H
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.539546900317283	-0.617025565129526	29	2	0.00316455696202532	632	10285	84617,7277	TUBB6,TUBA4A
R-HSA-202040	G-protein activation	0.539546900317283	-0.617025565129526	29	2	0.00316455696202532	632	10285	2773,2781	GNAI3,GNAZ
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.539546900317283	-0.617025565129526	29	2	0.00316455696202532	632	10285	1495,253260	CTNNA1,RICTOR
R-HSA-195258	RHO GTPase Effectors	0.542084874332798	-0.612332695092203	294	18	0.0284810126582278	632	10285	1856,5585,23081,85415,1495,10787,1855,1730,2316,23433,3015,7514,1742,5526,5500,10810,8341,51517	DVL2,PKN1,KDM4C,RHPN2,CTNNA1,NCKAP1,DVL1,DIAPH2,FLNA,RHOQ,H2AZ1,XPO1,DLG4,PPP2R5B,PPP1CB,WASF3,H2BC15,NCKIPSD
R-HSA-4615885	SUMOylation of DNA replication proteins	0.543501822112686	-0.609722219873253	46	3	0.00474683544303797	632	10285	9818,8480,55706	NUP58,RAE1,NDC1
R-HSA-446652	Interleukin-1 signaling	0.543501822112686	-0.609722219873253	46	3	0.00474683544303797	632	10285	3656,5604,1326	IRAK2,MAP2K1,MAP3K8
R-HSA-418555	G alpha (s) signalling events	0.545564529447566	-0.605934186575851	146	9	0.0142405063291139	632	10285	5143,1395,2781,136,114,797,2773,5732,133	PDE4C,CRHR2,GNAZ,ADORA2B,ADCY8,CALCB,GNAI3,PTGER2,ADM
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.54708015168541	-0.603159957705153	63	4	0.00632911392405063	632	10285	1975,7458,3646,8662	EIF4B,EIF4H,EIF3E,EIF3B
R-HSA-1226099	Signaling by FGFR in disease	0.54708015168541	-0.603159957705153	63	4	0.00632911392405063	632	10285	5335,2261,5437,2549	PLCG1,FGFR3,POLR2H,GAB1
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.547979415228358	-0.601517556191547	229	14	0.0221518987341772	632	10285	3815,8915,2549,253260,2261,5526,5335,5970,3164,868,3708,10125,23239,2309	KIT,BCL10,GAB1,RICTOR,FGFR3,PPP2R5B,PLCG1,RELA,NR4A1,CBLB,ITPR1,RASGRP1,PHLPP1,FOXO3
R-HSA-5654696	Downstream signaling of activated FGFR2	0.558121668388581	-0.583178296661766	30	2	0.00316455696202532	632	10285	2549,5335	GAB1,PLCG1
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.558121668388581	-0.583178296661766	30	2	0.00316455696202532	632	10285	3708,5335	ITPR1,PLCG1
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	0.558121668388581	-0.583178296661766	30	2	0.00316455696202532	632	10285	92912,55236	UBE2Q2,UBA6
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.558121668388581	-0.583178296661766	30	2	0.00316455696202532	632	10285	56852,8450	RAD18,CUL4B
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.558281227143469	-0.582892452265244	47	3	0.00474683544303797	632	10285	2961,4331,5437	GTF2E2,MNAT1,POLR2H
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.558281227143469	-0.582892452265244	47	3	0.00474683544303797	632	10285	2961,4331,5437	GTF2E2,MNAT1,POLR2H
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.558281227143469	-0.582892452265244	47	3	0.00474683544303797	632	10285	5437,4331,2961	POLR2H,MNAT1,GTF2E2
R-HSA-5576892	Phase 0 - rapid depolarisation	0.558281227143469	-0.582892452265244	47	3	0.00474683544303797	632	10285	817,6330,786	CAMK2D,SCN4B,CACNG1
R-HSA-73776	RNA Polymerase II Promoter Escape	0.558281227143469	-0.582892452265244	47	3	0.00474683544303797	632	10285	2961,4331,5437	GTF2E2,MNAT1,POLR2H
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.558281227143469	-0.582892452265244	47	3	0.00474683544303797	632	10285	2961,5437,4331	GTF2E2,POLR2H,MNAT1
R-HSA-167161	HIV Transcription Initiation	0.558281227143469	-0.582892452265244	47	3	0.00474683544303797	632	10285	4331,5437,2961	MNAT1,POLR2H,GTF2E2
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.559510827787978	-0.580692398802622	131	8	0.0126582278481013	632	10285	23239,253260,2309,3164,2549,5526,3815,2261	PHLPP1,RICTOR,FOXO3,NR4A1,GAB1,PPP2R5B,KIT,FGFR3
R-HSA-8873719	RAB geranylgeranylation	0.559722208056711	-0.580314675371527	64	4	0.00632911392405063	632	10285	55647,25837,5876,9363	RAB20,RAB26,RABGGTB,RAB33A
R-HSA-202670	ERKs are inactivated	0.561733463787347	-0.576727805310638	13	1	0.00158227848101266	632	10285	5598	MAPK7
R-HSA-5210891	Uptake and function of anthrax toxins	0.561733463787347	-0.576727805310638	13	1	0.00158227848101266	632	10285	5604	MAP2K1
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.561733463787347	-0.576727805310638	13	1	0.00158227848101266	632	10285	64210	MMS19
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.561733463787347	-0.576727805310638	13	1	0.00158227848101266	632	10285	3708	ITPR1
R-HSA-171007	p38MAPK events	0.561733463787347	-0.576727805310638	13	1	0.00158227848101266	632	10285	5600	MAPK11
R-HSA-190372	FGFR3c ligand binding and activation	0.561733463787347	-0.576727805310638	13	1	0.00158227848101266	632	10285	2261	FGFR3
R-HSA-5626467	RHO GTPases activate IQGAPs	0.561733463787347	-0.576727805310638	13	1	0.00158227848101266	632	10285	1495	CTNNA1
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.561733463787347	-0.576727805310638	13	1	0.00158227848101266	632	10285	7431	VIM
R-HSA-74217	Purine salvage	0.561733463787347	-0.576727805310638	13	1	0.00158227848101266	632	10285	1633	DCK
R-HSA-2029481	FCGR activation	0.561733463787347	-0.576727805310638	13	1	0.00158227848101266	632	10285	7525	YES1
R-HSA-190239	FGFR3 ligand binding and activation	0.561733463787347	-0.576727805310638	13	1	0.00158227848101266	632	10285	2261	FGFR3
R-HSA-1663150	The activation of arylsulfatases	0.561733463787347	-0.576727805310638	13	1	0.00158227848101266	632	10285	153642	ARSK
R-HSA-76002	Platelet activation, signaling and aggregation	0.569269189752701	-0.56340186401763	282	17	0.0268987341772152	632	10285	3560,3716,2773,10125,87,3708,374354,308,7076,226,7414,7422,88,7277,2316,5660,3690	IL2RB,JAK1,GNAI3,RASGRP1,ACTN1,ITPR1,NHLRC2,ANXA5,TIMP1,ALDOA,VCL,VEGFA,ACTN2,TUBA4A,FLNA,PSAP,ITGB3
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.572744054094069	-0.557316339030975	82	5	0.00791139240506329	632	10285	7277,9702,55559,11190,9662	TUBA4A,CEP57,HAUS7,CEP250,CEP135
R-HSA-380287	Centrosome maturation	0.572744054094069	-0.557316339030975	82	5	0.00791139240506329	632	10285	9662,11190,9702,55559,7277	CEP135,CEP250,CEP57,HAUS7,TUBA4A
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	0.572744054094069	-0.557316339030975	82	5	0.00791139240506329	632	10285	54732,113220,51594,26286,51014	TMED9,KIF12,NBAS,ARFGAP3,TMED7
R-HSA-418597	G alpha (z) signalling events	0.572769124578695	-0.557272567409493	48	3	0.00474683544303797	632	10285	2781,2773,114	GNAZ,GNAI3,ADCY8
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.572769124578695	-0.557272567409493	48	3	0.00474683544303797	632	10285	10014,8841,3516	HDAC5,HDAC3,RBPJ
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.572769124578695	-0.557272567409493	48	3	0.00474683544303797	632	10285	5600,7128,3656	MAPK11,TNFAIP3,IRAK2
R-HSA-390466	Chaperonin-mediated protein folding	0.573893592345148	-0.555311279037054	99	6	0.00949367088607595	632	10285	2773,8877,7277,84617,8841,2781	GNAI3,SPHK1,TUBA4A,TUBB6,HDAC3,GNAZ
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.573893592345148	-0.555311279037054	99	6	0.00949367088607595	632	10285	115548,6456,1856,950,143425,4036	FCHO2,SH3GL2,DVL2,SCARB2,SYT9,LRP2
R-HSA-5339562	Uptake and actions of bacterial toxins	0.57615648498162	-0.551375979867989	31	2	0.00316455696202532	632	10285	5604,6616	MAP2K1,SNAP25
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.57615648498162	-0.551375979867989	31	2	0.00316455696202532	632	10285	84706,26227	GPT2,PHGDH
R-HSA-1296065	Inwardly rectifying K+ channels	0.57615648498162	-0.551375979867989	31	2	0.00316455696202532	632	10285	3762,3761	KCNJ5,KCNJ4
R-HSA-114452	Activation of BH3-only proteins	0.57615648498162	-0.551375979867989	31	2	0.00316455696202532	632	10285	90427,27113	BMF,BBC3
R-HSA-1296071	Potassium Channels	0.58386238583363	-0.53808996461738	100	6	0.00949367088607595	632	10285	51305,3790,170850,3762,3752,3761	KCNK9,KCNS3,KCNG3,KCNJ5,KCND3,KCNJ4
R-HSA-212165	Epigenetic regulation of gene expression	0.586836849428896	-0.533008437430552	151	9	0.0142405063291139	632	10285	79101,23451,3015,51082,4331,8819,5437,8341,1789	TAF1D,SF3B1,H2AZ1,POLR1D,MNAT1,SAP30,POLR2H,H2BC15,DNMT3B
R-HSA-6783783	Interleukin-10 signaling	0.586958035423035	-0.532801951619218	49	3	0.00474683544303797	632	10285	3383,7076,3716	ICAM1,TIMP1,JAK1
R-HSA-5675482	Regulation of necroptotic cell death	0.588698460951015	-0.529841177269302	14	1	0.00158227848101266	632	10285	8717	TRADD
R-HSA-209560	NF-kB is activated and signals survival	0.588698460951015	-0.529841177269302	14	1	0.00158227848101266	632	10285	5970	RELA
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.588698460951015	-0.529841177269302	14	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-2024101	CS/DS degradation	0.588698460951015	-0.529841177269302	14	1	0.00158227848101266	632	10285	3074	HEXB
R-HSA-174403	Glutathione synthesis and recycling	0.588698460951015	-0.529841177269302	14	1	0.00158227848101266	632	10285	2729	GCLC
R-HSA-177504	Retrograde neurotrophin signalling	0.588698460951015	-0.529841177269302	14	1	0.00158227848101266	632	10285	6456	SH3GL2
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.588698460951015	-0.529841177269302	14	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.588698460951015	-0.529841177269302	14	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.588698460951015	-0.529841177269302	14	1	0.00158227848101266	632	10285	2956	MSH6
R-HSA-1483213	Synthesis of PE	0.588698460951015	-0.529841177269302	14	1	0.00158227848101266	632	10285	9663	LPIN2
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.588698460951015	-0.529841177269302	14	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.588698460951015	-0.529841177269302	14	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.588698460951015	-0.529841177269302	14	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-399719	Trafficking of AMPA receptors	0.593647478144914	-0.521469606929702	32	2	0.00316455696202532	632	10285	817,1742	CAMK2D,DLG4
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.593647478144914	-0.521469606929702	32	2	0.00316455696202532	632	10285	1742,5331	DLG4,PLCB3
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.593647478144914	-0.521469606929702	32	2	0.00316455696202532	632	10285	1742,817	DLG4,CAMK2D
R-HSA-196071	Metabolism of steroid hormones	0.593647478144914	-0.521469606929702	32	2	0.00316455696202532	632	10285	134429,51171	STARD4,HSD17B14
R-HSA-2187338	Visual phototransduction	0.593710893383144	-0.521362789578158	101	6	0.00949367088607595	632	10285	4023,4036,6382,9249,3339,388531	LPL,LRP2,SDC1,DHRS3,HSPG2,RGS9BP
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.594461523018438	-0.520099286529621	84	5	0.00791139240506329	632	10285	7128,5970,8887,7187,4791	TNFAIP3,RELA,TAX1BP1,TRAF3,NFKB2
R-HSA-162587	HIV Life Cycle	0.594882947092279	-0.519390620365917	152	9	0.0142405063291139	632	10285	55706,8480,4331,23327,8731,2961,7514,9818,5437	NDC1,RAE1,MNAT1,NEDD4L,RNMT,GTF2E2,XPO1,NUP58,POLR2H
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.596464197482357	-0.516736060230649	67	4	0.00632911392405063	632	10285	23081,8341,3015,5585	KDM4C,H2BC15,H2AZ1,PKN1
R-HSA-425407	SLC-mediated transmembrane transport	0.599035338312085	-0.512434687094192	287	17	0.0268987341772152	632	10285	27173,3099,144195,8480,55706,6519,6533,9818,65010,57030,10991,254428,6513,6520,9123,3098,6515	SLC39A1,HK2,SLC2A14,RAE1,NDC1,SLC3A1,SLC6A6,NUP58,SLC26A6,SLC17A7,SLC38A3,SLC41A1,SLC2A1,SLC3A2,SLC16A3,HK1,SLC2A3
R-HSA-5654736	Signaling by FGFR1	0.600841721831203	-0.509423737149708	50	3	0.00474683544303797	632	10285	23769,5335,2549	FLRT1,PLCG1,GAB1
R-HSA-73893	DNA Damage Bypass	0.600841721831203	-0.509423737149708	50	3	0.00474683544303797	632	10285	56852,5980,8450	RAD18,REV3L,CUL4B
R-HSA-73887	Death Receptor Signalling	0.600841721831203	-0.509423737149708	50	3	0.00474683544303797	632	10285	8887,8717,7128	TAX1BP1,TRADD,TNFAIP3
R-HSA-373755	Semaphorin interactions	0.608297753610641	-0.497090790559484	68	4	0.00632911392405063	632	10285	5365,27289,23129,8829	PLXNB3,RND1,PLXND1,NRP1
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.608297753610641	-0.497090790559484	68	4	0.00632911392405063	632	10285	5970,4791,5437,51082	RELA,NFKB2,POLR2H,POLR1D
R-HSA-1980145	Signaling by NOTCH2	0.610593286231038	-0.493324194105324	33	2	0.00316455696202532	632	10285	3516,4853	RBPJ,NOTCH2
R-HSA-8856828	Clathrin-mediated endocytosis	0.610941157036922	-0.492754630443479	137	8	0.0126582278481013	632	10285	6456,115548,950,4036,143425,5286,11252,1856	SH3GL2,FCHO2,SCARB2,LRP2,SYT9,PIK3C2A,PACSIN2,DVL2
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	83401	ELOVL3
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	5335	PLCG1
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	6456	SH3GL2
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	6256	RXRA
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-5358508	Mismatch Repair	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	2956	MSH6
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	145482	PTGR2
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	54464	XRN1
R-HSA-5682910	LGI-ADAM interactions	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	1742	DLG4
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	83401	ELOVL3
R-HSA-391903	Eicosanoid ligand-binding receptors	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	5732	PTGER2
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.614006860601876	-0.487749177278729	15	1	0.00158227848101266	632	10285	1856	DVL2
R-HSA-1227986	Signaling by ERBB2	0.614415110891277	-0.487084502901511	51	3	0.00474683544303797	632	10285	5335,7525,2549	PLCG1,YES1,GAB1
R-HSA-397795	G-protein beta:gamma signalling	0.614415110891277	-0.487084502901511	51	3	0.00474683544303797	632	10285	3560,5331,3716	IL2RB,PLCB3,JAK1
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	0.619916539690577	-0.478170423406493	69	4	0.00632911392405063	632	10285	4331,3725,1386,5437	MNAT1,JUN,ATF2,POLR2H
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.619916539690577	-0.478170423406493	69	4	0.00632911392405063	632	10285	3998,9871,10282,7039	LMAN1,SEC24D,BET1,TGFA
R-HSA-388841	Costimulation by the CD28 family	0.619916539690577	-0.478170423406493	69	4	0.00632911392405063	632	10285	1326,5526,253260,7525	MAP3K8,PPP2R5B,RICTOR,YES1
R-HSA-1643685	Disease	0.623157801003237	-0.472955500127695	858	51	0.0806962025316456	632	10285	4791,9372,3725,11044,5526,3164,5437,153090,3516,4088,7414,831,9509,9510,7187,2309,6469,2549,55706,8480,3815,2961,9818,54437,3690,253260,10014,79412,7058,6122,2261,5970,23327,6382,5507,3841,4331,8731,3339,5604,6616,8087,4853,5335,80853,7514,80070,6456,2926,8841,2997	NFKB2,ZFYVE9,JUN,TENT4A,PPP2R5B,NR4A1,POLR2H,DAB2IP,RBPJ,SMAD3,VCL,CAST,ADAMTS2,ADAMTS1,TRAF3,FOXO3,SHH,GAB1,NDC1,RAE1,KIT,GTF2E2,NUP58,SEMA5B,ITGB3,RICTOR,HDAC5,KREMEN2,THBS2,RPL3,FGFR3,RELA,NEDD4L,SDC1,PPP1R3C,KPNA5,MNAT1,RNMT,HSPG2,MAP2K1,SNAP25,FXR1,NOTCH2,PLCG1,KDM7A,XPO1,ADAMTS20,SH3GL2,GRSF1,HDAC3,GYS1
R-HSA-390522	Striated Muscle Contraction	0.626994764763777	-0.466817088043123	34	2	0.00316455696202532	632	10285	7431,88	VIM,ACTN2
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.626994764763777	-0.466817088043123	34	2	0.00316455696202532	632	10285	7277,84617	TUBA4A,TUBB6
R-HSA-391251	Protein folding	0.631832610544932	-0.459130776648721	105	6	0.00949367088607595	632	10285	2773,8841,2781,84617,8877,7277	GNAI3,HDAC3,GNAZ,TUBB6,SPHK1,TUBA4A
R-HSA-399956	CRMPs in Sema3A signaling	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	8829	NRP1
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	5277	PIGA
R-HSA-110312	Translesion synthesis by REV1	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	5980	REV3L
R-HSA-5218859	Regulated Necrosis	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	8717	TRADD
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	136	ADORA2B
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	8717	TRADD
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	5335	PLCG1
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	7187	TRAF3
R-HSA-163615	PKA activation	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	114	ADCY8
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	3656	IRAK2
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	8829	NRP1
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	3690	ITGB3
R-HSA-159418	Recycling of bile acids and salts	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	6256	RXRA
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	3690	ITGB3
R-HSA-1963642	PI3K events in ERBB2 signaling	0.637760284559734	-0.449792795771571	16	1	0.00158227848101266	632	10285	2549	GAB1
R-HSA-191859	snRNP Assembly	0.640616085235688	-0.445324932481846	53	3	0.00474683544303797	632	10285	8480,55706,9818	RAE1,NDC1,NUP58
R-HSA-194441	Metabolism of non-coding RNA	0.640616085235688	-0.445324932481846	53	3	0.00474683544303797	632	10285	55706,8480,9818	NDC1,RAE1,NUP58
R-HSA-72165	mRNA Splicing - Minor Pathway	0.640616085235688	-0.445324932481846	53	3	0.00474683544303797	632	10285	154007,5437,23451	SNRNP48,POLR2H,SF3B1
R-HSA-5578749	Transcriptional regulation by small RNAs	0.641029963082199	-0.444679078875946	106	6	0.00949367088607595	632	10285	9818,3015,55706,8480,8341,5437	NUP58,H2AZ1,NDC1,RAE1,H2BC15,POLR2H
R-HSA-4791275	Signaling by WNT in cancer	0.642854720023465	-0.44183652113853	35	2	0.00316455696202532	632	10285	5526,79412	PPP2R5B,KREMEN2
R-HSA-113418	Formation of the Early Elongation Complex	0.642854720023465	-0.44183652113853	35	2	0.00316455696202532	632	10285	4331,5437	MNAT1,POLR2H
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.642854720023465	-0.44183652113853	35	2	0.00316455696202532	632	10285	5437,4331	POLR2H,MNAT1
R-HSA-68875	Mitotic Prophase	0.643434433720387	-0.440935147237514	141	8	0.0126582278481013	632	10285	3015,255919,10592,9818,9663,55706,8480,8341	H2AZ1,CNEP1R1,SMC2,NUP58,LPIN2,NDC1,RAE1,H2BC15
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	0.64594981559016	-0.437033463062113	89	5	0.00791139240506329	632	10285	79958,22930,23258,89781,22898	DENND1C,RAB3GAP1,DENND5A,HPS4,DENND3
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.650088999115695	-0.430646003748923	107	6	0.00949367088607595	632	10285	10991,57030,65010,6519,6533,6520	SLC38A3,SLC17A7,SLC26A6,SLC3A1,SLC6A6,SLC3A2
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.653238689230185	-0.425812689342589	54	3	0.00474683544303797	632	10285	8450,4331,5437	CUL4B,MNAT1,POLR2H
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	0.659007615012977	-0.417020189139752	108	6	0.00949367088607595	632	10285	3015,23451,79101,5437,51082,8341	H2AZ1,SF3B1,TAF1D,POLR2H,POLR1D,H2BC15
R-HSA-432142	Platelet sensitization by LDL	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-5656121	Translesion synthesis by POLI	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	5980	REV3L
R-HSA-140534	Ligand-dependent caspase activation	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	8717	TRADD
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	3656	IRAK2
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	114	ADCY8
R-HSA-193639	p75NTR signals via NF-kB	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	5970	RELA
R-HSA-196299	Beta-catenin phosphorylation cascade	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-435354	Zinc transporters	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	27173	SLC39A1
R-HSA-5627117	RHO GTPases Activate ROCKs	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	5500	PPP1CB
R-HSA-5625900	RHO GTPases activate CIT	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	1742	DLG4
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	3708	ITPR1
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	80347	COASY
R-HSA-164378	PKA activation in glucagon signalling	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	114	ADCY8
R-HSA-5655862	Translesion synthesis by POLK	0.660054130138035	-0.415433431964082	17	1	0.00158227848101266	632	10285	5980	REV3L
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.662528455815909	-0.411691769869221	247	14	0.0221518987341772	632	10285	3185,5725,10181,154007,84321,55706,8480,3183,9818,5437,10283,11017,5093,23451	HNRNPF,PTBP1,RBM5,SNRNP48,THOC3,NDC1,RAE1,HNRNPC,NUP58,POLR2H,CWC27,SNRNP27,PCBP1,SF3B1
R-HSA-1980143	Signaling by NOTCH1	0.66417653780207	-0.409207294659077	73	4	0.00632911392405063	632	10285	3516,8650,8841,10014	RBPJ,NUMB,HDAC3,HDAC5
R-HSA-72306	tRNA processing	0.667783947400803	-0.403790589795639	109	6	0.00949367088607595	632	10285	9818,54913,8480,55706,54802,2058	NUP58,RPP25,RAE1,NDC1,TRIT1,EPRS1
R-HSA-392499	Metabolism of proteins	0.670109777636889	-0.400313732799377	1619	96	0.151898734177215	632	10285	349667,11340,51255,5277,116372,7416,136,26286,23062,56605,54732,8330,4088,10282,23480,5329,51014,51299,10402,9509,84617,9945,3015,153642,9510,4248,9363,92912,4122,55706,8480,8915,25837,54437,6482,467,3998,6122,55647,890,30001,55288,79695,10318,374378,3339,57646,2720,79589,2781,8341,7039,80273,6675,5893,3183,7494,6478,4351,4092,493861,5526,8900,1975,3487,134266,7277,7458,3646,8702,7128,9063,79369,79091,7187,9804,9818,7417,8313,7058,9871,2773,220441,3485,8662,8877,6484,1395,5876,55033,1649,55236,80070,8841,84733,9695	RTN4RL2,EXOSC8,RNF181,PIGA,LYPD1,VDAC1,ADORA2B,ARFGAP3,GGA2,ERO1B,TMED9,H2AC15,SMAD3,BET1,SEC61G,PLAUR,TMED7,NRN1,ST3GAL6,ADAMTS2,TUBB6,GFPT2,H2AZ1,ARSK,ADAMTS1,MGAT3,RAB33A,UBE2Q2,MAN2A2,NDC1,RAE1,BCL10,RAB26,SEMA5B,ST3GAL1,ATF3,LMAN1,RPL3,RAB20,CCNA2,ERO1A,RHOT1,GALNT12,TNIP1,GALNT18,HSPG2,USP28,GLB1,RNF128,GNAZ,H2BC15,TGFA,GRPEL1,UAP1,RAD52,HNRNPC,XBP1,SIAH2,MPI,SMAD7,EID3,PPP2R5B,CCNA1,EIF4B,IGFBP4,GRPEL2,TUBA4A,EIF4H,EIF3E,B4GALT4,TNFAIP3,PIAS2,B3GNT4,METTL22,TRAF3,TOMM20,NUP58,VDAC2,AXIN2,THBS2,SEC24D,GNAI3,RNF152,IGFBP2,EIF3B,SPHK1,ST3GAL4,CRHR2,RABGGTB,FKBP14,DDIT3,UBA6,ADAMTS20,HDAC3,CBX2,EDEM1
R-HSA-5633007	Regulation of TP53 Activity	0.670882044640662	-0.399161947864797	162	9	0.0142405063291139	632	10285	5565,5600,890,900,8900,11200,3622,204851,253260	PRKAB2,MAPK11,CCNA2,CCNG1,CCNA1,CHEK2,ING2,HIPK1,RICTOR
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.672721665411334	-0.396423607822353	197	11	0.0174050632911392	632	10285	10125,2309,253260,23239,3815,8915,2261,5526,2549,3164,5970	RASGRP1,FOXO3,RICTOR,PHLPP1,KIT,BCL10,FGFR3,PPP2R5B,GAB1,NR4A1,RELA
R-HSA-373080	Class B/2 (Secretin family receptors)	0.674795381379525	-0.393345772762429	92	5	0.00791139240506329	632	10285	7481,797,133,1395,6469	WNT11,CALCB,ADM,CRHR2,SHH
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.674795381379525	-0.393345772762429	92	5	0.00791139240506329	632	10285	51299,5277,116372,349667,5329	NRN1,PIGA,LYPD1,RTN4RL2,PLAUR
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.676416366032509	-0.390946466460199	110	6	0.00949367088607595	632	10285	79101,3015,51082,5437,4331,8341	TAF1D,H2AZ1,POLR1D,POLR2H,MNAT1,H2BC15
R-HSA-8856688	Golgi-to-ER retrograde transport	0.676416366032509	-0.390946466460199	110	6	0.00949367088607595	632	10285	22930,26286,113220,51014,51594,54732	RAB3GAP1,ARFGAP3,KIF12,TMED7,NBAS,TMED9
R-HSA-5688426	Deubiquitination	0.67724442181873	-0.389723034568047	301	17	0.0268987341772152	632	10285	9804,79589,7187,8341,7416,8900,7128,57646,8313,4092,7417,6478,10318,55288,8330,4088,890	TOMM20,RNF128,TRAF3,H2BC15,VDAC1,CCNA1,TNFAIP3,USP28,AXIN2,SMAD7,VDAC2,SIAH2,TNIP1,RHOT1,H2AC15,SMAD3,CCNA2
R-HSA-5578775	Ion homeostasis	0.677522380078701	-0.389312693447374	56	3	0.00474683544303797	632	10285	444,3708,817	ASPH,ITPR1,CAMK2D
R-HSA-74160	Gene Expression	0.679075259285861	-0.387023319147507	1821	108	0.170886075949367	632	10285	201164,2058,4853,890,8780,4331,5565,8731,7571,8341,7039,10765,54802,8125,9282,204851,5725,7700,6122,3815,16,8480,5600,55706,2961,64121,7422,7832,8793,51082,84449,6256,860,23327,23480,11200,3185,3622,7004,4088,84626,7762,8819,90338,3015,6095,3725,6897,84524,10181,85456,11340,5437,1789,6619,54541,27113,7538,10283,54913,900,29028,5876,147837,1615,84874,2617,55726,2063,7514,5093,58528,22936,253260,10767,7767,388566,9572,9818,158399,1386,8662,54989,23451,7559,3646,3516,5915,64859,7458,3726,9975,79744,5914,2821,27244,79101,4092,54464,154007,84321,10397,3183,665,3164,11017,8900,1975	PLD6,EPRS1,NOTCH2,CCNA2,RIOK3,MNAT1,PRKAB2,RNMT,ZNF23,H2BC15,TGFA,KDM5B,TRIT1,ANP32A,MED14,HIPK1,PTBP1,ZNF141,RPL3,KIT,AARS1,RAE1,MAPK11,NDC1,GTF2E2,RRAGC,VEGFA,BTG2,TNFRSF10D,POLR1D,ZNF333,RXRA,RUNX2,NEDD4L,SEC61G,CHEK2,HNRNPF,ING2,TEAD4,SMAD3,KRBA1,ZNF215,SAP30,ZNF160,H2AZ1,RORA,JUN,TARS1,ZC3H8,RBM5,TNKS1BP1,EXOSC8,POLR2H,DNMT3B,SNAPC3,DDIT4,BBC3,ZFP36,CWC27,RPP25,CCNG1,ATAD2,RABGGTB,ZNF563,DARS1,ZNF514,GARS1,INTS13,NR2F6,XPO1,PCBP1,RRAGD,ELL2,RICTOR,HBS1L,ZNF224,ZNF470,NR1D1,NUP58,ZNF483,ATF2,EIF3B,ZNF770,SF3B1,ZNF12,EIF3E,RBPJ,RARB,NABP1,EIF4H,JUNB,NR1D2,ZNF419,RARA,GPI,SESN1,TAF1D,SMAD7,XRN1,SNRNP48,THOC3,NDRG1,HNRNPC,BNIP3L,NR4A1,SNRNP27,CCNA1,EIF4B
R-HSA-418457	cGMP effects	0.680977950729246	-0.384225351140577	18	1	0.00158227848101266	632	10285	3708	ITPR1
R-HSA-69205	G1/S-Specific Transcription	0.680977950729246	-0.384225351140577	18	1	0.00158227848101266	632	10285	8900	CCNA1
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.680977950729246	-0.384225351140577	18	1	0.00158227848101266	632	10285	2261	FGFR3
R-HSA-1369062	ABC transporters in lipid homeostasis	0.680977950729246	-0.384225351140577	18	1	0.00158227848101266	632	10285	23461	ABCA5
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.680977950729246	-0.384225351140577	18	1	0.00158227848101266	632	10285	5335	PLCG1
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.680977950729246	-0.384225351140577	18	1	0.00158227848101266	632	10285	7187	TRAF3
R-HSA-5625740	RHO GTPases activate PKNs	0.684056665034509	-0.379714521173226	93	5	0.00791139240506329	632	10285	8341,23081,5585,3015,5500	H2BC15,KDM4C,PKN1,H2AZ1,PPP1CB
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	0.684945482931102	-0.378416030849017	75	4	0.00632911392405063	632	10285	9818,55706,8480,84321	NUP58,NDC1,RAE1,THOC3
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.684945482931102	-0.378416030849017	75	4	0.00632911392405063	632	10285	23030,8341,11200,9025	KDM4B,H2BC15,CHEK2,RNF8
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.687237836869119	-0.375074850355867	38	2	0.00316455696202532	632	10285	10125,3690	RASGRP1,ITGB3
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.687237836869119	-0.375074850355867	38	2	0.00316455696202532	632	10285	2878,30001	GPX3,ERO1A
R-HSA-5655302	Signaling by FGFR1 in disease	0.687237836869119	-0.375074850355867	38	2	0.00316455696202532	632	10285	2549,5335	GAB1,PLCG1
R-HSA-69275	G2/M Transition	0.688410266663124	-0.373370300951308	182	10	0.0158227848101266	632	10285	5500,890,9662,11190,4331,8900,9702,55559,7514,7277	PPP1CB,CCNA2,CEP135,CEP250,MNAT1,CCNA1,CEP57,HAUS7,XPO1,TUBA4A
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.689183572671769	-0.3722476099697	57	3	0.00474683544303797	632	10285	7163,5286,6456	TPD52,PIK3C2A,SH3GL2
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.693138836288888	-0.366524958892599	94	5	0.00791139240506329	632	10285	5526,2549,3815,2261,23239	PPP2R5B,GAB1,KIT,FGFR3,PHLPP1
R-HSA-877300	Interferon gamma signaling	0.693138836288888	-0.366524958892599	94	5	0.00791139240506329	632	10285	9021,3383,817,3394,3716	SOCS3,ICAM1,CAMK2D,IRF8,JAK1
R-HSA-73864	RNA Polymerase I Transcription	0.693244063886013	-0.366373157254951	112	6	0.00949367088607595	632	10285	3015,79101,8341,4331,5437,51082	H2AZ1,TAF1D,H2BC15,MNAT1,POLR2H,POLR1D
R-HSA-5693606	DNA Double Strand Break Response	0.694985176036888	-0.363864763088147	76	4	0.00632911392405063	632	10285	9025,11200,8341,23030	RNF8,CHEK2,H2BC15,KDM4B
R-HSA-913531	Interferon Signaling	0.698133029364307	-0.359345607897246	201	11	0.0174050632911392	632	10285	9021,9818,3383,817,8480,55706,3841,5335,2317,3394,3716	SOCS3,NUP58,ICAM1,CAMK2D,RAE1,NDC1,KPNA5,PLCG1,FLNB,IRF8,JAK1
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.70052559262209	-0.355924379080035	58	3	0.00474683544303797	632	10285	10014,8841,3516	HDAC5,HDAC3,RBPJ
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.70052559262209	-0.355924379080035	58	3	0.00474683544303797	632	10285	3516,8841,10014	RBPJ,HDAC3,HDAC5
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.70052559262209	-0.355924379080035	58	3	0.00474683544303797	632	10285	10014,8841,3516	HDAC5,HDAC3,RBPJ
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.70052559262209	-0.355924379080035	58	3	0.00474683544303797	632	10285	8841,3516,10014	HDAC3,RBPJ,HDAC5
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.70052559262209	-0.355924379080035	58	3	0.00474683544303797	632	10285	3516,8841,10014	RBPJ,HDAC3,HDAC5
R-HSA-936837	Ion transport by P-type ATPases	0.70052559262209	-0.355924379080035	58	3	0.00474683544303797	632	10285	148229,817,51076	ATP8B3,CAMK2D,CUTC
R-HSA-8851708	Signaling by FGFR2 IIIa TM	0.700615813301126	-0.355795597389937	19	1	0.00158227848101266	632	10285	5437	POLR2H
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.700615813301126	-0.355795597389937	19	1	0.00158227848101266	632	10285	6616	SNAP25
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.700615813301126	-0.355795597389937	19	1	0.00158227848101266	632	10285	6533	SLC6A6
R-HSA-156584	Cytosolic sulfonation of small molecules	0.700615813301126	-0.355795597389937	19	1	0.00158227848101266	632	10285	9060	PAPSS2
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.700615813301126	-0.355795597389937	19	1	0.00158227848101266	632	10285	1395	CRHR2
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.700615813301126	-0.355795597389937	19	1	0.00158227848101266	632	10285	5286	PIK3C2A
R-HSA-71403	Citric acid cycle (TCA cycle)	0.700615813301126	-0.355795597389937	19	1	0.00158227848101266	632	10285	6392	SDHD
R-HSA-8876725	Protein methylation	0.700615813301126	-0.355795597389937	19	1	0.00158227848101266	632	10285	79091	METTL22
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.700615813301126	-0.355795597389937	19	1	0.00158227848101266	632	10285	3656	IRAK2
R-HSA-453274	Mitotic G2-G2/M phases	0.701444140194512	-0.35461401169855	184	10	0.0158227848101266	632	10285	5500,8900,9702,55559,7514,7277,9662,890,11190,4331	PPP1CB,CCNA1,CEP57,HAUS7,XPO1,TUBA4A,CEP135,CCNA2,CEP250,MNAT1
R-HSA-167172	Transcription of the HIV genome	0.704794493883643	-0.349849016701066	77	4	0.00632911392405063	632	10285	2961,8731,5437,4331	GTF2E2,RNMT,POLR2H,MNAT1
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	0.714237704401364	-0.336539452718254	40	2	0.00316455696202532	632	10285	8841,8877	HDAC3,SPHK1
R-HSA-199977	ER to Golgi Anterograde Transport	0.716959725376372	-0.332735610983359	133	7	0.0110759493670886	632	10285	3998,9871,51014,7039,26286,10282,54732	LMAN1,SEC24D,TMED7,TGFA,ARFGAP3,BET1,TMED9
R-HSA-8874081	MET activates PTK2 signaling	0.719046634068553	-0.329829063741919	20	1	0.00158227848101266	632	10285	284217	LAMA1
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.719046634068553	-0.329829063741919	20	1	0.00158227848101266	632	10285	2261	FGFR3
R-HSA-5654720	PI-3K cascade:FGFR4	0.719046634068553	-0.329829063741919	20	1	0.00158227848101266	632	10285	2549	GAB1
R-HSA-194223	HDL-mediated lipid transport	0.719046634068553	-0.329829063741919	20	1	0.00158227848101266	632	10285	19	ABCA1
R-HSA-8876384	Listeria monocytogenes entry into host cells	0.719046634068553	-0.329829063741919	20	1	0.00158227848101266	632	10285	6456	SH3GL2
R-HSA-418217	G beta:gamma signalling through PLC beta	0.719046634068553	-0.329829063741919	20	1	0.00158227848101266	632	10285	5331	PLCB3
R-HSA-6804760	Regulation of TP53 Activity through Methylation	0.719046634068553	-0.329829063741919	20	1	0.00158227848101266	632	10285	11200	CHEK2
R-HSA-15869	Metabolism of nucleotides	0.719303561741043	-0.329471810444396	97	5	0.00791139240506329	632	10285	1633,3615,205,5471,10606	DCK,IMPDH2,AK4,PPAT,PAICS
R-HSA-6807878	COPI-mediated anterograde transport	0.723722826338964	-0.323346796445433	79	4	0.00632911392405063	632	10285	10282,51014,26286,54732	BET1,TMED7,ARFGAP3,TMED9
R-HSA-5654743	Signaling by FGFR4	0.726988833278825	-0.3188441615682	41	2	0.00316455696202532	632	10285	2549,5335	GAB1,PLCG1
R-HSA-4086398	Ca2+ pathway	0.732656990221234	-0.311077639933267	61	3	0.00474683544303797	632	10285	3708,5331,7481	ITPR1,PLCB3,WNT11
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.732656990221234	-0.311077639933267	61	3	0.00474683544303797	632	10285	10810,10787,51517	WASF3,NCKAP1,NCKIPSD
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.736344493532595	-0.306057207895107	21	1	0.00158227848101266	632	10285	4853	NOTCH2
R-HSA-3000480	Scavenging by Class A Receptors	0.736344493532595	-0.306057207895107	21	1	0.00158227848101266	632	10285	78989	COLEC11
R-HSA-6807004	Negative regulation of MET activity	0.736344493532595	-0.306057207895107	21	1	0.00158227848101266	632	10285	6456	SH3GL2
R-HSA-5654689	PI-3K cascade:FGFR1	0.736344493532595	-0.306057207895107	21	1	0.00158227848101266	632	10285	2549	GAB1
R-HSA-500657	Presynaptic function of Kainate receptors	0.736344493532595	-0.306057207895107	21	1	0.00158227848101266	632	10285	5331	PLCB3
R-HSA-3928662	EPHB-mediated forward signaling	0.73925494875853	-0.302112425975671	42	2	0.00316455696202532	632	10285	1949,7525	EFNB3,YES1
R-HSA-6782315	tRNA modification in the nucleus and cytosol	0.73925494875853	-0.302112425975671	42	2	0.00316455696202532	632	10285	2058,54802	EPRS1,TRIT1
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.743841731092083	-0.295926993805419	100	5	0.00791139240506329	632	10285	7277,9702,55559,11190,9662	TUBA4A,CEP57,HAUS7,CEP250,CEP135
R-HSA-211000	Gene Silencing by RNA	0.745155645124286	-0.29416216279333	137	7	0.0110759493670886	632	10285	8341,5437,201164,8480,55706,3015,9818	H2BC15,POLR2H,PLD6,RAE1,NDC1,H2AZ1,NUP58
R-HSA-168256	Immune System	0.747822444590212	-0.290589702727716	2101	123	0.194620253164557	632	10285	8887,3708,9867,10125,5437,6515,10855,153090,3560,1742,1154,3725,6095,3162,1399,7431,868,8836,23239,7076,55276,1326,23480,5329,7087,4179,3841,51082,23327,23014,154214,55706,8480,5600,8915,3815,2549,92912,88,7422,6456,2720,5923,6494,25801,3074,5604,1265,78989,23108,6616,63893,1852,9252,4126,7704,132014,51517,5909,80176,7525,5292,5526,2040,3164,5660,6478,9021,302,114,4791,158747,817,5315,26118,11322,7187,2821,10810,8987,2309,8904,7128,6624,51646,230,3726,7414,5836,226,54509,54014,2261,1386,3615,1847,3716,3977,2675,5970,3690,5924,9871,253260,9818,3572,51330,3394,6386,3310,5335,2317,5223,55236,5236,23526,10787,8916,114088,5598,10549,3656,3383	TAX1BP1,ITPR1,PJA2,RASGRP1,POLR2H,SLC2A3,HPSE,DAB2IP,IL2RB,DLG4,CISH,JUN,RORA,HMOX1,CRKL,VIM,CBLB,GGH,PHLPP1,TIMP1,PGM2,MAP3K8,SEC61G,PLAUR,ICAM5,CD46,KPNA5,POLR1D,NEDD4L,FBXO21,RNF217,NDC1,RAE1,MAPK11,BCL10,KIT,GAB1,UBE2Q2,ACTN2,VEGFA,SH3GL2,GLB1,RASGRF1,SIPA1,GCA,HEXB,MAP2K1,CNN2,COLEC11,RAP1GAP2,SNAP25,UBE2O,DUSP9,RPS6KA5,MANBA,ZBTB16,IL17RE,NCKIPSD,RAP1GAP,SPSB1,YES1,PIM1,PPP2R5B,STOM,NR4A1,PSAP,SIAH2,SOCS3,ANXA2,ADCY8,NFKB2,MOSPD2,CAMK2D,PKM,WSB1,TMC6,TRAF3,GPI,WASF3,STBD1,FOXO3,CPNE1,TNFAIP3,FSCN1,YPEL5,ALDOC,JUNB,VCL,PYGL,ALDOA,RHOF,BRWD1,FGFR3,ATF2,IMPDH2,DUSP5,JAK1,LIFR,GFRA2,RELA,ITGB3,RASGRF2,SEC24D,RICTOR,NUP58,IL6ST,TNFRSF12A,IRF8,SDCBP,HSPA6,PLCG1,FLNB,PGAM1,UBA6,PGM1,ARHGAP45,NCKAP1,HERC3,TRIM9,MAPK7,PRDX4,IRAK2,ICAM1
R-HSA-75109	Triglyceride Biosynthesis	0.750401956276873	-0.287146274314744	82	4	0.00632911392405063	632	10285	9663,84803,83401,6319	LPIN2,GPAT3,ELOVL3,SCD
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.75104740443268	-0.286286507462187	43	2	0.00316455696202532	632	10285	9580,7514	SOX13,XPO1
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.75104740443268	-0.286286507462187	43	2	0.00316455696202532	632	10285	4331,8450	MNAT1,CUL4B
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	0.75104740443268	-0.286286507462187	43	2	0.00316455696202532	632	10285	2781,2773	GNAZ,GNAI3
R-HSA-977225	Amyloid fiber formation	0.751661045544901	-0.285469793952205	101	5	0.00791139240506329	632	10285	3015,8341,23062,6478,3339	H2AZ1,H2BC15,GGA2,SIAH2,HSPG2
R-HSA-5358351	Signaling by Hedgehog	0.751885713377666	-0.285170943473357	138	7	0.0110759493670886	632	10285	8650,27152,79809,6469,339745,114,91653	NUMB,INTU,TTC21B,SHH,SPOPL,ADCY8,BOC
R-HSA-203765	eNOS activation and regulation	0.75257893234696	-0.284249394375711	22	1	0.00158227848101266	632	10285	114757	CYGB
R-HSA-166663	Initial triggering of complement	0.75257893234696	-0.284249394375711	22	1	0.00158227848101266	632	10285	78989	COLEC11
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.75257893234696	-0.284249394375711	22	1	0.00158227848101266	632	10285	9695	EDEM1
R-HSA-202131	Metabolism of nitric oxide	0.75257893234696	-0.284249394375711	22	1	0.00158227848101266	632	10285	114757	CYGB
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.75257893234696	-0.284249394375711	22	1	0.00158227848101266	632	10285	10449	ACAA2
R-HSA-168254	Influenza Infection	0.756715552758134	-0.278767852092412	157	8	0.0126582278481013	632	10285	6122,3841,2926,5437,7514,9818,8480,55706	RPL3,KPNA5,GRSF1,POLR2H,XPO1,NUP58,RAE1,NDC1
R-HSA-5668914	Diseases of metabolism	0.76237799137634	-0.271312794613464	44	2	0.00316455696202532	632	10285	5507,2997	PPP1R3C,GYS1
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.76237799137634	-0.271312794613464	44	2	0.00316455696202532	632	10285	27113,90427	BBC3,BMF
R-HSA-72172	mRNA Splicing	0.766865087069396	-0.265444389997384	195	10	0.0158227848101266	632	10285	3183,23451,5093,11017,154007,10181,10283,3185,5725,5437	HNRNPC,SF3B1,PCBP1,SNRNP27,SNRNP48,RBM5,CWC27,HNRNPF,PTBP1,POLR2H
R-HSA-109582	Hemostasis	0.767725081900415	-0.264323576195187	632	35	0.055379746835443	632	10285	10125,30846,3708,7525,6520,139818,226,8793,3716,5526,2773,3560,6382,5660,3690,23764,302,7422,88,87,308,374354,113220,7076,9123,23186,50848,10603,51317,5335,5329,2316,58494,7414,7277	RASGRP1,EHD2,ITPR1,YES1,SLC3A2,DOCK11,ALDOA,TNFRSF10D,JAK1,PPP2R5B,GNAI3,IL2RB,SDC1,PSAP,ITGB3,MAFF,ANXA2,VEGFA,ACTN2,ACTN1,ANXA5,NHLRC2,KIF12,TIMP1,SLC16A3,RCOR1,F11R,SH2B2,PHF21A,PLCG1,PLAUR,FLNA,JAM2,VCL,TUBA4A
R-HSA-3371571	HSF1-dependent transactivation	0.767815229215887	-0.26420616173863	23	1	0.00158227848101266	632	10285	817	CAMK2D
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.767815229215887	-0.26420616173863	23	1	0.00158227848101266	632	10285	2773	GNAI3
R-HSA-5654695	PI-3K cascade:FGFR2	0.767815229215887	-0.26420616173863	23	1	0.00158227848101266	632	10285	2549	GAB1
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.767815229215887	-0.26420616173863	23	1	0.00158227848101266	632	10285	2617	GARS1
R-HSA-8855121	VLDL interactions	0.767815229215887	-0.26420616173863	23	1	0.00158227848101266	632	10285	7436	VLDLR
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.770654050930558	-0.260515707891761	443	24	0.0379746835443038	632	10285	3690,5924,2150,3269,3815,88,817,3708,10125,153090,84634,2261,1847,3560,3716,5526,1742,2675,5604,5598,1852,7414,5331,5923	ITGB3,RASGRF2,F2RL1,HRH1,KIT,ACTN2,CAMK2D,ITPR1,RASGRP1,DAB2IP,KISS1R,FGFR3,DUSP5,IL2RB,JAK1,PPP2R5B,DLG4,GFRA2,MAP2K1,MAPK7,DUSP9,VCL,PLCB3,RASGRF1
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.771196725828006	-0.259811781249786	65	3	0.00474683544303797	632	10285	8900,890,11200	CCNA1,CCNA2,CHEK2
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.771196725828006	-0.259811781249786	65	3	0.00474683544303797	632	10285	2549,3815,2261	GAB1,KIT,FGFR3
R-HSA-5334118	DNA methylation	0.771196725828006	-0.259811781249786	65	3	0.00474683544303797	632	10285	3015,8341,1789	H2AZ1,H2BC15,DNMT3B
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.771196725828006	-0.259811781249786	65	3	0.00474683544303797	632	10285	5437,4331,8450	POLR2H,MNAT1,CUL4B
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.771196725828006	-0.259811781249786	65	3	0.00474683544303797	632	10285	8900,11200,890	CCNA1,CHEK2,CCNA2
R-HSA-166658	Complement cascade	0.773258841786297	-0.257141432905808	45	2	0.00316455696202532	632	10285	78989,4179	COLEC11,CD46
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	0.778711480478751	-0.250114673373484	179	9	0.0142405063291139	632	10285	22930,113220,26286,51014,4122,54732,51594,7110,10226	RAB3GAP1,KIF12,ARFGAP3,TMED7,MAN2A2,TMED9,NBAS,TMF1,PLIN3
R-HSA-6782135	Dual incision in TC-NER	0.780090842267164	-0.248344901634874	66	3	0.00474683544303797	632	10285	4331,5437,8450	MNAT1,POLR2H,CUL4B
R-HSA-70895	Branched-chain amino acid catabolism	0.782114661603139	-0.245753923094409	24	1	0.00158227848101266	632	10285	10295	BCKDK
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.782114661603139	-0.245753923094409	24	1	0.00158227848101266	632	10285	27289	RND1
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.782114661603139	-0.245753923094409	24	1	0.00158227848101266	632	10285	3708	ITPR1
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.782114661603139	-0.245753923094409	24	1	0.00158227848101266	632	10285	6256	RXRA
R-HSA-5632684	Hedgehog 'on' state	0.782842450698285	-0.244823815627703	86	4	0.00632911392405063	632	10285	91653,8650,6469,339745	BOC,NUMB,SHH,SPOPL
R-HSA-453279	Mitotic G1-G1/S phases	0.783630772193276	-0.243817323400424	143	7	0.0110759493670886	632	10285	1032,1031,8900,890,4171,894,4331	CDKN2D,CDKN2C,CCNA1,CCNA2,MCM2,CCND2,MNAT1
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.788698341222757	-0.237371361759359	67	3	0.00474683544303797	632	10285	54583,64344,8994	EGLN1,HIF3A,LIMD1
R-HSA-69615	G1/S DNA Damage Checkpoints	0.788698341222757	-0.237371361759359	67	3	0.00474683544303797	632	10285	890,11200,8900	CCNA2,CHEK2,CCNA1
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.790408197250003	-0.235205761587578	87	4	0.00632911392405063	632	10285	9818,55706,8480,84321	NUP58,NDC1,RAE1,THOC3
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.790408197250003	-0.235205761587578	87	4	0.00632911392405063	632	10285	2549,5526,3815,2261	GAB1,PPP2R5B,KIT,FGFR3
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.795534750687946	-0.228740748075518	25	1	0.00158227848101266	632	10285	5437	POLR2H
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.795534750687946	-0.228740748075518	25	1	0.00158227848101266	632	10285	5437	POLR2H
R-HSA-3295583	TRP channels	0.795534750687946	-0.228740748075518	25	1	0.00158227848101266	632	10285	54795	TRPM4
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.795534750687946	-0.228740748075518	25	1	0.00158227848101266	632	10285	205	AK4
R-HSA-162588	Budding and maturation of HIV virion	0.795534750687946	-0.228740748075518	25	1	0.00158227848101266	632	10285	23327	NEDD4L
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.795534750687946	-0.228740748075518	25	1	0.00158227848101266	632	10285	9871	SEC24D
R-HSA-211981	Xenobiotics	0.795534750687946	-0.228740748075518	25	1	0.00158227848101266	632	10285	405	ARNT
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.797024522201771	-0.22686983253254	68	3	0.00474683544303797	632	10285	405,56603,6256	ARNT,CYP26B1,RXRA
R-HSA-168255	Influenza Life Cycle	0.801172052226719	-0.22167955819189	146	7	0.0110759493670886	632	10285	6122,2926,5437,7514,9818,55706,8480	RPL3,GRSF1,POLR2H,XPO1,NUP58,NDC1,RAE1
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.803327664774601	-0.218992597487619	48	2	0.00316455696202532	632	10285	3560,3716	IL2RB,JAK1
R-HSA-909733	Interferon alpha/beta signaling	0.805074885036258	-0.216819981000359	69	3	0.00474683544303797	632	10285	9021,3716,3394	SOCS3,JAK1,IRF8
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.805074885036258	-0.216819981000359	69	3	0.00474683544303797	632	10285	8341,79101,3015	H2BC15,TAF1D,H2AZ1
R-HSA-73848	Pyrimidine metabolism	0.808129491179492	-0.213032971940765	26	1	0.00158227848101266	632	10285	1633	DCK
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.808129491179492	-0.213032971940765	26	1	0.00158227848101266	632	10285	7481	WNT11
R-HSA-5687128	MAPK6/MAPK4 signaling	0.811843612646273	-0.208447552632519	90	4	0.00632911392405063	632	10285	3725,2309,989,7514	JUN,FOXO3,SEPTIN7,XPO1
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	0.81253488304725	-0.207596432718608	49	2	0.00316455696202532	632	10285	10226,7110	PLIN3,TMF1
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.817610054058429	-0.20136976257011	149	7	0.0110759493670886	632	10285	4331,6619,8341,51082,5437,79101,3015	MNAT1,SNAPC3,H2BC15,POLR1D,POLR2H,TAF1D,H2AZ1
R-HSA-72163	mRNA Splicing - Major Pathway	0.819637664471084	-0.198892908974542	187	9	0.0142405063291139	632	10285	3185,5725,10283,5437,11017,3183,5093,23451,10181	HNRNPF,PTBP1,CWC27,POLR2H,SNRNP27,HNRNPC,PCBP1,SF3B1,RBM5
R-HSA-977606	Regulation of Complement cascade	0.819949567347827	-0.198512443849597	27	1	0.00158227848101266	632	10285	4179	CD46
R-HSA-400685	Sema4D in semaphorin signaling	0.819949567347827	-0.198512443849597	27	1	0.00158227848101266	632	10285	27289	RND1
R-HSA-180024	DARPP-32 events	0.819949567347827	-0.198512443849597	27	1	0.00158227848101266	632	10285	5143	PDE4C
R-HSA-901042	Calnexin/calreticulin cycle	0.819949567347827	-0.198512443849597	27	1	0.00158227848101266	632	10285	9695	EDEM1
R-HSA-1474228	Degradation of the extracellular matrix	0.820241960402762	-0.198155908587604	111	5	0.00791139240506329	632	10285	831,1299,7076,9510,3339	CAST,COL9A3,TIMP1,ADAMTS1,HSPG2
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.820370978603448	-0.197998628100678	71	3	0.00474683544303797	632	10285	8900,4331,890	CCNA1,MNAT1,CCNA2
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.821355431436894	-0.196799338200217	50	2	0.00316455696202532	632	10285	5437,4331	POLR2H,MNAT1
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.821355431436894	-0.196799338200217	50	2	0.00316455696202532	632	10285	5437,4331	POLR2H,MNAT1
R-HSA-167169	HIV Transcription Elongation	0.821355431436894	-0.196799338200217	50	2	0.00316455696202532	632	10285	5437,4331	POLR2H,MNAT1
R-HSA-68949	Orc1 removal from chromatin	0.827628449260094	-0.189190958085224	72	3	0.00474683544303797	632	10285	8900,4171,890	CCNA1,MCM2,CCNA2
R-HSA-69052	Switching of origins to a post-replicative state	0.827628449260094	-0.189190958085224	72	3	0.00474683544303797	632	10285	890,4171,8900	CCNA2,MCM2,CCNA1
R-HSA-69202	Cyclin E associated events during G1/S transition	0.827628449260094	-0.189190958085224	72	3	0.00474683544303797	632	10285	8900,890,4331	CCNA1,CCNA2,MNAT1
R-HSA-171306	Packaging Of Telomere Ends	0.82980197513427	-0.186568190832804	51	2	0.00316455696202532	632	10285	3015,8341	H2AZ1,H2BC15
R-HSA-111933	Calmodulin induced events	0.831042555600652	-0.185074275328794	28	1	0.00158227848101266	632	10285	114	ADCY8
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	0.831042555600652	-0.185074275328794	28	1	0.00158227848101266	632	10285	22930	RAB3GAP1
R-HSA-5576893	Phase 2 - plateau phase	0.831042555600652	-0.185074275328794	28	1	0.00158227848101266	632	10285	786	CACNG1
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.831042555600652	-0.185074275328794	28	1	0.00158227848101266	632	10285	83401	ELOVL3
R-HSA-111997	CaM pathway	0.831042555600652	-0.185074275328794	28	1	0.00158227848101266	632	10285	114	ADCY8
R-HSA-3214841	PKMTs methylate histone lysines	0.834633531186701	-0.180762535275753	73	3	0.00474683544303797	632	10285	5970,64754,4791	RELA,SMYD3,NFKB2
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.834633531186701	-0.180762535275753	73	3	0.00474683544303797	632	10285	7163,5286,6456	TPD52,PIK3C2A,SH3GL2
R-HSA-421837	Clathrin derived vesicle budding	0.834633531186701	-0.180762535275753	73	3	0.00474683544303797	632	10285	6456,7163,5286	SH3GL2,TPD52,PIK3C2A
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.837887085328869	-0.176871930623023	52	2	0.00316455696202532	632	10285	4331,5437	MNAT1,POLR2H
R-HSA-69300	Removal of licensing factors from origins	0.841392312771275	-0.172697244103161	74	3	0.00474683544303797	632	10285	890,4171,8900	CCNA2,MCM2,CCNA1
R-HSA-2299718	Condensation of Prophase Chromosomes	0.841392312771275	-0.172697244103161	74	3	0.00474683544303797	632	10285	3015,10592,8341	H2AZ1,SMC2,H2BC15
R-HSA-212300	PRC2 methylates histones and DNA	0.841392312771275	-0.172697244103161	74	3	0.00474683544303797	632	10285	3015,1789,8341	H2AZ1,DNMT3B,H2BC15
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.841453114726404	-0.172624983211979	29	1	0.00158227848101266	632	10285	2261	FGFR3
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	0.845623202988492	-0.167681405128384	53	2	0.00316455696202532	632	10285	8662,3646	EIF3B,EIF3E
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.851223164610263	-0.161080946702244	30	1	0.00158227848101266	632	10285	8650	NUMB
R-HSA-445095	Interaction between L1 and Ankyrins	0.851223164610263	-0.161080946702244	30	1	0.00158227848101266	632	10285	6330	SCN4B
R-HSA-420029	Tight junction interactions	0.851223164610263	-0.161080946702244	30	1	0.00158227848101266	632	10285	50848	F11R
R-HSA-111996	Ca-dependent events	0.851223164610263	-0.161080946702244	30	1	0.00158227848101266	632	10285	114	ADCY8
R-HSA-5683826	Surfactant metabolism	0.851223164610263	-0.161080946702244	30	1	0.00158227848101266	632	10285	136	ADORA2B
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.851845417928272	-0.160350202970513	156	7	0.0110759493670886	632	10285	51317,10603,113220,30846,139818,23186,23764	PHF21A,SH2B2,KIF12,EHD2,DOCK11,RCOR1,MAFF
R-HSA-114604	GPVI-mediated activation cascade	0.853022607351983	-0.158969228498191	54	2	0.00316455696202532	632	10285	3560,3716	IL2RB,JAK1
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	0.853505319455699	-0.158403504247206	117	5	0.00791139240506329	632	10285	8662,1975,6122,7458,3646	EIF3B,EIF4B,RPL3,EIF4H,EIF3E
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	0.853505319455699	-0.158403504247206	117	5	0.00791139240506329	632	10285	3646,1975,7458,6122,8662	EIF3E,EIF4B,EIF4H,RPL3,EIF3B
R-HSA-5663220	RHO GTPases Activate Formins	0.853505319455699	-0.158403504247206	117	5	0.00791139240506329	632	10285	1856,7514,1730,1855,5526	DVL2,XPO1,DIAPH2,DVL1,PPP2R5B
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.854255857184796	-0.157524531487215	137	6	0.00949367088607595	632	10285	6122,9818,5437,55706,2926,8480	RPL3,NUP58,POLR2H,NDC1,GRSF1,RAE1
R-HSA-193704	p75 NTR receptor-mediated signalling	0.854926461134099	-0.156739824113956	97	4	0.00632911392405063	632	10285	25791,5924,8841,5970	NGEF,RASGRF2,HDAC3,RELA
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.86009738895352	-0.150709653176875	55	2	0.00316455696202532	632	10285	83401,6319	ELOVL3,SCD
R-HSA-69304	Regulation of DNA replication	0.86025235034407	-0.150529502144293	77	3	0.00474683544303797	632	10285	4171,890,8900	MCM2,CCNA2,CCNA1
R-HSA-5693607	Processing of DNA double-strand break ends	0.860341905737423	-0.150425403931576	98	4	0.00632911392405063	632	10285	8900,9025,890,8341	CCNA1,RNF8,CCNA2,H2BC15
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	0.860392053933463	-0.150367116947964	31	1	0.00158227848101266	632	10285	3622	ING2
R-HSA-418360	Platelet calcium homeostasis	0.860392053933463	-0.150367116947964	31	1	0.00158227848101266	632	10285	3708	ITPR1
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.867684530017249	-0.1419270750644	311	15	0.0237341772151899	632	10285	80176,868,9867,23327,8916,23014,114088,154214,9021,63893,55236,6478,7704,26118,92912	SPSB1,CBLB,PJA2,NEDD4L,HERC3,FBXO21,TRIM9,RNF217,SOCS3,UBE2O,UBA6,SIAH2,ZBTB16,WSB1,UBE2Q2
R-HSA-69190	DNA strand elongation	0.868996717659264	-0.14041593087087	32	1	0.00158227848101266	632	10285	4171	MCM2
R-HSA-68962	Activation of the pre-replicative complex	0.868996717659264	-0.14041593087087	32	1	0.00158227848101266	632	10285	4171	MCM2
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.868996717659264	-0.14041593087087	32	1	0.00158227848101266	632	10285	7076	TIMP1
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.871707160655202	-0.137301736411674	79	3	0.00474683544303797	632	10285	8450,4331,5437	CUL4B,MNAT1,POLR2H
R-HSA-2871837	FCERI mediated NF-kB activation	0.871707160655202	-0.137301736411674	79	3	0.00474683544303797	632	10285	8915,10125,5970	BCL10,RASGRP1,RELA
R-HSA-1221632	Meiotic synapsis	0.871707160655202	-0.137301736411674	79	3	0.00474683544303797	632	10285	8341,23353,3015	H2BC15,SUN1,H2AZ1
R-HSA-2408522	Selenoamino acid metabolism	0.872710571391119	-0.136151311455369	121	5	0.00791139240506329	632	10285	2058,1491,6122,1615,9060	EPRS1,CTH,RPL3,DARS1,PAPSS2
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.87556360022816	-0.132887485430794	101	4	0.00632911392405063	632	10285	3708,8915,4791,5970	ITPR1,BCL10,NFKB2,RELA
R-HSA-5610787	Hedgehog 'off' state	0.87556360022816	-0.132887485430794	101	4	0.00632911392405063	632	10285	8650,114,27152,79809	NUMB,ADCY8,INTU,TTC21B
R-HSA-1839126	FGFR2 mutant receptor activation	0.877071824908829	-0.13116639154973	33	1	0.00158227848101266	632	10285	5437	POLR2H
R-HSA-392518	Signal amplification	0.877071824908829	-0.13116639154973	33	1	0.00158227848101266	632	10285	2773	GNAI3
R-HSA-186712	Regulation of beta-cell development	0.877071824908829	-0.13116639154973	33	1	0.00158227848101266	632	10285	3516	RBPJ
R-HSA-163359	Glucagon signaling in metabolic regulation	0.877071824908829	-0.13116639154973	33	1	0.00158227848101266	632	10285	114	ADCY8
R-HSA-202433	Generation of second messenger molecules	0.877071824908829	-0.13116639154973	33	1	0.00158227848101266	632	10285	5335	PLCG1
R-HSA-73894	DNA Repair	0.882110304069636	-0.125438169491416	316	15	0.0237341772151899	632	10285	8450,8900,23030,2956,54890,5980,5437,8341,9025,890,4331,5893,51008,56852,11200	CUL4B,CCNA1,KDM4B,MSH6,ALKBH5,REV3L,POLR2H,H2BC15,RNF8,CCNA2,MNAT1,RAD52,ASCC1,RAD18,CHEK2
R-HSA-192105	Synthesis of bile acids and bile salts	0.884649917641363	-0.122563285520555	34	1	0.00158227848101266	632	10285	6256	RXRA
R-HSA-113510	E2F mediated regulation of DNA replication	0.884649917641363	-0.122563285520555	34	1	0.00158227848101266	632	10285	8900	CCNA1
R-HSA-4641258	Degradation of DVL	0.885384289591889	-0.121733502695271	59	2	0.00316455696202532	632	10285	1856,1855	DVL2,DVL1
R-HSA-72613	Eukaryotic Translation Initiation	0.889741397770905	-0.116824422780291	125	5	0.00791139240506329	632	10285	1975,7458,6122,3646,8662	EIF4B,EIF4H,RPL3,EIF3E,EIF3B
R-HSA-72737	Cap-dependent Translation Initiation	0.889741397770905	-0.116824422780291	125	5	0.00791139240506329	632	10285	3646,1975,7458,6122,8662	EIF3E,EIF4B,EIF4H,RPL3,EIF3B
R-HSA-199991	Membrane Trafficking	0.889993266064239	-0.116541382504531	610	31	0.0490506329113924	632	10285	26286,23062,5286,23433,3998,9871,22930,10226,1856,89781,7163,51594,9363,4122,22898,113220,6456,7039,4036,11252,64786,7110,79958,950,23258,51014,115548,143425,10282,54732,5565	ARFGAP3,GGA2,PIK3C2A,RHOQ,LMAN1,SEC24D,RAB3GAP1,PLIN3,DVL2,HPS4,TPD52,NBAS,RAB33A,MAN2A2,DENND3,KIF12,SH3GL2,TGFA,LRP2,PACSIN2,TBC1D15,TMF1,DENND1C,SCARB2,DENND5A,TMED7,FCHO2,SYT9,BET1,TMED9,PRKAB2
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.891009275230476	-0.115400441654762	60	2	0.00316455696202532	632	10285	1299,4015	COL9A3,LOX
R-HSA-193648	NRAGE signals death through JNK	0.891009275230476	-0.115400441654762	60	2	0.00316455696202532	632	10285	25791,5924	NGEF,RASGRF2
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.89176154108739	-0.114556512760845	35	1	0.00158227848101266	632	10285	388531	RGS9BP
R-HSA-5693532	DNA Double-Strand Break Repair	0.894979970061364	-0.110953940777419	167	7	0.0110759493670886	632	10285	8341,11200,8900,23030,5893,890,9025	H2BC15,CHEK2,CCNA1,KDM4B,RAD52,CCNA2,RNF8
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.896377149298425	-0.109394029015239	61	2	0.00316455696202532	632	10285	890,8900	CCNA2,CCNA1
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.896377149298425	-0.109394029015239	61	2	0.00316455696202532	632	10285	5970,4791	RELA,NFKB2
R-HSA-2514856	The phototransduction cascade	0.898435366074062	-0.107100510711537	36	1	0.00158227848101266	632	10285	388531	RGS9BP
R-HSA-432720	Lysosome Vesicle Biogenesis	0.898435366074062	-0.107100510711537	36	1	0.00158227848101266	632	10285	6456	SH3GL2
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	0.898435366074062	-0.107100510711537	36	1	0.00158227848101266	632	10285	9695	EDEM1
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.901498208267586	-0.103697223842031	62	2	0.00316455696202532	632	10285	5565,23433	PRKAB2,RHOQ
R-HSA-176187	Activation of ATR in response to replication stress	0.904698303780469	-0.100153756849436	37	1	0.00158227848101266	632	10285	4171	MCM2
R-HSA-73728	RNA Polymerase I Promoter Opening	0.906382456365315	-0.0982939247454683	63	2	0.00316455696202532	632	10285	3015,8341	H2AZ1,H2BC15
R-HSA-69242	S Phase	0.908244350840153	-0.0962418277293428	130	5	0.00791139240506329	632	10285	8900,890,4171,114799,4331	CCNA1,CCNA2,MCM2,ESCO1,MNAT1
R-HSA-211945	Phase 1 - Functionalization of compounds	0.90932795890715	-0.0950494589970832	109	4	0.00632911392405063	632	10285	56603,405,6256,128	CYP26B1,ARNT,RXRA,ADH5
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	0.910575613707744	-0.0936783369059671	38	1	0.00158227848101266	632	10285	5437	POLR2H
R-HSA-5689901	Metalloprotease DUBs	0.910575613707744	-0.0936783369059671	38	1	0.00158227848101266	632	10285	8330	H2AC15
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	0.910575613707744	-0.0936783369059671	38	1	0.00158227848101266	632	10285	5437	POLR2H
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.910575613707744	-0.0936783369059671	38	1	0.00158227848101266	632	10285	5893	RAD52
R-HSA-156590	Glutathione conjugation	0.910575613707744	-0.0936783369059671	38	1	0.00158227848101266	632	10285	2729	GCLC
R-HSA-382551	Transmembrane transport of small molecules	0.913187123934885	-0.0908144643658001	677	34	0.0537974683544304	632	10285	50636,51076,65010,57030,817,6533,6519,9818,114,3099,8480,55706,3162,6520,6515,3098,23327,2040,54795,148229,2555,254428,444,2561,65267,94015,27173,144195,9123,10058,23461,6513,6340,10991	ANO7,CUTC,SLC26A6,SLC17A7,CAMK2D,SLC6A6,SLC3A1,NUP58,ADCY8,HK2,RAE1,NDC1,HMOX1,SLC3A2,SLC2A3,HK1,NEDD4L,STOM,TRPM4,ATP8B3,GABRA2,SLC41A1,ASPH,GABRB2,WNK3,TTYH2,SLC39A1,SLC2A14,SLC16A3,ABCB6,ABCA5,SLC2A1,SCNN1G,SLC38A3
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.913577546729827	-0.0903870170791771	88	3	0.00474683544303797	632	10285	2961,5437,4331	GTF2E2,POLR2H,MNAT1
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.914850376490558	-0.0889947500390914	132	5	0.00791139240506329	632	10285	9025,890,5893,8341,8900	RNF8,CCNA2,RAD52,H2BC15,CCNA1
R-HSA-112382	Formation of RNA Pol II elongation complex	0.915479058909269	-0.088307789067722	65	2	0.00316455696202532	632	10285	4331,5437	MNAT1,POLR2H
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.915479058909269	-0.088307789067722	65	2	0.00316455696202532	632	10285	5437,4331	POLR2H,MNAT1
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.916091004754513	-0.0876395690742261	39	1	0.00158227848101266	632	10285	153642	ARSK
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.916091004754513	-0.0876395690742261	39	1	0.00158227848101266	632	10285	8450	CUL4B
R-HSA-167290	Pausing and recovery of HIV elongation	0.921266730411845	-0.0820056750878932	40	1	0.00158227848101266	632	10285	5437	POLR2H
R-HSA-1442490	Collagen degradation	0.921266730411845	-0.0820056750878932	40	1	0.00158227848101266	632	10285	1299	COL9A3
R-HSA-167287	HIV elongation arrest and recovery	0.921266730411845	-0.0820056750878932	40	1	0.00158227848101266	632	10285	5437	POLR2H
R-HSA-2980736	Peptide hormone metabolism	0.92449909425066	-0.0785032078734905	91	3	0.00474683544303797	632	10285	56605,1395,30001	ERO1B,CRHR2,ERO1A
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.92449909425066	-0.0785032078734905	91	3	0.00474683544303797	632	10285	3015,8313,8341	H2AZ1,AXIN2,H2BC15
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.925877989669927	-0.07701281363278	373	17	0.0268987341772152	632	10285	23327,9867,868,80176,92912,26118,7704,55236,23480,6478,8916,23014,9871,114088,9021,154214,63893	NEDD4L,PJA2,CBLB,SPSB1,UBE2Q2,WSB1,ZBTB16,UBA6,SEC61G,SIAH2,HERC3,FBXO21,SEC24D,TRIM9,SOCS3,RNF217,UBE2O
R-HSA-201681	TCF dependent signaling in response to WNT	0.925952499893418	-0.0769323416630711	238	10	0.0158227848101266	632	10285	8341,1855,8313,79412,6422,5526,7514,3015,1856,9580	H2BC15,DVL1,AXIN2,KREMEN2,SFRP1,PPP2R5B,XPO1,H2AZ1,DVL2,SOX13
R-HSA-5620924	Intraflagellar transport	0.926123677829971	-0.0767474918830243	41	1	0.00158227848101266	632	10285	79809	TTC21B
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.926123677829971	-0.0767474918830243	41	1	0.00158227848101266	632	10285	5980	REV3L
R-HSA-5696400	Dual Incision in GG-NER	0.926123677829971	-0.0767474918830243	41	1	0.00158227848101266	632	10285	8450	CUL4B
R-HSA-5653656	Vesicle-mediated transport	0.926476823079255	-0.0763662491343719	650	32	0.0506329113924051	632	10285	26286,23062,23433,5286,3998,9871,22930,1856,89781,7163,10226,9363,4122,51594,22898,6456,113220,7039,64786,4036,11252,79958,7110,51014,23258,950,78989,115548,10282,143425,5565,54732	ARFGAP3,GGA2,RHOQ,PIK3C2A,LMAN1,SEC24D,RAB3GAP1,DVL2,HPS4,TPD52,PLIN3,RAB33A,MAN2A2,NBAS,DENND3,SH3GL2,KIF12,TGFA,TBC1D15,LRP2,PACSIN2,DENND1C,TMF1,TMED7,DENND5A,SCARB2,COLEC11,FCHO2,BET1,SYT9,PRKAB2,TMED9
R-HSA-1169091	Activation of NF-kappaB in B cells	0.927580962119406	-0.0751751976153802	68	2	0.00316455696202532	632	10285	5970,8915	RELA,BCL10
R-HSA-983189	Kinesins	0.930681451718886	-0.0718382173767449	42	1	0.00158227848101266	632	10285	113220	KIF12
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.931237859934577	-0.0712405456852045	69	2	0.00316455696202532	632	10285	9025,8341	RNF8,H2BC15
R-HSA-5693538	Homology Directed Repair	0.932224089985312	-0.0701820532991824	138	5	0.00791139240506329	632	10285	8900,5893,8341,9025,890	CCNA1,RAD52,H2BC15,RNF8,CCNA2
R-HSA-1852241	Organelle biogenesis and maintenance	0.934792603815266	-0.0674305883991565	340	15	0.0237341772151899	632	10285	9702,6256,55559,27031,9662,10891,1386,11190,79809,63875,8841,9572,7277,5565,5600	CEP57,RXRA,HAUS7,NPHP3,CEP135,PPARGC1A,ATF2,CEP250,TTC21B,MRPL17,HDAC3,NR1D1,TUBA4A,PRKAB2,MAPK11
R-HSA-194068	Bile acid and bile salt metabolism	0.934958452854046	-0.0672531861309517	43	1	0.00158227848101266	632	10285	6256	RXRA
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.934958452854046	-0.0672531861309517	43	1	0.00158227848101266	632	10285	78989	COLEC11
R-HSA-375280	Amine ligand-binding receptors	0.934958452854046	-0.0672531861309517	43	1	0.00158227848101266	632	10285	3269	HRH1
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.934958452854046	-0.0672531861309517	43	1	0.00158227848101266	632	10285	114	ADCY8
R-HSA-69473	G2/M DNA damage checkpoint	0.937097260096788	-0.0649682026675521	95	3	0.00474683544303797	632	10285	9025,11200,8341	RNF8,CHEK2,H2BC15
R-HSA-72766	Translation	0.938541183098099	-0.0634285420876671	162	6	0.00949367088607595	632	10285	3646,6122,23480,7458,1975,8662	EIF3E,RPL3,SEC61G,EIF4H,EIF4B,EIF3B
R-HSA-917937	Iron uptake and transport	0.938971951945024	-0.0629696703530907	44	1	0.00158227848101266	632	10285	3162	HMOX1
R-HSA-4086400	PCP/CE pathway	0.939928340616762	-0.0619516400104233	96	3	0.00474683544303797	632	10285	1856,1855,7481	DVL2,DVL1,WNT11
R-HSA-69206	G1/S Transition	0.939947057941176	-0.0619317266433687	119	4	0.00632911392405063	632	10285	8900,890,4171,4331	CCNA1,CCNA2,MCM2,MNAT1
R-HSA-69278	Cell Cycle, Mitotic	0.940851595317137	-0.0609698613802977	514	24	0.0379746835443038	632	10285	4331,890,7277,255919,114799,8341,1031,1032,11190,4171,9662,3015,7514,55559,55706,8480,9818,5500,894,5526,9663,10592,9702,8900	MNAT1,CCNA2,TUBA4A,CNEP1R1,ESCO1,H2BC15,CDKN2C,CDKN2D,CEP250,MCM2,CEP135,H2AZ1,XPO1,HAUS7,NDC1,RAE1,NUP58,PPP1CB,CCND2,PPP2R5B,LPIN2,SMC2,CEP57,CCNA1
R-HSA-774815	Nucleosome assembly	0.941188610604672	-0.060611723132159	72	2	0.00316455696202532	632	10285	8341,3015	H2BC15,H2AZ1
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.941188610604672	-0.060611723132159	72	2	0.00316455696202532	632	10285	8341,3015	H2BC15,H2AZ1
R-HSA-6811438	Intra-Golgi traffic	0.942738158990202	-0.0589667029965856	45	1	0.00158227848101266	632	10285	4122	MAN2A2
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.944190162145629	-0.0574276901726647	73	2	0.00316455696202532	632	10285	890,8900	CCNA2,CCNA1
R-HSA-5621481	C-type lectin receptors (CLRs)	0.94636301756209	-0.0551290440446183	144	5	0.00791139240506329	632	10285	8915,3708,4791,9252,5970	BCL10,ITPR1,NFKB2,RPS6KA5,RELA
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.947045657966946	-0.0544079736880113	74	2	0.00316455696202532	632	10285	8900,890	CCNA1,CCNA2
R-HSA-8948216	Collagen chain trimerization	0.94958861934032	-0.0517264204464484	47	1	0.00158227848101266	632	10285	1299	COL9A3
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.952344546173717	-0.0488283914176816	76	2	0.00316455696202532	632	10285	890,8900	CCNA2,CCNA1
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	0.952344546173717	-0.0488283914176816	76	2	0.00316455696202532	632	10285	3015,8341	H2AZ1,H2BC15
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.952344546173717	-0.0488283914176816	76	2	0.00316455696202532	632	10285	25791,5924	NGEF,RASGRF2
R-HSA-69239	Synthesis of DNA	0.95239516393857	-0.0487752421452679	101	3	0.00474683544303797	632	10285	8900,4171,890	CCNA1,MCM2,CCNA2
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.954800338092651	-0.0462530304196494	77	2	0.00316455696202532	632	10285	890,8900	CCNA2,CCNA1
R-HSA-5617833	Cilium Assembly	0.955216298010035	-0.0458174740835445	192	7	0.0110759493670886	632	10285	27031,9662,11190,79809,55559,9702,7277	NPHP3,CEP135,CEP250,TTC21B,HAUS7,CEP57,TUBA4A
R-HSA-3858494	Beta-catenin independent WNT signaling	0.956046884386972	-0.0449483248874809	149	5	0.00791139240506329	632	10285	1855,5331,7481,3708,1856	DVL1,PLCB3,WNT11,ITPR1,DVL2
R-HSA-162906	HIV Infection	0.958250199434849	-0.0426463665974674	236	9	0.0142405063291139	632	10285	9818,7514,23327,2961,8731,4331,8480,55706,5437	NUP58,XPO1,NEDD4L,GTF2E2,RNMT,MNAT1,RAE1,NDC1,POLR2H
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.958670266849835	-0.0422080934097183	104	3	0.00474683544303797	632	10285	7187,4791,51330	TRAF3,NFKB2,TNFRSF12A
R-HSA-3214858	RMTs methylate histone arginines	0.9593537883436	-0.0414953583208654	79	2	0.00316455696202532	632	10285	3015,8330	H2AZ1,H2AC15
R-HSA-72689	Formation of a pool of free 40S subunits	0.960583673492483	-0.0402141860519152	105	3	0.00474683544303797	632	10285	3646,6122,8662	EIF3E,RPL3,EIF3B
R-HSA-156580	Phase II conjugation	0.962413712831791	-0.038310865844841	106	3	0.00474683544303797	632	10285	219970,9060,2729	GLYATL2,PAPSS2,GCLC
R-HSA-445717	Aquaporin-mediated transport	0.963344600258897	-0.0373440908416825	52	1	0.00158227848101266	632	10285	114	ADCY8
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.963465905576618	-0.0372181777666666	81	2	0.00316455696202532	632	10285	8900,890	CCNA1,CCNA2
R-HSA-157579	Telomere Maintenance	0.96536919945341	-0.0352446607049233	82	2	0.00316455696202532	632	10285	8341,3015	H2BC15,H2AZ1
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.965608473295346	-0.0349968340764363	53	1	0.00158227848101266	632	10285	27031	NPHP3
R-HSA-69306	DNA Replication	0.967436088601887	-0.033105914552768	109	3	0.00474683544303797	632	10285	8900,890,4171	CCNA1,CCNA2,MCM2
R-HSA-69610	p53-Independent DNA Damage Response	0.967732734902893	-0.0327993301351961	54	1	0.00158227848101266	632	10285	11200	CHEK2
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.967732734902893	-0.0327993301351961	54	1	0.00158227848101266	632	10285	11200	CHEK2
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.967732734902893	-0.0327993301351961	54	1	0.00158227848101266	632	10285	11200	CHEK2
R-HSA-162909	Host Interactions of HIV factors	0.96857079168352	-0.0319337046571131	134	4	0.00632911392405063	632	10285	9818,7514,8480,55706	NUP58,XPO1,RAE1,NDC1
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.969556722197876	-0.0309162993601547	158	5	0.00791139240506329	632	10285	6392,5165,9123,6256,5163	SDHD,PDK3,SLC16A3,RXRA,PDK1
R-HSA-68877	Mitotic Prometaphase	0.970425146677448	-0.0300210079643832	111	3	0.00474683544303797	632	10285	5526,7514,10592	PPP2R5B,XPO1,SMC2
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.970524126929143	-0.0299190163738487	85	2	0.00316455696202532	632	10285	8450,4331	CUL4B,MNAT1
R-HSA-73857	RNA Polymerase II Transcription	0.970793498849689	-0.0296415018458831	159	5	0.00791139240506329	632	10285	2961,8731,84321,4331,5437	GTF2E2,RNMT,THOC3,MNAT1,POLR2H
R-HSA-4641257	Degradation of AXIN	0.971596283066059	-0.0288149074418617	56	1	0.00158227848101266	632	10285	8313	AXIN2
R-HSA-69541	Stabilization of p53	0.971596283066059	-0.0288149074418617	56	1	0.00158227848101266	632	10285	11200	CHEK2
R-HSA-5696398	Nucleotide Excision Repair	0.971820553420682	-0.02858410738764	112	3	0.00474683544303797	632	10285	4331,5437,8450	MNAT1,POLR2H,CUL4B
R-HSA-1280218	Adaptive Immune System	0.97287412156644	-0.0275005766284038	810	38	0.060126582278481	632	10285	5335,6456,868,2309,23239,6494,7704,3383,23480,1326,55236,63893,23108,114088,7087,8916,5526,2261,3164,23327,5970,5909,10125,9867,3708,7525,80176,92912,2549,8915,3815,26118,6478,154214,9021,253260,9871,23014	PLCG1,SH3GL2,CBLB,FOXO3,PHLPP1,SIPA1,ZBTB16,ICAM1,SEC61G,MAP3K8,UBA6,UBE2O,RAP1GAP2,TRIM9,ICAM5,HERC3,PPP2R5B,FGFR3,NR4A1,NEDD4L,RELA,RAP1GAP,RASGRP1,PJA2,ITPR1,YES1,SPSB1,UBE2Q2,GAB1,BCL10,KIT,WSB1,SIAH2,RNF217,SOCS3,RICTOR,SEC24D,FBXO21
R-HSA-453276	Regulation of mitotic cell cycle	0.973541124894846	-0.0268152106914827	87	2	0.00316455696202532	632	10285	8900,890	CCNA1,CCNA2
R-HSA-351202	Metabolism of polyamines	0.973541124894846	-0.0268152106914827	87	2	0.00316455696202532	632	10285	2628,1159	GATM,CKMT1B
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.973541124894846	-0.0268152106914827	87	2	0.00316455696202532	632	10285	890,8900	CCNA2,CCNA1
R-HSA-912446	Meiotic recombination	0.974935626716717	-0.0253838340442526	88	2	0.00316455696202532	632	10285	3015,8341	H2AZ1,H2BC15
R-HSA-416482	G alpha (12/13) signalling events	0.974935626716717	-0.0253838340442526	88	2	0.00316455696202532	632	10285	25791,5924	NGEF,RASGRF2
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.974997869817399	-0.0253199927893441	58	1	0.00158227848101266	632	10285	6469	SHH
R-HSA-195721	Signaling by Wnt	0.976307400460926	-0.0239777826697184	336	13	0.0205696202531646	632	10285	3708,8341,5331,7481,5526,6422,7514,3015,9580,1855,79412,8313,1856	ITPR1,H2BC15,PLCB3,WNT11,PPP2R5B,SFRP1,XPO1,H2AZ1,SOX13,DVL1,KREMEN2,AXIN2,DVL2
R-HSA-2142753	Arachidonic acid metabolism	0.976542931546314	-0.0237365649146555	59	1	0.00158227848101266	632	10285	145482	PTGR2
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.977992654541775	-0.0222531196690066	60	1	0.00158227848101266	632	10285	4791	NFKB2
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.977992654541775	-0.0222531196690066	60	1	0.00158227848101266	632	10285	6469	SHH
R-HSA-418346	Platelet homeostasis	0.978706096032306	-0.0215238898660665	91	2	0.00316455696202532	632	10285	3708,5526	ITPR1,PPP2R5B
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.979352912961514	-0.0208632183032952	61	1	0.00158227848101266	632	10285	8650	NUMB
R-HSA-71291	Metabolism of amino acids and derivatives	0.979430810158976	-0.0207836820108668	361	14	0.0221518987341772	632	10285	6520,10295,2729,1159,84706,125061,6122,2058,1491,9060,56267,2628,26227,1615	SLC3A2,BCKDK,GCLC,CKMT1B,GPT2,AFMID,RPL3,EPRS1,CTH,PAPSS2,KYAT3,GATM,PHGDH,DARS1
R-HSA-192823	Viral mRNA Translation	0.979836250505538	-0.0203698125997086	92	2	0.00316455696202532	632	10285	6122,2926	RPL3,GRSF1
R-HSA-202403	TCR signaling	0.979977402180793	-0.020225766582573	119	3	0.00474683544303797	632	10285	8915,5970,5335	BCL10,RELA,PLCG1
R-HSA-72187	mRNA 3'-end processing	0.980629219600316	-0.0195608525337305	62	1	0.00158227848101266	632	10285	84321	THOC3
R-HSA-416476	G alpha (q) signalling events	0.980695297316055	-0.0194934718272808	192	6	0.00949367088607595	632	10285	84634,3708,5331,10125,2150,3269	KISS1R,ITPR1,PLCB3,RASGRP1,F2RL1,HRH1
R-HSA-1640170	Cell Cycle	0.981681308963032	-0.018488555923983	621	27	0.0427215189873418	632	10285	11200,4331,890,7277,255919,8341,114799,1031,1032,11190,9662,4171,3015,7514,55559,55706,8480,9025,9818,23353,5500,894,5526,9663,10592,8900,9702	CHEK2,MNAT1,CCNA2,TUBA4A,CNEP1R1,H2BC15,ESCO1,CDKN2C,CDKN2D,CEP250,CEP135,MCM2,H2AZ1,XPO1,HAUS7,NDC1,RAE1,RNF8,NUP58,SUN1,PPP1CB,CCND2,PPP2R5B,LPIN2,SMC2,CCNA1,CEP57
R-HSA-1500620	Meiosis	0.981858951898148	-0.0183076144488921	121	3	0.00474683544303797	632	10285	23353,3015,8341	SUN1,H2AZ1,H2BC15
R-HSA-5663205	Infectious disease	0.983191789129372	-0.0169510719354723	388	15	0.0237341772151899	632	10285	3841,2926,6456,5437,7514,23327,6122,6616,5604,9818,8731,2961,4331,8480,55706	KPNA5,GRSF1,SH3GL2,POLR2H,XPO1,NEDD4L,RPL3,SNAP25,MAP2K1,NUP58,RNMT,GTF2E2,MNAT1,RAE1,NDC1
R-HSA-202424	Downstream TCR signaling	0.985490926417023	-0.0146153595174674	98	2	0.00316455696202532	632	10285	8915,5970	BCL10,RELA
R-HSA-211859	Biological oxidations	0.9855461597219	-0.0145593146005248	222	7	0.0110759493670886	632	10285	2729,128,6256,9060,219970,56603,405	GCLC,ADH5,RXRA,PAPSS2,GLYATL2,CYP26B1,ARNT
R-HSA-4608870	Asymmetric localization of PCP proteins	0.985921811803766	-0.0141782258972461	67	1	0.00158227848101266	632	10285	1856	DVL2
R-HSA-5358346	Hedgehog ligand biogenesis	0.985921811803766	-0.0141782258972461	67	1	0.00158227848101266	632	10285	6469	SHH
R-HSA-69620	Cell Cycle Checkpoints	0.986649540071436	-0.0134403785185003	201	6	0.00949367088607595	632	10285	890,9025,4171,8900,11200,8341	CCNA2,RNF8,MCM2,CCNA1,CHEK2,H2BC15
R-HSA-68867	Assembly of the pre-replicative complex	0.987609551802731	-0.0124678498256728	69	1	0.00158227848101266	632	10285	4171	MCM2
R-HSA-5658442	Regulation of RAS by GAPs	0.988376071308998	-0.011692014682188	70	1	0.00158227848101266	632	10285	153090	DAB2IP
R-HSA-2132295	MHC class II antigen presentation	0.988996886078748	-0.0110640959197426	103	2	0.00316455696202532	632	10285	9871,6456	SEC24D,SH3GL2
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.988996886078748	-0.0110640959197426	103	2	0.00316455696202532	632	10285	7514,5526	XPO1,PPP2R5B
R-HSA-73856	RNA Polymerase II Transcription Termination	0.98909524145131	-0.0109646512363794	71	1	0.00158227848101266	632	10285	84321	THOC3
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.98909524145131	-0.0109646512363794	71	1	0.00158227848101266	632	10285	84321	THOC3
R-HSA-6809371	Formation of the cornified envelope	0.98909524145131	-0.0109646512363794	71	1	0.00158227848101266	632	10285	1829	DSG2
R-HSA-5689603	UCH proteinases	0.990154784927208	-0.00989399966331978	105	2	0.00316455696202532	632	10285	4092,8330	SMAD7,H2AC15
R-HSA-382556	ABC-family proteins mediated transport	0.991193497227411	-0.00884550919375771	107	2	0.00316455696202532	632	10285	23461,10058	ABCA5,ABCB6
R-HSA-375276	Peptide ligand-binding receptors	0.991665976521511	-0.00836894561545315	188	5	0.00791139240506329	632	10285	84634,4986,2831,2150,5660	KISS1R,OPRK1,NPBWR1,F2RL1,PSAP
R-HSA-73886	Chromosome Maintenance	0.992124932135118	-0.00790623997465986	109	2	0.00316455696202532	632	10285	8341,3015	H2BC15,H2AZ1
R-HSA-68886	M Phase	0.992953860064067	-0.00707108120878389	308	10	0.0158227848101266	632	10285	8341,55706,8480,5526,9663,3015,9818,255919,7514,10592	H2BC15,NDC1,RAE1,PPP2R5B,LPIN2,H2AZ1,NUP58,CNEP1R1,XPO1,SMC2
R-HSA-69481	G2/M Checkpoints	0.993777817895922	-0.00624162055414555	169	4	0.00632911392405063	632	10285	8341,11200,9025,4171	H2BC15,CHEK2,RNF8,MCM2
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.994378161847682	-0.00563770016145666	115	2	0.00316455696202532	632	10285	23480,6122	SEC61G,RPL3
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.99493529015352	-0.00507757896000053	83	1	0.00158227848101266	632	10285	5526	PPP2R5B
R-HSA-1236974	ER-Phagosome pathway	0.995543386249676	-0.00446657405722786	85	1	0.00158227848101266	632	10285	23480	SEC61G
R-HSA-69002	DNA Replication Pre-Initiation	0.995819521526724	-0.00418924110325999	86	1	0.00158227848101266	632	10285	4171	MCM2
R-HSA-68874	M/G1 Transition	0.995819521526724	-0.00418924110325999	86	1	0.00158227848101266	632	10285	4171	MCM2
R-HSA-5368286	Mitochondrial translation initiation	0.996078572657894	-0.00392913629831284	87	1	0.00158227848101266	632	10285	63875	MRPL17
R-HSA-5419276	Mitochondrial translation termination	0.996078572657894	-0.00392913629831284	87	1	0.00158227848101266	632	10285	63875	MRPL17
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	0.996170096963663	-0.0038372558947978	179	4	0.00632911392405063	632	10285	54913,8780,6122,11340	RPP25,RIOK3,RPL3,EXOSC8
R-HSA-5389840	Mitochondrial translation elongation	0.996321595028823	-0.00368518693906766	88	1	0.00158227848101266	632	10285	63875	MRPL17
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.996623859961249	-0.00338185205954343	124	2	0.00316455696202532	632	10285	3383,7087	ICAM1,ICAM5
R-HSA-611105	Respiratory electron transport	0.997152308944863	-0.00285175344142335	92	1	0.00158227848101266	632	10285	6392	SDHD
R-HSA-156902	Peptide chain elongation	0.997152308944863	-0.00285175344142335	92	1	0.00158227848101266	632	10285	6122	RPL3
R-HSA-5368287	Mitochondrial translation	0.997494510189493	-0.00250863380269375	94	1	0.00158227848101266	632	10285	63875	MRPL17
R-HSA-2408557	Selenocysteine synthesis	0.99764988939962	-0.00235287644450698	95	1	0.00158227848101266	632	10285	6122	RPL3
R-HSA-418594	G alpha (i) signalling events	0.997751189736276	-0.00225134263478538	242	6	0.00949367088607595	632	10285	4986,2781,2831,8490,2773,114	OPRK1,GNAZ,NPBWR1,RGS5,GNAI3,ADCY8
R-HSA-156842	Eukaryotic Translation Elongation	0.997795647006941	-0.0022067861554745	96	1	0.00158227848101266	632	10285	6122	RPL3
R-HSA-72764	Eukaryotic Translation Termination	0.997795647006941	-0.0022067861554745	96	1	0.00158227848101266	632	10285	6122	RPL3
R-HSA-8868773	rRNA processing in the nucleus and cytosol	0.99788396400471	-0.00211827796273798	191	4	0.00632911392405063	632	10285	11340,6122,8780,54913	EXOSC8,RPL3,RIOK3,RPP25
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.998180957897725	-0.00182069856845284	99	1	0.00158227848101266	632	10285	6122	RPL3
R-HSA-1236975	Antigen processing-Cross presentation	0.998399693884204	-0.00160158797338652	101	1	0.00158227848101266	632	10285	23480	SEC61G
R-HSA-72312	rRNA processing	0.998720052303012	-0.00128076752967848	201	4	0.00632911392405063	632	10285	8780,54913,11340,6122	RIOK3,RPP25,EXOSC8,RPL3
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.999258471645806	-0.000741803422333454	113	1	0.00158227848101266	632	10285	6392	SDHD
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.999410334923936	-0.00058983899688865	322	8	0.0126582278481013	632	10285	84634,2150,2831,5660,136,4986,5732,3269	KISS1R,F2RL1,NPBWR1,PSAP,ADORA2B,OPRK1,PTGER2,HRH1
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	0.999526780668027	-0.000473331335576832	120	1	0.00158227848101266	632	10285	6122	RPL3
R-HSA-927802	Nonsense-Mediated Decay (NMD)	0.999526780668027	-0.000473331335576832	120	1	0.00158227848101266	632	10285	6122	RPL3
R-HSA-500792	GPCR ligand binding	0.99963364366474	-0.000366423460136922	453	13	0.0205696202531646	632	10285	3269,133,5732,797,5660,2150,136,4986,2831,7481,6469,1395,84634	HRH1,ADM,PTGER2,CALCB,PSAP,F2RL1,ADORA2B,OPRK1,NPBWR1,WNT11,SHH,CRHR2,KISS1R
R-HSA-2467813	Separation of Sister Chromatids	0.999737075683023	-0.000262958887635111	168	2	0.00316455696202532	632	10285	7514,5526	XPO1,PPP2R5B
R-HSA-68882	Mitotic Anaphase	0.999862807919375	-0.000137201492318993	179	2	0.00316455696202532	632	10285	7514,5526	XPO1,PPP2R5B
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.999870711943122	-0.000129296415298824	180	2	0.00316455696202532	632	10285	7514,5526	XPO1,PPP2R5B
R-HSA-6805567	Keratinization	0.999998898253688	-1.10174691845472e-06	214	1	0.00158227848101266	632	10285	1829	DSG2
R-HSA-372790	Signaling by GPCR	0.999999842776346	-1.57223666087562e-07	1299	42	0.0664556962025316	632	10285	153090,5143,84634,1395,10125,4986,136,3708,2675,1742,2773,3716,5526,3560,1847,2261,25791,5660,2150,5924,3690,817,88,5732,114,797,3815,3269,80346,133,5923,6469,5331,7481,2831,2781,162998,5604,7414,1852,5598,8490	DAB2IP,PDE4C,KISS1R,CRHR2,RASGRP1,OPRK1,ADORA2B,ITPR1,GFRA2,DLG4,GNAI3,JAK1,PPP2R5B,IL2RB,DUSP5,FGFR3,NGEF,PSAP,F2RL1,RASGRF2,ITGB3,CAMK2D,ACTN2,PTGER2,ADCY8,CALCB,KIT,HRH1,REEP4,ADM,RASGRF1,SHH,PLCB3,WNT11,NPBWR1,GNAZ,OR7D2,MAP2K1,VCL,DUSP9,MAPK7,RGS5
R-HSA-388396	GPCR downstream signaling	0.999999993611213	-6.38878755023041e-09	974	24	0.0379746835443038	632	10285	2781,2831,5331,162998,8490,1395,84634,5143,136,3708,4986,10125,25791,3560,3716,2773,5924,2150,133,80346,3269,797,114,5732	GNAZ,NPBWR1,PLCB3,OR7D2,RGS5,CRHR2,KISS1R,PDE4C,ADORA2B,ITPR1,OPRK1,RASGRP1,NGEF,IL2RB,JAK1,GNAI3,RASGRF2,F2RL1,ADM,REEP4,HRH1,CALCB,ADCY8,PTGER2
R-HSA-381753	Olfactory Signaling Pathway	0.999999999731196	-2.68804362979129e-10	391	2	0.00316455696202532	632	10285	80346,162998	REEP4,OR7D2
R-HSA-6787639	GDP-fucose biosynthesis	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-176417	Phosphorylation of Emi1	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-6793080	rRNA modification in the mitochondrion	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-6798163	Choline catabolism	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-190370	FGFR1b ligand binding and activation	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-444257	RSK activation	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-1237112	Methionine salvage pathway	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-166662	Lectin pathway of complement activation	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-5676934	Protein repair	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-5690714	CD22 mediated BCR regulation	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-5336415	Uptake and function of diphtheria toxin	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-187015	Activation of TRKA receptors	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-8857538	PTK6 promotes HIF1A stabilization	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-8849470	PTK6 Regulates Cell Cycle	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-388479	Vasopressin-like receptors	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-205025	NADE modulates death signalling	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-6799990	Metal sequestration by antimicrobial proteins	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-111957	Cam-PDE 1 activation	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-1566977	Fibronectin matrix formation	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-428808	Na+-dependent glucose transporters	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-3000484	Scavenging by Class F Receptors	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-500753	Pyrimidine biosynthesis	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-1482798	Acyl chain remodeling of CL	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-3065679	SUMO is proteolytically processed	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.999999999984948	-1.50520656913893e-11	6	0	0	632	10285
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-446107	Type I hemidesmosome assembly	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-75072	mRNA Editing	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-5625970	RHO GTPases activate KTN1	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-196780	Biotin transport and metabolism	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-211999	CYP2E1 reactions	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-8851805	MET activates RAS signaling	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-549127	Organic cation transport	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-2470946	Cohesin Loading onto Chromatin	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-193048	Androgen biosynthesis	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-1980150	Signaling by NOTCH4	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-2022923	Dermatan sulfate biosynthesis	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-1980148	Signaling by NOTCH3	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999998909	-1.09142226611926e-12	11	0	0	632	10285
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	1.00000000000712	7.1226916657438e-12	27	0	0	632	10285
R-HSA-1482788	Acyl chain remodelling of PC	1.00000000000712	7.1226916657438e-12	27	0	0	632	10285
R-HSA-77387	Insulin receptor recycling	1.00000000000712	7.1226916657438e-12	27	0	0	632	10285
R-HSA-209952	Peptide hormone biosynthesis	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-181431	Acetylcholine Binding And Downstream Events	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-69166	Removal of the Flap Intermediate	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-418359	Reduction of cytosolic Ca++ levels	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-418885	DCC mediated attractive signaling	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-69109	Leading Strand Synthesis	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-190322	FGFR4 ligand binding and activation	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-1250347	SHC1 events in ERBB4 signaling	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-69091	Polymerase switching	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-419408	Lysosphingolipid and LPA receptors	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-174411	Polymerase switching on the C-strand of the telomere	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-1679131	Trafficking and processing of endosomal TLR	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-428540	Activation of Rac	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-209543	p75NTR recruits signalling complexes	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-162594	Early Phase of HIV Life Cycle	1.00000000001116	1.11616640130248e-11	14	0	0	632	10285
R-HSA-5621480	Dectin-2 family	1.00000000001134	1.13361553556527e-11	28	0	0	632	10285
R-HSA-190828	Gap junction trafficking	1.00000000001134	1.13361553556527e-11	28	0	0	632	10285
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	1.00000000001134	1.13361553556527e-11	28	0	0	632	10285
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	1.00000000001134	1.13361553556527e-11	28	0	0	632	10285
R-HSA-352238	Breakdown of the nuclear lamina	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-1296067	Potassium transport channels	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-198745	Signalling to STAT3	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-1307965	betaKlotho-mediated ligand binding	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-3249367	STAT6-mediated induction of chemokines	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-977442	GABA A (rho) receptor activation	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-379397	Enzymatic degradation of dopamine by COMT	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-190827	Transport of connexins along the secretory pathway	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-191650	Regulation of gap junction activity	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-350864	Regulation of thyroid hormone activity	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-380615	Serotonin clearance from the synaptic cleft	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-73927	Depurination	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-190704	Oligomerization of connexins into connexons	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-217271	FMO oxidises nucleophiles	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-193681	Ceramide signalling	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-8853336	Signaling by plasma membrane FGFR1 fusions	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-177539	Autointegration results in viral DNA circles	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-265473	Trafficking of dietary sterols	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-844455	The NLRP1 inflammasome	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-427589	Type II Na+/Pi cotransporters	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-844615	The AIM2 inflammasome	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-163282	Mitochondrial transcription initiation	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-1483248	Synthesis of PIPs at the ER membrane	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-111446	Activation of BIM and translocation to mitochondria	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-111458	Formation of apoptosome	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-110331	Cleavage of the damaged purine	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-5602680	MyD88 deficiency (TLR5)	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-5357572	Lysosomal glycogen catabolism	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-1299503	TWIK related potassium channel (TREK)	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-77108	Utilization of Ketone Bodies	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-8875791	MET activates STAT3	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-165181	Inhibition of TSC complex formation by PKB	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-351200	Interconversion of polyamines	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-175567	Integration of viral DNA into host genomic DNA	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-8849472	PTK6 Down-Regulation	1.00000000001437	1.43697717841593e-11	3	0	0	632	10285
R-HSA-390666	Serotonin receptors	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-73621	Pyrimidine catabolism	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-844456	The NLRP3 inflammasome	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-389359	CD28 dependent Vav1 pathway	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-5689877	Josephin domain DUBs	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-4641265	Repression of WNT target genes	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-879518	Transport of organic anions	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-190373	FGFR1c ligand binding and activation	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-1236977	Endosomal/Vacuolar pathway	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-211958	Miscellaneous substrates	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-8851680	Butyrophilin (BTN) family interactions	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-417957	P2Y receptors	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-71064	Lysine catabolism	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-209822	Glycoprotein hormones	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-166786	Creation of C4 and C2 activators	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-211979	Eicosanoids	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-3371511	HSF1 activation	1.00000000001481	1.48061496477664e-11	12	0	0	632	10285
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-389542	NADPH regeneration	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-1855231	Synthesis of IPs in the ER lumen	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-162589	Reverse Transcription of HIV RNA	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-6809583	Retinoid metabolism disease events	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-5083628	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-171286	Synthesis and processing of ENV and VPU	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-3248023	Regulation by TREX1	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-162585	Uncoating of the HIV Virion	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-8853333	Signaling by FGFR2 fusions	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-5657655	MGMT-mediated DNA damage reversal	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-163316	Mitochondrial transcription termination	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-2023837	Signaling by FGFR2 amplification mutants	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-164525	Plus-strand DNA synthesis	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-1300645	Acrosome Reaction	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-1839120	Signaling by FGFR1 amplification mutants	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-5083633	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-169131	Inhibition of PKR	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-1483076	Synthesis of CL	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-1222449	Mtb iron assimilation by chelation	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-140180	COX reactions	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-2408552	Methylation of MeSeH for excretion	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-5263617	Metabolism of ingested MeSeO2H into MeSeH	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-164516	Minus-strand DNA synthesis	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-5602410	TLR3 deficiency - HSE	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-5602415	UNC93B1 deficiency - HSE	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-2534343	Interaction With Cumulus Cells	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-5083629	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-1222499	Response of Mtb to phagocytosis	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-1839128	FGFR4 mutant receptor activation	1.00000000001515	1.51509083057277e-11	1	0	0	632	10285
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-844623	The IPAF inflammasome	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-916853	Degradation of GABA	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-888568	GABA synthesis	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-111995	phospho-PLA2 pathway	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-192905	vRNP Assembly	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-190872	Transport of connexons to the plasma membrane	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-75064	mRNA Editing: A to I Conversion	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-8849175	Threonine catabolism	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-5683177	Defective ABCC8 can cause hypoglycemias and hyperglycemias	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-70688	Proline catabolism	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-451307	Activation of Na-permeable Kainate Receptors	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-5652227	Fructose biosynthesis	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-6804754	Regulation of TP53 Expression	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-168277	Influenza Virus Induced Apoptosis	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-75896	Plasmalogen biosynthesis	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-168268	Virus Assembly and Release	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-141334	PAOs oxidise polyamines to amines	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-165160	PDE3B signalling	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-205017	NFG and proNGF binds to p75NTR	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-5357609	Glycogen storage disease type II (GAA)	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-168316	Assembly of Viral Components at the Budding Site	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-203754	NOSIP mediated eNOS trafficking	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-187042	TRKA activation by NGF	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-75102	C6 deamination of adenosine	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-71737	Pyrophosphate hydrolysis	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-111452	Activation and oligomerization of BAK protein	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-8942233	Intestinal infectious diseases	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-111457	Release of apoptotic factors from the mitochondria	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-177162	Conjugation of phenylacetate with glutamine	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-114294	Activation, translocation and oligomerization of BAX	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-428559	Proton-coupled neutral amino acid transporters	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-77042	Formation of editosomes by ADAR proteins	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-8854521	Interaction between PHLDA1 and AURKA	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-141424	Amplification of signal from the kinetochores	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-5602566	TICAM1 deficiency - HSE	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-351143	Agmatine biosynthesis	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-5602636	IKBKB deficiency causes SCID	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-380612	Metabolism of serotonin	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-1483101	Synthesis of PS	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-156582	Acetylation	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	1.00000000001521	1.52067364776742e-11	2	0	0	632	10285
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-888593	Reuptake of GABA	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-8935690	Miscellaneous digestion events	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-209905	Catecholamine biosynthesis	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-8848584	Wax biosynthesis	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-8866906	TFAP2 (AP-2) family regulates transcription of other transcription factors	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-6803544	Ion influx/efflux at host-pathogen interface	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-8847453	Synthesis of PIPs in the nucleus	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-6807047	Cholesterol biosynthesis via desmosterol	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-209563	Axonal growth stimulation	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-4551638	SUMOylation of chromatin organization proteins	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-399710	Activation of AMPA receptors	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-447115	Interleukin-12 signaling	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-69560	Transcriptional activation of p53 responsive genes	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-442745	Activation of CaMK IV	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-428776	Class II GLUTs	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-1296061	HCN channels	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-165158	Activation of AKT2	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-5603037	IRAK4 deficiency (TLR5)	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-173107	Binding and entry of HIV virion	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-379401	Dopamine clearance from the synaptic cleft	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-173736	Alternative complement activation	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-75944	Transcription from mitochondrial promoters	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-6783984	Glycine degradation	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-427975	Proton/oligopeptide cotransporters	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-176034	Interactions of Tat with host cellular proteins	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-211163	AKT-mediated inactivation of FOXO1A	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-140179	Amine Oxidase reactions	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-6807062	Cholesterol biosynthesis via lathosterol	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-2473224	Antagonism of Activin by Follistatin	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-3000497	Scavenging by Class H Receptors	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-1296025	ATP sensitive Potassium channels	1.00000000001522	1.52202820100322e-11	4	0	0	632	10285
R-HSA-69186	Lagging Strand Synthesis	1.00000000001675	1.67522627692168e-11	20	0	0	632	10285
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	1.00000000001675	1.67522627692168e-11	20	0	0	632	10285
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	1.00000000001675	1.67522627692168e-11	20	0	0	632	10285
R-HSA-5654719	SHC-mediated cascade:FGFR4	1.00000000001675	1.67522627692168e-11	20	0	0	632	10285
R-HSA-190241	FGFR2 ligand binding and activation	1.00000000001675	1.67522627692168e-11	20	0	0	632	10285
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	1.00000000001675	1.67522627692168e-11	20	0	0	632	10285
R-HSA-5223345	Miscellaneous transport and binding events	1.00000000001794	1.79415544098198e-11	19	0	0	632	10285
R-HSA-176412	Phosphorylation of the APC/C	1.00000000001794	1.79415544098198e-11	19	0	0	632	10285
R-HSA-110320	Translesion Synthesis by POLH	1.00000000001794	1.79415544098198e-11	19	0	0	632	10285
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	1.00000000001794	1.79415544098198e-11	19	0	0	632	10285
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	1.00000000001794	1.79415544098198e-11	19	0	0	632	10285
R-HSA-190861	Gap junction assembly	1.00000000001794	1.79415544098198e-11	19	0	0	632	10285
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	1.00000000001794	1.79415544098198e-11	19	0	0	632	10285
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	1.00000000001794	1.79415544098198e-11	19	0	0	632	10285
R-HSA-5654712	FRS-mediated FGFR4 signaling	1.00000000001814	1.81366068598052e-11	22	0	0	632	10285
R-HSA-5620916	VxPx cargo-targeting to cilium	1.00000000001814	1.81366068598052e-11	22	0	0	632	10285
R-HSA-77595	Processing of Intronless Pre-mRNAs	1.00000000001814	1.81366068598052e-11	22	0	0	632	10285
R-HSA-1482801	Acyl chain remodelling of PS	1.00000000001814	1.81366068598052e-11	22	0	0	632	10285
R-HSA-4641263	Regulation of FZD by ubiquitination	1.00000000001814	1.81366068598052e-11	22	0	0	632	10285
R-HSA-1250196	SHC1 events in ERBB2 signaling	1.00000000001814	1.81366068598052e-11	22	0	0	632	10285
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	1.00000000001814	1.81366068598052e-11	22	0	0	632	10285
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	1.00000000001814	1.81366068598052e-11	22	0	0	632	10285
R-HSA-140875	Common Pathway of Fibrin Clot Formation	1.00000000001814	1.81366068598052e-11	22	0	0	632	10285
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	1.00000000001814	1.81366068598052e-11	22	0	0	632	10285
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	1.00000000001814	1.81366068598052e-11	22	0	0	632	10285
R-HSA-389948	PD-1 signaling	1.00000000001854	1.85412128137217e-11	23	0	0	632	10285
R-HSA-400508	Incretin synthesis, secretion, and inactivation	1.00000000001854	1.85412128137217e-11	23	0	0	632	10285
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	1.00000000001854	1.85412128137217e-11	23	0	0	632	10285
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	1.00000000001854	1.85412128137217e-11	23	0	0	632	10285
R-HSA-5654699	SHC-mediated cascade:FGFR2	1.00000000001854	1.85412128137217e-11	23	0	0	632	10285
R-HSA-5654693	FRS-mediated FGFR1 signaling	1.00000000001854	1.85412128137217e-11	23	0	0	632	10285
R-HSA-428930	Thromboxane signalling through TP receptor	1.00000000001854	1.85412128137217e-11	23	0	0	632	10285
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	1.00000000001854	1.85412128137217e-11	23	0	0	632	10285
R-HSA-1295596	Spry regulation of FGF signaling	1.00000000001907	1.90743042516459e-11	16	0	0	632	10285
R-HSA-549132	Organic cation/anion/zwitterion transport	1.00000000001907	1.90743042516459e-11	16	0	0	632	10285
R-HSA-190242	FGFR1 ligand binding and activation	1.00000000001907	1.90743042516459e-11	16	0	0	632	10285
R-HSA-1963640	GRB2 events in ERBB2 signaling	1.00000000001907	1.90743042516459e-11	16	0	0	632	10285
R-HSA-1834941	STING mediated induction of host immune responses	1.00000000001907	1.90743042516459e-11	16	0	0	632	10285
R-HSA-163210	Formation of ATP by chemiosmotic coupling	1.00000000001907	1.90743042516459e-11	16	0	0	632	10285
R-HSA-5686938	Regulation of TLR by endogenous ligand	1.00000000001907	1.90743042516459e-11	16	0	0	632	10285
R-HSA-1170546	Prolactin receptor signaling	1.00000000001907	1.90743042516459e-11	16	0	0	632	10285
R-HSA-5576890	Phase 3 - rapid repolarisation	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-193634	Axonal growth inhibition (RHOA activation)	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-110329	Cleavage of the damaged pyrimidine	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-5358493	Synthesis of diphthamide-EEF2	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-164944	Nef and signal transduction	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-72731	Recycling of eIF2:GDP	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-73928	Depyrimidination	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-68952	DNA replication initiation	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-174430	Telomere C-strand synthesis initiation	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-804914	Transport of fatty acids	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-1253288	Downregulation of ERBB4 signaling	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-444821	Relaxin receptors	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-70921	Histidine catabolism	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	1.0000000000193	1.92952538201974e-11	8	0	0	632	10285
R-HSA-175474	Assembly Of The HIV Virion	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-3270619	IRF3-mediated induction of type I IFN	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-432047	Passive transport by Aquaporins	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-190375	FGFR2c ligand binding and activation	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-75892	Platelet Adhesion to exposed collagen	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-2168880	Scavenging of heme from plasma	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-2995410	Nuclear Envelope Reassembly	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-375281	Hormone ligand-binding receptors	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-425561	Sodium/Calcium exchangers	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-1480926	O2/CO2 exchange in erythrocytes	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-198323	AKT phosphorylates targets in the cytosol	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	1.00000000001979	1.97918219967645e-11	13	0	0	632	10285
R-HSA-171319	Telomere Extension By Telomerase	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-3595172	Defective CHST3 causes SEDCJD	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-3656225	Defective CHST6 causes MCDC1	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-164843	2-LTR circle formation	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-3595177	Defective CHSY1 causes TPBS	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-426117	Cation-coupled Chloride cotransporters	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-75158	TRAIL  signaling	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-174577	Activation of C3 and C5	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-111471	Apoptotic factor-mediated response	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-420597	Nectin/Necl  trans heterodimerization	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-429593	Inositol transporters	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-426496	Post-transcriptional silencing by small RNAs	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-5652084	Fructose metabolism	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-5619102	SLC transporter disorders	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-182218	Nef Mediated CD8 Down-regulation	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.0000000000209	2.08961149749926e-11	7	0	0	632	10285
R-HSA-191273	Cholesterol biosynthesis	1.00000000002106	2.10577497557702e-11	24	0	0	632	10285
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	1.00000000002106	2.10577497557702e-11	24	0	0	632	10285
R-HSA-937041	IKK complex recruitment mediated by RIP1	1.00000000002106	2.10577497557702e-11	24	0	0	632	10285
R-HSA-171052	LDL-mediated lipid transport	1.00000000002106	2.10577497557702e-11	24	0	0	632	10285
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	1.00000000002106	2.10577497557702e-11	24	0	0	632	10285
R-HSA-156588	Glucuronidation	1.00000000002106	2.10577497557702e-11	24	0	0	632	10285
R-HSA-1482839	Acyl chain remodelling of PE	1.00000000002269	2.26902287010156e-11	29	0	0	632	10285
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	1.00000000002269	2.26902287010156e-11	29	0	0	632	10285
R-HSA-390918	Peroxisomal lipid metabolism	1.00000000002269	2.26902287010156e-11	29	0	0	632	10285
R-HSA-70635	Urea cycle	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-8868766	rRNA processing in the mitochondrion	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-2161522	Abacavir transport and metabolism	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-74259	Purine catabolism	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-425381	Bicarbonate transporters	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-167590	Nef Mediated CD4 Down-regulation	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-2465910	MASTL Facilitates Mitotic Progression	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-390450	Folding of actin by CCT/TriC	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-209968	Thyroxine biosynthesis	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-74749	Signal attenuation	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-2562578	TRIF-mediated programmed cell death	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-727802	Transport of nucleotide sugars	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-1250342	PI3K events in ERBB4 signaling	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-190377	FGFR2b ligand binding and activation	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-159740	Gamma-carboxylation of protein precursors	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-1300644	Interaction With The Zona Pellucida	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-5687613	Diseases associated with surfactant metabolism	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-3215018	Processing and activation of SUMO	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-73929	Base-Excision Repair, AP Site Formation	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-190873	Gap junction degradation	1.00000000002317	2.31661508298302e-11	10	0	0	632	10285
R-HSA-1187000	Fertilization	1.0000000000241	2.40965177175643e-11	26	0	0	632	10285
R-HSA-1474165	Reproduction	1.0000000000241	2.40965177175643e-11	26	0	0	632	10285
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	1.00000000002429	2.4287379922156e-11	32	0	0	632	10285
R-HSA-376176	Signaling by Robo receptor	1.00000000002429	2.4287379922156e-11	32	0	0	632	10285
R-HSA-8849473	PTK6 Expression	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-196819	Vitamin B1 (thiamin) metabolism	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-390651	Dopamine receptors	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-1306955	GRB7 events in ERBB2 signaling	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-157881	Cyclin B2 mediated events	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-1300652	Sperm:Oocyte Membrane Binding	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-3000471	Scavenging by Class B Receptors	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-167827	The proton buffering model	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-380095	Tachykinin receptors bind tachykinins	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-391906	Leukotriene receptors	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-203641	NOSTRIN mediated eNOS trafficking	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-8869496	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-166187	Mitochondrial Uncoupling Proteins	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-167826	The fatty acid cycling model	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-444209	Free fatty acid receptors	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-6785470	tRNA processing in the mitochondrion	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-70350	Fructose catabolism	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-112307	Transmission across Electrical Synapses	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-5683678	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-8866423	VLDL biosynthesis	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-74713	IRS activation	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-111463	SMAC binds to IAPs	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-75157	FasL/ CD95L signaling	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-111448	Activation of NOXA and translocation to mitochondria	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-2161541	Abacavir metabolism	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-2161517	Abacavir transmembrane transport	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-111461	Cytochrome c-mediated apoptotic response	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-187024	NGF-independant TRKA activation	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-427652	Sodium-coupled phosphate cotransporters	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-71032	Propionyl-CoA catabolism	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-5662702	Melanin biosynthesis	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-426048	Arachidonate production from DAG	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-111469	SMAC-mediated apoptotic response	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-71262	Carnitine synthesis	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-561048	Organic anion transport	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-114516	Disinhibition of SNARE formation	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-112303	Electric Transmission Across Gap Junctions	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-389599	Alpha-oxidation of phytanate	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-390648	Muscarinic acetylcholine receptors	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-209931	Serotonin and melatonin biosynthesis	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-69478	G2/M DNA replication checkpoint	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-1614517	Sulfide oxidation to sulfate	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	1.00000000002475	2.47521807523863e-11	5	0	0	632	10285
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	1.00000000002495	2.49550064849654e-11	17	0	0	632	10285
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	1.00000000002495	2.49550064849654e-11	17	0	0	632	10285
R-HSA-2033519	Activated point mutants of FGFR2	1.00000000002495	2.49550064849654e-11	17	0	0	632	10285
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	1.00000000002495	2.49550064849654e-11	17	0	0	632	10285
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	1.00000000002495	2.49550064849654e-11	17	0	0	632	10285
R-HSA-192456	Digestion of dietary lipid	1.00000000002495	2.49550064849654e-11	17	0	0	632	10285
R-HSA-622312	Inflammasomes	1.00000000002495	2.49550064849654e-11	17	0	0	632	10285
R-HSA-1482922	Acyl chain remodelling of PI	1.00000000002495	2.49550064849654e-11	17	0	0	632	10285
R-HSA-156711	Polo-like kinase mediated events	1.00000000002495	2.49550064849654e-11	17	0	0	632	10285
R-HSA-3296482	Defects in vitamin and cofactor metabolism	1.00000000002495	2.49550064849654e-11	17	0	0	632	10285
R-HSA-3232118	SUMOylation of transcription factors	1.00000000002495	2.49550064849654e-11	17	0	0	632	10285
R-HSA-73884	Base Excision Repair	1.00000000002516	2.51613028379528e-11	37	0	0	632	10285
R-HSA-73933	Resolution of Abasic Sites (AP sites)	1.00000000002516	2.51613028379528e-11	37	0	0	632	10285
R-HSA-5619115	Disorders of transmembrane transporters	1.00000000002594	2.59385896401639e-11	76	0	0	632	10285
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-194002	Glucocorticoid biosynthesis	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-163765	ChREBP activates metabolic gene expression	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-189085	Digestion of dietary carbohydrate	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-425986	Sodium/Proton exchangers	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-1300642	Sperm Motility And Taxes	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-110357	Displacement of DNA glycosylase by APEX1	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-162592	Integration of provirus	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-1462054	Alpha-defensins	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-75094	Formation of the Editosome	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-2428933	SHC-related events triggered by IGF1R	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-419771	Opsins	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-193697	p75NTR regulates axonogenesis	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-196025	Formation of annular gap junctions	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-428543	Inactivation of Cdc42 and Rac	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-390696	Adrenoceptors	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-2214320	Anchoring fibril formation	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-166665	Terminal pathway of complement	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-2453864	Retinoid cycle disease events	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-2474795	Diseases associated with visual transduction	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-2179392	EGFR Transactivation by Gastrin	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-1296052	Ca2+ activated K+ channels	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-8854691	Interleukin-19, 20, 22, 24	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-72200	mRNA Editing: C to U Conversion	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-428890	Role of Abl in Robo-Slit signaling	1.00000000002686	2.68639835442514e-11	9	0	0	632	10285
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	1.00000000002705	2.70471494346631e-11	39	0	0	632	10285
R-HSA-6783310	Fanconi Anemia Pathway	1.00000000002705	2.70471494346631e-11	39	0	0	632	10285
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	1.00000000002705	2.70471494346631e-11	39	0	0	632	10285
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	1.00000000002732	2.73242492566046e-11	57	0	0	632	10285
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	1.00000000002804	2.80376101849212e-11	21	0	0	632	10285
R-HSA-5423646	Aflatoxin activation and detoxification	1.00000000002804	2.80376101849212e-11	21	0	0	632	10285
R-HSA-5654688	SHC-mediated cascade:FGFR1	1.00000000002804	2.80376101849212e-11	21	0	0	632	10285
R-HSA-69618	Mitotic Spindle Checkpoint	1.00000000002804	2.80376101849212e-11	21	0	0	632	10285
R-HSA-210745	Regulation of gene expression in beta cells	1.00000000002804	2.80376101849212e-11	21	0	0	632	10285
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	1.00000000002804	2.80376101849212e-11	21	0	0	632	10285
R-HSA-933541	TRAF6 mediated IRF7 activation	1.00000000002938	2.93828987650908e-11	35	0	0	632	10285
R-HSA-5693537	Resolution of D-Loop Structures	1.00000000002938	2.93828987650908e-11	35	0	0	632	10285
R-HSA-380108	Chemokine receptors bind chemokines	1.00000000003149	3.14860617128683e-11	48	0	0	632	10285
R-HSA-68884	Mitotic Telophase/Cytokinesis	1.00000000003161	3.16074940180414e-11	15	0	0	632	10285
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	1.00000000003161	3.16074940180414e-11	15	0	0	632	10285
R-HSA-156581	Methylation	1.00000000003161	3.16074940180414e-11	15	0	0	632	10285
R-HSA-211935	Fatty acids	1.00000000003161	3.16074940180414e-11	15	0	0	632	10285
R-HSA-205043	NRIF signals cell death from the nucleus	1.00000000003161	3.16074940180414e-11	15	0	0	632	10285
R-HSA-111447	Activation of BAD and translocation to mitochondria	1.00000000003161	3.16074940180414e-11	15	0	0	632	10285
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	1.00000000003161	3.16074940180414e-11	15	0	0	632	10285
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	1.00000000003161	3.16074940180414e-11	15	0	0	632	10285
R-HSA-69183	Processive synthesis on the lagging strand	1.00000000003161	3.16074940180414e-11	15	0	0	632	10285
R-HSA-69298	Association of licensing factors with the pre-replicative complex	1.00000000003161	3.16074940180414e-11	15	0	0	632	10285
R-HSA-6785631	ERBB2 Regulates Cell Motility	1.00000000003161	3.16074940180414e-11	15	0	0	632	10285
R-HSA-3371568	Attenuation phase	1.00000000003161	3.16074940180414e-11	15	0	0	632	10285
R-HSA-917977	Transferrin endocytosis and recycling	1.0000000000321	3.2095998379307e-11	30	0	0	632	10285
R-HSA-157858	Gap junction trafficking and regulation	1.0000000000321	3.2095998379307e-11	30	0	0	632	10285
R-HSA-420092	Glucagon-type ligand receptors	1.0000000000321	3.2095998379307e-11	30	0	0	632	10285
R-HSA-8863795	Downregulation of ERBB2 signaling	1.0000000000321	3.2095998379307e-11	30	0	0	632	10285
R-HSA-5669034	TNFs bind their physiological receptors	1.0000000000321	3.2095998379307e-11	30	0	0	632	10285
R-HSA-1461957	Beta defensins	1.00000000003222	3.22160867038626e-11	42	0	0	632	10285
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	1.00000000003412	3.4118877201449e-11	40	0	0	632	10285
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	1.00000000003412	3.4118877201449e-11	40	0	0	632	10285
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	1.00000000003433	3.43295053909661e-11	61	0	0	632	10285
R-HSA-5610783	Degradation of GLI2 by the proteasome	1.00000000003433	3.43295053909661e-11	61	0	0	632	10285
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	1.00000000003433	3.43295053909661e-11	61	0	0	632	10285
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	1.00000000003499	3.4994438323257e-11	60	0	0	632	10285
R-HSA-5619084	ABC transporter disorders	1.00000000003608	3.60801727336064e-11	69	0	0	632	10285
R-HSA-169911	Regulation of Apoptosis	1.0000000000364	3.64008048107181e-11	54	0	0	632	10285
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	1.00000000003807	3.80667624793915e-11	31	0	0	632	10285
R-HSA-180786	Extension of Telomeres	1.00000000003807	3.80667624793915e-11	31	0	0	632	10285
R-HSA-1839124	FGFR1 mutant receptor activation	1.00000000003807	3.80667624793915e-11	31	0	0	632	10285
R-HSA-5654733	Negative regulation of FGFR4 signaling	1.00000000003807	3.80667624793915e-11	31	0	0	632	10285
R-HSA-6790901	rRNA modification in the nucleus and cytosol	1.00000000003867	3.86653599073384e-11	62	0	0	632	10285
R-HSA-5678895	Defective CFTR causes cystic fibrosis	1.00000000003867	3.86653599073384e-11	62	0	0	632	10285
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	1.00000000003899	3.89927401654095e-11	52	0	0	632	10285
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	1.00000000003899	3.89927401654095e-11	52	0	0	632	10285
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	1.00000000003899	3.89927401654095e-11	52	0	0	632	10285
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	1.00000000003899	3.89927401654095e-11	52	0	0	632	10285
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	1.00000000003924	3.9243857734013e-11	56	0	0	632	10285
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	1.00000000003924	3.9243857734013e-11	56	0	0	632	10285
R-HSA-209776	Amine-derived hormones	1.00000000003939	3.93907772974004e-11	18	0	0	632	10285
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	1.00000000003939	3.93907772974004e-11	18	0	0	632	10285
R-HSA-210993	Tie2 Signaling	1.00000000003939	3.93907772974004e-11	18	0	0	632	10285
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	1.00000000003939	3.93907772974004e-11	18	0	0	632	10285
R-HSA-1482925	Acyl chain remodelling of PG	1.00000000003939	3.93907772974004e-11	18	0	0	632	10285
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	1.00000000004048	4.04756669803808e-11	43	0	0	632	10285
R-HSA-1236394	Signaling by ERBB4	1.00000000004048	4.04756669803808e-11	43	0	0	632	10285
R-HSA-6799198	Complex I biogenesis	1.00000000004114	4.1139015802553e-11	51	0	0	632	10285
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	1.00000000004114	4.1139015802553e-11	51	0	0	632	10285
R-HSA-1461973	Defensins	1.00000000004114	4.1139015802553e-11	51	0	0	632	10285
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	1.00000000004114	4.1139015802553e-11	51	0	0	632	10285
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	1.00000000004162	4.16159075248388e-11	73	0	0	632	10285
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	1.00000000004301	4.30135635879918e-11	25	0	0	632	10285
R-HSA-389661	Glyoxylate metabolism and glycine degradation	1.00000000004301	4.30135635879918e-11	25	0	0	632	10285
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	1.00000000004301	4.30135635879918e-11	25	0	0	632	10285
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	1.00000000004301	4.30135635879918e-11	25	0	0	632	10285
R-HSA-1251985	Nuclear signaling by ERBB4	1.00000000004301	4.30135635879918e-11	25	0	0	632	10285
R-HSA-5654700	FRS-mediated FGFR2 signaling	1.00000000004301	4.30135635879918e-11	25	0	0	632	10285
R-HSA-6803157	Antimicrobial peptides	1.00000000004308	4.30751498036172e-11	97	0	0	632	10285
R-HSA-1222556	ROS, RNS production in phagocytes	1.0000000000431	4.30989090457278e-11	33	0	0	632	10285
R-HSA-5654726	Negative regulation of FGFR1 signaling	1.0000000000431	4.30989090457278e-11	33	0	0	632	10285
R-HSA-5656169	Termination of translesion DNA synthesis	1.00000000004411	4.41076350062135e-11	34	0	0	632	10285
R-HSA-5654727	Negative regulation of FGFR2 signaling	1.00000000004411	4.41076350062135e-11	34	0	0	632	10285
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	1.00000000004411	4.41076350062135e-11	34	0	0	632	10285
R-HSA-180585	Vif-mediated degradation of APOBEC3G	1.00000000004416	4.41550391680255e-11	55	0	0	632	10285
R-HSA-5685942	HDR through Homologous Recombination (HRR)	1.0000000000452	4.51954469093392e-11	68	0	0	632	10285
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	1.0000000000452	4.51954469093392e-11	68	0	0	632	10285
R-HSA-180534	Vpu mediated degradation of CD4	1.00000000005102	5.10242443794073e-11	53	0	0	632	10285
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	1.00000000005102	5.10242443794073e-11	53	0	0	632	10285
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	1.00000000005465	5.4653871930912e-11	64	0	0	632	10285
